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Abstract 
This thesis is divided into three main chapters. A general introduction including 
the results from the successful direct arylation of oxazoles forms the first chapter. 
The second chapter highlights our results of the useful direct arylation of 2H-
indazoles, which was developed using our previously identified conditions. 
Finally, the third chapter describes our efforts towards the total synthesis of the 
cyclic polyoxazole natural product, mechercharmycin A. 
The functional isation of heteroaromatic compounds by transition metal (TM) 
catalysed C-C bond formation complements classic condensation chemistry as a 
strategy for poly-functional heteroaromatic synthesis. Whereas classic 
heterocyclic synthesis frequently involves the preparation of appropriately 
substituted acyclic precursors which undergo cyclo-condensation as a final step, 
TM-catalysed cross couplings offer the possibility of taking the parent, 
commercially available heteroarenes and selectively functionalising the C-H 
bonds around the heteroarene nucleus. Whilst the condensation route is generally 
reliable and built upon many years of literature precedent, the preparation of the 
appropriately substituted precursor is necessarily multi-step and the subsequent 
condensation is usually carried out under forcing conditions. The TM-catalysed 
approach offers significant advantages of speed and synthetic expediency in 
comparison, along with the potential for mild C-C bond forming reaction 
conditions. 
Importantly, the cross-coupling route enables the introduction of diversity at a 
late stage, rather than the early stage mandated by the condensation approach, a 
strategic advantage in the type of intensive analog synthesis required by 
contemporary medicinal and agrochemical chemistry. 
The TM-catalysed approach becomes even more attractive if direct arylation can 
be incorporated as a C-C bond forming reaction. Here, the stoichiometric 
metallation required for classic cross-couplings such as the Suzuki-Miyaura, 
Stille and Negishi reactions is dispensed with, in favour of direct C-H bond 
functional i sati on. Reported in this thesis is the preparation of assorted 2,5-
diaryloxazoles as well as 2,3-diarylindazoles using TM-catalysed chemistry. The 
oxazole and indazole heteroarene structures have widespread application in 
medicinal, agrochemical, natural products and materials chemistry. 
We have taken our methodology further and subsequently investigated the 
potential of direct arylations on oxazoles, targeting challenging molecules such as 
mechercharmycin A, a cytotoxic natural product. 
Chapter 1. 
General Introduction and Direct 
Arylation of Oxazoles 
13 
1.1 Introduction 
1.1.1 Oxazole 
Oxazole is a five membered it-electron excessive aromatic heterocyclic compound 
with a nitrogen atom in the 3-position and an oxygen atom in the 1-position (Figure 
1). The 2-position of oxazole is partially electropositive due to the electronegativity 
of the neighbouring heteroatoms making it the most acidic (pKa -20) in the 
molecule, followed by the 5-position and least acidic, the 4-position. The 5-position 
in addition, is reactive towards electrophilic substitution reactions as it is very 
electron rich.' It was over 100 years ago that the first oxazole has been reported, the 
oxazole literature has since then continuously grown and oxazole related publications 
can now be found in many areas of chemistry such as medicinal chemistry, materials 
science as well as natural products. 2-5  Oxazole itself is a liquid at room temperature 
and has a boiling point of 69°C. 
Figure 1. 1,3-Oxazole and its numbering.' 
Naturally occurring oxazoles used to be considered very rare until about 20 years 
ago, when several natural products such as the calyculins, hennoxazoles and 
ulapualides were isolated from marine organisms.6 In nature, oxazoles are assembled 
using either a serine or a threonine moiety as the key structural motif for biosynthesis 
(Scheme 1).7  Examples of this biosynthesis include microcin, epothilone D (both 
thiazole) and sulfomycins I-Ill (oxazole).'-" 
The lone pair of a base such as histamine abstracts the hydrogen on the acidic 
hydroxyl group, which in turn then attacks the carbonyl carbon of the peptide moiety 
in an intramolecular fashion (Scheme 1). A second removal of a hydrogen atom, this 
time on the nitrogen of the previously formed 5-membered ring, ultimately 
eliminates water from the reaction. The then formed intermediate undergoes an 
14 
enzymatic oxidation to generate the oxazole, substituted at the 2- and 4-positions. In 
the case of threonine the 5-position is substituted with a methyl group, in the case of 
serine it remains vacant. Oxazole is a weak base with a pKa of 0.8 (conjugate acid), 
compared to a pKa of 7 for imidazole.1  
-\ 	0 
R3 H 
3 
-2H, 2e- 	Rl R2 	
B 
R3 
Oxazole 
-H20 
- R 
R3 4 
0 
Oxazoline 
Scheme 1. The in vivo pathway (ribosomal) to generate oxazoles.7 
In addition to the amino acid biosynthetic pathway there has been an increasing 
amount of data suggesting a possible non-ribosomal (non-amino acid) biosynthetic 
pathway in the biosynthesis of marine derived oxazoles. Uemura et al. have 
investigated a possible Beckmann rearrangement of u,13-unsaturated  oximes or a-
formyl 
CHO 	
Beckmann 
r ement 	0 earrang 	
H- 
0 
6 	 7 	 8 
Scheme 2. Possible non-amino acid pathway for the biosynthesis of marine 
derived oxazoles.1' 
In 2005 the group was able to publish a Beckmann rearrangement using 
cyclododecanone. Treatment of the ketone with trimethyl orthoformate and 
15 
BF3.OEt2, followed by oxime formation gave a-formyl ketoximine dimethyl acetal. 
Heating this compound with PPA in toluene afforded the oxazole in an excellent 
yield." A one-step procedure was also developed but showed a significant drop in 
isolated yields of the corresponding oxazole. Several other oxazole analogues have 
been synthesised in this manner; this research provided the first experimental results 
to support the non-amino acid pathway of oxazoles. Investigations into the 
elucidation of this biogenesis of oxazoles remain an interesting topic. We have yet to 
fully understand and experimentally prove that this approach is indeed possible in 
nature. 11 
Spectroscopically, oxazole and its analogues have characteristic resonances in the 1 H 
NMR as well as the '3C NMR. 1,3-Oxazole itself resonates between 7.00 ppm and 
8.00 ppm in the proton spectrum. Substituents on one of the three carbons can 
produce chemical shifts of up to a full ppm. Resonances in the carbon spectrum are 
typically in the aromatic region ranging from 125.4 ppm for C4 in the unsubstituted 
1,3-oxazole up to 161.1 ppm for C2 with a sulfur substituent (S-CH3) attached .2 The 
parent 1,3-oxazole also shows absorbances in the JR and UV analysis has its 2Iax  at 
205 nm in methanol. Oxazoles continue, after more than a century, to be of great 
interest in synthetic chemistry. 
1.1.2 Synthesis of Oxazoles 
Many different approaches to synthesise oxazoles have been communicated in the 
past and present literature. The decision of which approach is chosen for a synthesis 
depends highly on the desired substitution pattern of the target oxazole compound. 
One of the earliest syntheses of 2,5 -di substituted oxazoles is the Robinson-Gabriel 
synthesis. The Robinson-Gabriel method is the reaction of 2-acylamino-ketones to 
oxazoles via a dehydration in acidic medium. Generally concentrated sulphuric acid 
can be used as a dehydrating agent but phosphorus-oxychloride has been shown to 
have similar effects. The 2-acylamino-ketones utilised in this transformation can be 
obtained via the Dakin-West reaction. 12-14 
16 
a 	H2SO4  
RNAR1 -H20 
	
R2 
H 	 R1 
9 10 
Scheme 3. The Robinson-Gabriel synthesis of oxazoles. 12 
A more recent application of the Robinson-Gabriel synthesis by Pulici et al. sees the 
use of solid-supported resins in combination with trifluoroacetic anhydride to 
generate functionalised oxazoles. 15 
R1C(0)C(0)K, 5 eq., 	 Acylchioride, 
AcOH cat 	 DIPEA, 
DCM 
C1 SH 10 
0-NH2 
3q 0-NH Me 
Rink amide 
11 	 12 
TFA/DME 
24hrs, r.t. 
Ph 
0_N Me 	 1°me 
13 
	
14 
Scheme 4. Trifluoroacetic anhydride-mediated solid-phase version of the 
Robinson Gabriel synthesis of oxazoles. 15 
Early procedures to generate oxazoles also included the oxidation of oxazolines. 
Nickel peroxide has been shown to be an efficient reagent for the oxidation of 
activated oxazolines containing an electron-withdrawing group, such as esters for 
example. 16  The Ni02 method was originally reported by Meyers and Evans and still 
to this day, remains one of the most widely used methods to generate oxazoles, even 
with the advent of other, newer methodologies. 17  The oxidation of oxazolines to 
oxazoles is a heterogeneous process in which the starting material is refluxed in 
benzene with excess of Ni02. This methodology was used in the synthesis of 
eupolauramine and provided the oxazole product 16 from an inactivated oxazoline 15 
in a modest 55 % isolated yield.18 In addition to Ni02, other oxidants can be used to 
generate oxazoles. Reagents such as Mn02 and copper salts such as CuBr2 have been 
shown to promote the formation of oxazole with high efficiencies. 11-2'  Table 1 
17 
highlights several reactions and conditions used to generate substituted oxazoles 
from oxazoline precursors. 
Table 1. Oxidation of oxazolines to oxazoles. 
R1 	N 
R2 	 "~r 
- 
o 	
R2 
15 	 16 
Entry R' R2 R3 Yield (%) 
 C6H5 CH2CN 4-CH3S-C6H4 
54a 
 C6H5 CH2000C6H5 4-CH3S-C6H4 40a 
 C6H5 CO,Me H 55b 
 C6H5CH=CH CO2Me H 6 
lb 
V) iPr CO2Me H 76c 
Vi) C-C61-111 CO2Me H 6E7]  
a = CuBr2 / LiBr / CaCO3, b = nickel peroxide, c = NBS 
Further, BrCCI3 / DBU has been reported to oxidise oxazolines in a similar fashion. 
This reaction does not involve a metal-based oxidation, but works via halogenation 
of the oxazoline followed by a dehydrohalogenation to give an overall net oxidation. 
Williams et al. have used this method with high efficiency in their attempt to 
generate bis-oxazoles.26 
	
COOMe BrCCI3 	COOMe 
N 	DBU 
J6 	 1 75% 
17 	 18 
O_<NV
DBU COOMe 0 :'
BrCCI3 	0_JNVCOOMe 
N O 	 87% 7N 0 
19 20 
Scheme 5. Use of BrCCI3 in the oxidation of oxazolines to oxazoles.26 
W. 
Another strong and highly mentionable classic synthesis of oxazoles is the Fischer 
synthesis of oxazoles, developed by Fischer et al. in 1896.27  The reaction involves 
the use of an aldehyde and cyanohydrins in acidic medium (anhydrous HC1) and 
ether as solvent. This approach is another one-step condensation reaction, 
complementary to the Robinson-Gabriel approach to generate 2,5-disubstituted 
oxazoles (Scheme 6).2728 
OH 
	
	 HCI 	N_fPh 
Ph N + PhyH ether Ph 0  
0 
21 	 22 	 23 
Scheme 6. Fischer synthesis of oxazoles using hydrochloric acid in ether. 
27,28 
An approach via a condensation of an aromatic acid chloride with 2-
bromoethylamine hydrobromide in benzene utilising five equivalents of 
triethylamine followed by treatment of the intermediate with N-bromosuccinamide 
(NBS), carbon tetrachloride and azabisisobutyronitrile (AIBN) seems very feasible if 
the five position is to be substituted. With this approach, the 4-position of the 
oxazole remains vacant for possible further modifications. 29 
I\ 
CKO 	 NN O 	NBS,AIBN NN 0 Et3N 	 cci4 
+ 	Br 	
N H 3 	
benzene 	 reflux 
Br 	24 h, reflux 12 hrs 
G 67% 	 56% 
24 	 25 	 26 	 27 
Scheme 7. Two step oxazole formation.29 
There are also more modern, and sometimes higher yielding TosMIC 
(toluenesulphonylmethyl isocyanides) reactions to be found in the literature.30 This 
method, developed by the Dutch chemist van Leusen, involves the use of an 
aldehyde (such as benzaldehyde, or any other substituted benzaldehyde analogue), 
which is treated with ammonium hydroxide, piperazine and THF to generate imines, 
19 
which give oxazoles substituted at the 5-position in high yields (see results and 
discussion for more details on this reaction).31  
0 C1 	 1rN 
NH4OH 	O) 
)+ TosMIC piperazine, THF 
24 	28 	
29 
Scheme 8. Reaction using T0sMIC to generate 5-substituted oxazole.30'3' 
Another very broadly applied pathway to oxazoles is the synthesis from peptide 
precursors. Scheme 9 shows the two-step synthesis of a 2,4-di substituted oxazole via 
dehydration (in this case using Burgess' reagent), followed by the oxidation of the 
obtained intermediate using BrCCI3 and DBU as the base. 32 
	
HO 	
0 	Burgess reagent 
IN AR II 	H 
0 
30 
R 
N 	
BrCCI3 
R 
0 
DBU 
0 
OMe OMe 
31 32 
Scheme 9. Two step procedure to form 2,4-disubstituted oxazoles.32 
Another classical condensation approach to form the oxazole framework is a 
modification of the well-known Robinson-Gabriel synthesis. 33  The Hantzsch oxazole 
synthesis employs a benzamide (with varying substitutents on the aromatic ring to 
generate diversity for the starting materials) as well as chloro-acetaldehyde (highly 
toxic), acetic anhydride and in addition, elevated temperatures. Yields for these 
classic condensation transformations are generally found to range from 30 % up to a 
maximum of 60 % due to polymer formation and the extreme reactivity of the 
chloroacetaldehyde. 
20 
I — \ 
ONH2 	 NO 
a H 	---------- Ac20 heat 
33 	34 
	
35 
Scheme 10. Synthesis of 2-aryl substituted oxazoles via condensation 
reaction. 33 
For further examples and a list of several other miscellaneous methods to generate 
oxazoles up to the year 2003, refer to Palmer's book on oxazoles in reference 2, part 
A, chapter one.2 
11.3 Oxazoles in Natural Products 
Over the last two decades several oxazole containing natural products have been 
isolated and many of these isolated natural products show interesting biological 
activities such as antitumor, peripheral analgesic, antibacterial, antileukemic, 
antifungal as well as antiviral activities. 34-36  The general interest in oxazoles and 
therefore also in the functionalisation of these compounds has increased immensely 
and more synthetic efforts have been directed towards oxazole containing natural 
products in recent years.37'38 A review highlighting recent advances in the total 
syntheses of oxazole containing natural products has been published and provides an 
excellent overview. 39 Given the availability of this thorough review, we will focus 
solely on the structures of the oxazole containing natural products and will highlight 
the key step involving the oxazole core for the selected synthesis. 
21 
Figure 2. Structure of texaline.40 
The number of oxazole moieties in natural products can vary widely. Single oxazole 
containing structures such as texaline (36) (Figure 2) are known, as well as 
bisoxazoles, such as hennoxazoles, in which the oxazoles are connected directly to 
each other. Texaline, shown above, is a rare example of a 2,5-disubstituted oxazole. 40 
As mentioned above, one of the more prominent and potent bis-oxazole natural 
products in which large amounts of synthetic effort has been invested is (-)-
hennoxazole A, an antiviral compound. Hennoxazoles are 2,4'-bis-oxazole-
containing structures; they exhibit very good biological activity against the herpes 
simplex virus 1 (HSV-1) and in addition possess peripheral analgesic activity which 
is comparable to the one of indomethacin.41 
OH 
OMe 
IN 	0 
4b6e H~ 
-> 
37 
MeO2C\ 
OTIPS 
OqMe 
NH2 + 
OH 
OH 
38 
Scheme 11. (-)-Hennoxazole A and a key retrosynthetic step.43 
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Hennoxazole A was first isolated from PloyjIbrospongia sp., by Scheuer and co-
workers and synthesised via a convergent approach by Yokokawa et al. in 2000, one 
of many reported total syntheses of this compound .42'43 The key step in this total 
synthesis is a diastereoselective Mukaiyama aldol reaction. As previously described, 
the formation of the oxazole rings, which are linked together in a 2,4-fashion, was 
achieved using peptide chemistry (Scheme 11), followed by an oxidation of the 
cyclic oxazoline intermediate to the oxazole. 
In addition, di-oxazole structures have been isolated in which the oxazoles are not 
directly coupled to each other, usually two carbons apart. Examples of this type of 
oxazole natural product are siphonazole (Figure 3) or the synthetically more 
challenging diazonamide A (Scheme 12). Recently Moody and Linder have disclosed 
their synthetic efforts towards the very interesting di-oxazole containing natural 
product, siphonazole.44 
NN 
MeO"'H 	 40 
	0 
Figure 3. Structure of siphonazole.44 
It is an interesting synthesis because of the way the oxazoles were generated. Unlike 
most other syntheses of oxazoles, Moody chose a rhodium carbene condensation 
reaction instead of the classical amino-acid approach. Both oxazole rings in this 
natural product were constructed using rhodium"-carboxylates and diazocarbonyl 
reagents. The natural product was formed in an impressive ten steps using this non-
traditional approach to oxazole synthesis. 
A further prominent natural product, containing a pair of oxazoles, has been 
synthesised by several groups around the globe. Diazonamide A, an anticancer agent 
23 
and a bis-oxazole compound, isolated from a marine species found in the Philippines, 
has been synthesised twice (1st  and 2' approach) by Nicolaou and co-workers in an 
impressive fashion. 45,46 
H HNN 	N 
I 
 C1 
N' 	NH 
	I 
41 
H 	
0 H 
N N  CbzH ,, 
N H 
	
1 1, 	 Br 
NHLJ 
OBoc 
42 
') BocHNN OBn 
oJ'  
43 
Scheme 12. The structure and proposed retrosynthesis of diazonamide A 
based on Nicolaou's work.45'46 
The key step to form one of the two oxazole moieties in Nicolaou's second approach 
is a typical condensation / dehydration sequence as seen many times before and 
further discussed in this thesis. In this rather complex molecule however, the yield 
obtained was only 16 %. This yield can interestingly be directly compared to the 
yield of the formation of the first oxazole in diazonamide A (at the 3-position of 
indole) which was generated earlier in the synthesis in an impressive 88 % yield 
using similar conditions but on a very small, non-sterically hindered molecule at an 
earlier stage of the synthesis. This loss of yield is typical for these condensation 
reactions on larger, more sterically hindered molecules. It is also one of many 
reasons why a methodology, which does not involve the generation of these azoles in 
that fashion, would be very useful and of great value to the synthetic chemist. The 
harsh conditions usually employed in these dehydration / oxidation sequences could 
24 
very well be inappropriate should sensitive functional groups exist in the starting 
materials. 
In addition to the above work from Nicolaou's group, other groups have published 
their synthetic efforts towards the synthesis of diazonamide A in the peer-review 
literature. Harran's as well as Magnus' group have both communicated their 
approaches towards this exciting structure. 47,48  Harran's synthetic efforts produced an 
alternative structure for the natural product, revising the original structure proposed 
via X-ray analysis. 
Oxazole-containing structures come in all shapes and forms, some of them, such as 
telomestatin (Figure 4), presenting up to seven linked oxazoles in a cyclic form. 
Telomestatin, a marine natural product isolated from Streptomyces anulatus is known 
to act as a telomerase inhibitor. 49 
0 
/ZzJN>IT)—CH3 
NCH 
o 
N Y,  
I 
0 
44 
Figure 4. Structure of telomestatin, a potent telomerase inhibitor.49'50 
Telomestatin was first synthesised by Takayuki et al. in 2006 via a set of 
condensation reactions mimicking its biosynthetic pathway. 50  It should be noted that 
it's total synthesis had been reported prior to this 2006 publication but only in a 
patent by Taiho Pharmaceutical Co. Ltd. in 2002.' 
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Scheme 13. Synthesis of key-fragment in the total synthesis of 
telomestatin.50 
Doi's total synthesis of (R)-telomestatin commences with the oxidation of the 
secondary alcohol of the dipeptide 45, followed by a cyclodehydration with PPh3-12 
in the presence of Et3N. This sequence provided 46 in a respectable yield of 73 %. 
Hydrolysis of the ester to the acid, using LiOH, followed by coupling of the acid 
with the free amine 47 afforded bis-oxazole amide 48. Another cyclodehydration, 
this time using Burgess' reagent, followed by BrCC13-DBU treatment of 48 gave 
Cys-containing tris-oxazole 49 in 75% yield. 
The bio-mimetic synthesis to obtain these poly-oxazoles is to this date the most 
applied method and generally used by synthetic chemists. Starting materials are 
amino acids and peptides and the reactions follow a very general condensation I 
oxidation pattern. Examples of this approach are many, and compounds such as (-)- 
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hennoxazole A, (R)-telomestatin as well as mechercharmycin A (Figure 33, vide 
infra) have been generated via this approach.50'52 
Other poly-oxazole and mono-oxazole natural products exist and have been 
synthesised. A group of Streptogramin antibiotics are representatives of the mono 
2,4-disubstituted oxazole core. Virginiamycin M2, griseoviridin and madumycin II 
are 	all 2,4-di substituted oxazole containing molecules and syntheses of these 
structures have been reported (Figure 5). 53-55 
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Figure 5. Structures of three group A Streptogramin antibiotics.5355 
Even though the vast majority of oxazole containing natural products are 2,4-
disubstituted as in the examples seen above, there are a few cases of other 
substitution patterns, namely mono-substituted, 2,5 -di substituted as well as tn-
substituted oxazoles such as the previously discussed diazonamide A. 
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Further, one can clearly see that most of the approaches to oxazole-formation in 
natural products, with a few interesting exceptions, have utilised classic cyclisation / 
oxidation or oxidation / condensation methods. Several other poly-oxazole 
containing natural products are discussed in more detail in the final chapter of this 
thesis. 
1.1.4 Oxazoles in Medicinal Chemistry 
Oxazoles have also gained interest in industrial settings as more and more medicinal 
chemists are employing heteroaromatic compounds in the never ending quest for 
biologically active synthetic drugs and new chemical entities (NCE). Patent 
applications involving the oxazole core are not rare; reasons for this raised interest in 
azoles in general are the donor-acceptor (Lipinski's rule of five) abilities that 
oxazoles, imidazoles, thiazoles and others such as isoxazoles or pyrazoles, have to 
offer.56'57 A few oxazole containing molecules have already managed to be marketed, 
the anti-inflammatory and analgesic 2-diethylamino-4,5-diphenyloxazole is one of 
them (Figure 6).58 
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Figure 6. 2-Diethylamino-4,5-diphenyloxazole, an anti-inflammatory drug.58 
A further synthetic oxazole that has managed to appear on the market is 
zoxazolamine (Figure 7), a sedative and muscle relaxant, mechanism of action of 
which is not understood. Though it is no longer used, as it exhibits hepatic 
cytotoxicity, it is now a model substrate frequently used in studies on 
(methylcholanthrene-inducible) hepatic cytochrome P-450 activity. 59 The studies 
using zoxazolamine simply determine possible changes in oxidative enzyme activity 
on a pharmacological basis. 
CI 	N 
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Figure 7. Zoxazoleamine, a synthetic muscle relaxant.59 
From a medicinal chemistry standpoint, oxazoles have also gained popularity due to 
better and more effective methods to modify and / or generate them. Functional 
group transformations as well as the fairly new approach (as discussed in this thesis) 
of direct arylation have introduced a 'late stage diversification' approach compared 
to the 'classic peptide-condensation methodology' where the substituents around the 
azole ring have to be put in place early in the synthesis. 
Most of the aryl-substituted oxazoles (or thiazole analogues) are also known to be 
highly fluorescent and are commonly used as scintillators and optical brighteners in 
industry. 49  Mori et al. have described the photoluminescence of such compounds in 
detail .60 Their research shows the synthesis of 2,5-di-arylated thiazoles as well as di-
substituted thiophenes via direct arylation and the potential electron-transporting 
characteristics of these compounds, which possibly makes them a useful component 
in LED devices. 
Figure 8. Highly fluorescent 2,5-disubstituted thiazole. 
Mori et al. comment that the manipulation of the substituents on the aryl groups 
highly influences the light emitting characteristics of these compounds, a feature 
which we have also observed during the course of this research .60 
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1.1.5 Lithiation of Oxazole 
Research into the lithiation of oxazole itself could form enough material for a 
complete thesis. It has been the centre of attention for several research groups over 
the years. It has been shown that upon treatment of oxazoles and benzoxazoles with 
strong bases, such as n-butyl-lithium or LHMDS, ring-opening of the oxazole at the 
two-position occurs. 61 
It has been demonstrated by Barrett and Kohrt that oxazole can be deprotonated in 
the 2-position using n-BuLi at low temperatures. 62  The oxazol-2-yllithium could then 
be quenched with iodine to give the product in an excellent 90 % yield. The reaction 
is invaluable as it provides easy access to important oxazoles for the use in transition 
metal catalysed cross coupling reactions as well as many other reactions depending 
on the electrophile used to quench the reactive species which is formed in situ via 
lithiation at low temperatures under inert gas atmosphere (Scheme 14). 
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Scheme 14. The halogenation of oxazole in the 2-position.62 
NMR studies on this phenomenon have been published and suggest an isonitrile 
functional group as well as the lithium salt of the phenoxide. Oxazole is the only one 
of the three 1,3 -azoles (imidazole, thiazole and oxazole) that has been shown to 
exhibit such behaviour under basic conditions. 61 
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Scheme 15. Ring opening of benzoxazole under strongly basic conditions.6' 
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The first publication in this field of oxazole lithiation is a 1968 paper by Bowie et al. 
in which the group generated and observed the 2-lithium oxazole species using 
deuterated water by mass spectrometry. 63,64 
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Scheme 16. First lithiation of 2-unsubstituted oxazole followed by deuterium 
quench. 63,64 
Further investigations into the lithiation of oxazole yielded very interesting results, 
showing an equilibrium between the cyclic and the acyclic form of oxazole, 
depending of the electrophile used. Schroeder and his colleagues showed that when 
using benzaldehyde or as above described deuterium oxide, the 2-substituted oxazole 
was generated in its cyclic form. However, when TMSC1 was used as the 
electrophile, the ring-opened form was observed. 65 
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Scheme 17. Schroeder's ring-opening and ring-closing tautomeric 
equilibrium of oxazole.65 
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Several articles and communications followed this early research describing the 
effects of different electrophiles and substituents on the oxazole, and the role they 
play in generating the cyclic or acyclic products. Vedejs and Luchetta recently 
published a method for the iodination of oxazoles at C4 using 2-lithiooxazoles. 61  
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Scheme 18. Method for the lithiation of oxazoles at C4 via 2-Iithiooxazoles.6 ' 
The authors purposely chose oxazoles, which when treated with a strong lithium 
bases would favour the acyclic valence bond tautomer, making the C4 position more 
readily available for halogenation than the C2 position. The authors further 
commented on their optimisation of the reaction conditions. It was noted that 
interestingly when DMPU was added as a co-solvent, selectivity and reproducibility 
increased and reactions gave up to a 97:3 ratio of 4-iodo-oxazole 66. 
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12 Palladium Catalysis on Oxazoles 
1.21 Traditional Pd-catalysed Cross Couplings on Oxazoles 
Before reviewing the catalytic approaches to C-C bond formation involving 
oxazoles, we would like to point out that, as to be expected, early stage research 
involved equimolar amounts of 'catalysts' and classical reactions such as 
electrophilic substitutions or simple redox chemistry. 66,67  These methods are not 
presented in detail here as this introduction is aimed to give an overview of 
contemporary palladium catalysis on oxazoles. Early oxazole reactions however have 
been collected and reviewed in detail and can be found in Palmer's oxazole book .2 
To this date there has been a limited amount of research directed towards palladium 
catalysed cross coupling reactions on oxazoles. In general there are five traditional 
approaches towards transition metal catalysed carbon-carbon bond formation 
reactions on oxazoles, namely the Negishi coupling (zinc), the Suzuki reaction 
(boronic acids I esters), the Stille (tin), the Sonogashira (alkynes / copper) as well as 
the well known Heck reaction (alkenes). In addition to these reactions, C-N bond 
formation has been accomplished and recently the functionalisation of oxazoles has 
also been achieved using direct arylation methodologies, which will be the main 
focus of this thesis. 
The Negishi coupling uses oxazole (or benzoxazole), which is treated with a strong 
base to deprotonate the 2-position and then subsequent addition of ZnC12 generates 
the 2-chlorozincbenzoxazole species which is known to favor the cyclic form of 
oxazole. 68 The zincate then reacts with triflates (or halogens) such as 1 -naphthalene 
triflate and a Pd°-source at reflux to afford the cross-coupled products. This 
methodology proves very effective and many examples of 2-substituted oxazoles 
have been prepared via this approach (Scheme 19). From the three possible positions 
for the formation of organozinc reagent (on oxazole parent heterocycle), only the 2-
oxazolylzinc species has been successfully prepared and subsequently cross-coupled 
with aryliodides and triflates.68'69 
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Scheme 19. Negishi reaction of benzoxazole using ZnCl2 at low 
temperature S.69 
A more detailed example of the mentioned Suzuki reaction on oxazoles is the 
transformation of 76 with phenylboronic acid to give 77 in 92 % yield. Most attempts 
(also attempted in the Greaney group) of generating 2-oxazolylboronic acids and 
esters have failed due to the probable equilibrium between the cyclic and acyclic 
valence tautomers of the lithiooxazoles which make this position highly reactive and 
in situ formed products prone to decomposition and protodeborenation.1 
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a
~—Ph Ph 
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Scheme 20. Example of a Suzuki coupling involving a substituted 
benzoxazole.70 
Note that the cross coupling was achieved on a bromo-benzene analogue, not 
actually on the oxazole core. More relevant when discussing oxazole C-C bond 
formations is the Suzuki reaction published by the Greaney group in 2006. Using a 
previously synthesised 2-substituted oxazole pseudohalide, a range of aryl boronic 
acids were coupled in excellent yields. 71 
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Scheme 21. Carbon-carbon bond formation using microwave conditions in 
the Suzuki reaction of oxazoles.7' 
Another very prominent reaction of oxazoles is the mild and base free Stille 
reaction. 72 Similar to the Negishi reaction stannanes can be generated via the 
trapping of a previously generated ring-opened oxazol-2-yllithium species with 
tributyl tin chloride. These substrates can then be attached to a range of aryl halo-
compounds (Scheme 22). However, toxicity of the stannane and the generation of 
toxic side products are always a concern when utilising the Stille reaction. 
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Scheme 22. The Stille reaction of benzoxazole to 2-phenylbenzoxazole.72 
One of very few examples of a Sonogashira reaction of oxazoles is Yamanaka's Pd-
catalysed reaction of terminal alkynes with a substituted 4-bromo-oxazole (83) at 
elevated temperatures. Several internal alkynes were synthesised using this 
methodology.73 
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Scheme 23. Yamanaka's et al. approach to internal acetylenes on 
oxazoles.73 
Using the same starting material (83) as for the Sonogashira reaction, Yamanaka also 
coupled electron-deficient terminal alkenes in Heck reactions with moderate yields. 73 
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Scheme 24. Heck reaction of oxazoles performed in the Yamanaka group.73 
To complete the introduction of traditional C-C bond forming reactions on oxazoles 
we also have to look at a C-N bond formation reaction, which has been shown to 
work using oxazoles. This example, one of very few, shows that it is possible to 
couple secondary amines (89) to halo-oxazoles (in this case 2-chioro benzoxazole 
(88)) using palladium catalysis as well as a BINAP ligand (Scheme 25). 74 
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Scheme 25. C-N bond formation reaction on oxazoles via Buchwald's 
catalytic amination.74 
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As one can clearly see there is still a very large area of untouched chemistry in this 
field as a substantial amount of the chemistry developed until today focuses on the 2-
position of oxazole. Most of the examples published used oxazoles with the 4- and 5-
positions blocked, benzoxazole being the prime example. It would therefore be of 
great interest to use the different reactivities of the three carbons in oxazole to 
investigate regioselective modifications of this heterocycle. Recent synthetic 
investigations of groups around the world have targeted the development of new 
cross coupling methods such as the C-H functionalisation of azoles, including the 
oxazole moiety. 
Cross coupling reactions of azoles with two or more heteroatoms have recently been 
reviewed in detail by Stanetty and co-workers.75  
1.2.2 Direct Arylation Cross Couplings 
Direct and selective transformation of C-H bonds to new bonds such as C-C, C-O or 
C-N has always been a goal for organic chemists. 76  Transformations involving C-H 
bonds have great potential, as C-H bonds are found in almost all organic molecules. 
Steroids, terpenes, alkaloids, carbohydrates as well as many other structures such as 
azoles provide many carbon-hydrogen bonds for putative functionalisation via 
transition-metal catalysed direct arylation. It should be noted at this point that in the 
literature the terms C-H bond activation, C-H bond functionalisation, cross-
dehalogenative coupling as well as direct arylation have been used to describe the 
transformation discussed in scheme 26. 
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Traditional cross-coupling reactions via functional group transformations generally 
require an equimolar amount of halide on one of the reactants as well as an 
equimolar amount of metal, such as tin, zinc, copper or magnesium on the other. The 
utilisation of a direct arylation approach eliminates the need for the metal component 
as the C-H bond replaces the metal. This therefore reduces the waste generated and 
eliminates the use of toxic metals such as tin. In addition, the atom economy of the 
reaction is increased immensely as the metal, generally of high molecular weight, is 
replaced by the smallest possible atom, hydrogen. 77 
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Scheme 26. Comparison between traditional and direct arylation sp2 C-C 
bond forming approach. 
Currently the main challenge for the direct arylation of such complex and 
challenging molecules remains to be the regioselectivity. Many examples of direct 
arylations have been reported in the literature to this date, some of the most exciting 
ones are highlighted below. Indoles, pyridines, thiophenes, pyrroles, furans, 
isooxazoles, indolidines, imidazoles, oxazoles and other heterocycles all have been 
shown to be arylated on a C-H bond .78-84  Further the N, S and 0-arylation has 
recently been shown to work via iron-catalysed transformations.85'86 
The field of direct arylation has been reviewed extensively in the last decade. A 
superbly detailed review by Lautens et al. highlights the advances in the area and 
discusses future directions. 87  A further recent review by Miura and Satoh also 
discusses the catalytic direct arylation of heteroaromatic compounds.88 Additional 
reviews have been produced by Labinger and Bercaw, Fagnou, Godula and Sames, 
Sanford and Dick, as well as McGlacken and Bateman. 89-93  Upon reading these 
reviews, the reader can clearly see that the direct arylation of azoles, oxazole and 
pyrazole in particular was a rather untouched field when research into this project 
was commenced in 2006. 
1.2.2.1 General Direct Arylations 
The examples in the section below have been selected to represent the broad and 
diverse applicability of current direct arylation methodologies. 
Before investigating the Pd-catalysed direct arylation of oxazoles the Pd-catalysed 
direct arylation of other aromatic and heteroaromatic compounds is highlighted. In 
the literature, Fujiwara and co-workers are credited with the first true palladium 
promoted direct arylation reaction to form a C-C bond. The authors of this 1969 
publication constructed C-C bonds from arenes and with it, started the field of direct 
functionalisation of aromatic arenes.94 
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Scheme 27. First ever direct arylation / C-H functionalisation (equimolar Pd) 
by Fujiwara et al.94  
Several reports in the following few decades were published on the topic of 
palladium catalysed direct arylation and have recently been reviewed in detail by Shi, 
Yang and Li.95 Much more recent than the Fujiwara report and not included in the 
review is Ackermann and his co-worker's report on the palladium catalysed direct 
arylation of 1 ,2,3-triazoles with aryl-chlorides using conventional heating. 96  In this 
2008 report, N-alkyl and N-benzyl substituted 1,2,3-triazoles were reacted with cheap 
aryl-chlorides to afford fully substituted triazoles. High temperatures as well as a 
Pd(OAc)2 / PCy3 in combination with K2CO3 and toluene provided the products in 
good to excellent yields. Scheme 28 shows a representative example. 
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Scheme 28. Ackermann et al. described the direct arylation of 4-substituted 
1 ,2,3-triazoles.96 
A publication from Bellina et al. was disclosed in 2006 providing insight into the 
direct arylation of NH-free imidazoles.97 The parent heterocycle 105 was arylated in 
the 2-position using a catalytic amount of palladium in combination with two 
equivalents of CuT. DMF as well as forcing 140°C were used to generate a series of 
2-substituted imidazoles. It should be noted that when omitting the CuT, the 
selectivity decreases and 5-arylation can be observed. 97  This is typical for thiazoles 
and imidazoles.75  
Pd(OAc)2 (5% 
Cul (2 eq.) 	 HN 
DMF, 1400C, 48hrs 
105 	106 107 
Scheme 29. Pd and Cu co-catalysed direct arylation of NH-free imidazoles.97 
Doucet and Gottumukkala in 2008 published a palladium catalysed direct C4 
arylation of 2,5 -di substituted furans. The work describes the mono- and di-arylation 
of 2,5-disubstituted furans with aryibromides under elevated temperatures. Blocking 
of the 2- and 5-position of the furans is necessary to circumvent the direct arylation 
on those positions. Diarylation has also been observed by the authors and was 
mentioned as a major problem for this transformation. Use of 0.5% Pd-catalyst as 
well as aryibromides however make this reaction fairly attractive. 98 
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Scheme 30. Doucet's palladium-catalysed direct arylation of 2,5-
disubstituted furans.98  
Also in 2008, Fagnou's research group communicated the direct arylation of azole N-
oxides. Interestingly the N-oxide group dramatically increases the reactivity of all 
positions of thiazoles towards direct arylations. It also changes the weak azole bias of 
CS > C2 to a very consistent C2 > CS > C4. This increased reactivity and 
41 
regioselectivity allows for the stepwise functionalisation and synthesis of a tri-aryl-
substituted thiazole N-oxide. The N-oxide functionality can later be removed by 
deoxygenation.99 
Me 
	
e H 	 Br Pd(0Ac) (5%) 
.-...- 	 PPh3 (15%) 
0'(@ ~'~ ~CX C F o 
+ 	
K2CO3(2 eq.) 
1 -1 el- 	
N 
Me 	PhMe, 11000 
111 	 112 
F3 
113 
 
Scheme 31. Fagnou's N-oxide promoted direct arylation of thiazole.99 
Fagnou's group as well as others have also invested a vast amount of research into 
the regioselective direct functional i sati on of the indole heterocycle, this work has 
recently been reviewed.' 00 The clear highlight of the indole direct arylation to date is 
the oxidative coupling of N-acetyl indole (114) with benzene (99), as reported by 
Fagnou in 2007. The publication describes the coupling of two C-H bonds with each 
other under palladium catalysis with an equimolar amount of oxidant. Scheme 32 
shows this exciting transformation in more detail.101 
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Scheme 32. Fagnou's direct arylation of an indole-analogue using 
benzene.101 
Daugulis and Zaitsev have reported the catalytic coupling of haloolefins with 
anilides. In this highly challenging and interesting transformation the carbonyl group 
acts as a directing group for the electrophilic palladium which inserts into the C-H 
bond. 102 
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Scheme 33. Daugulis' C-H activation of anilides with haloolefins.'°2 
Daugulis also described the palladium catalysed ortho-arylation of heteroaromatic 
biphenyl motives as shown in scheme 34103 
Scheme 34. Daugulis and co-workers ortho-functionalisation using 
palladium. 103 
A further well known example showing the directing group abilities of pyridines, 
isooxazolines, pyrazines and pyrazoles is Sanford's Pd-catalysed ligand directed 
arene acetoylation. Several series of benzyl-substituted compounds including benzyl 
pyridine derivatives were used to generate ortho-functionalised aromatic rings as 
described below. 104 
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Scheme 35. Palladium catalysed ligand directed arene acetoylation.'°4 
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Lastly, the highlight of the year 2009 in terms of direct arylation research is 
presented. Although this is a non-palladium catalysed procedure, I still believe that 
this exciting transformation should be highlighted in this section as it shows the 
strength and impact simple methodology projects can have on the general chemistry 
community. Gaunt and Phipps reported a mew-selective direct arylation using Cu-
catalysis. This is a remarkable discovery of reactivity and undoubtedly complements 
the Pd-catalysed direct arylation methods for the ortho-arylation. Mew-C-H-bond 
cupration via dearomatizing 'oxy-cupration' has been hypothesised to be the key 
mechanistic transformation. 105 
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Scheme 36. Phipps' and Gaunt's Cu-catalysed meta-arylation. 105 
While a base is normally needed for direct arylation reactions, in many cases the 
precise role of the base is unclear. Some new evidence, however, suggests that in a 
few systems the base could be intimately involved in the formation of the 
diarylpalladium' species (and not just as a bystander whose role is to regenerate the 
active catalyst) '°6 Generally, inorganic bases such as K2CO3,  Cs2CO3, KOAc, t-
BuOK and CsOPiv are used and have shown to be effective in multiple cases due to 
increased solubility in organic solvents. Commonly used solvents are DMSO, NMP, 
CH3CN, DMF and DMA, nonpolar solvents such as xylene and toluene have also 
been shown to promote these kinds of transformations. Finally, temperatures of 100 
°C and above are generally used and typical reaction times range from several hours 
to days. '°6 
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1.2.2.2 Direct Arylation of Oxazoles 
The first reported direct arylation of an oxazole analogue is Ohta's reaction of 
oxazole (1) with a chioropyrazine (126), which selectively couples to the 5-position 
of oxazole. The conditions described in this 1992 publication are a potassium base as 
well as Pd(PPh3)4 (5 %) as the catalyst of choice. 107 
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Scheme 37. Ohta's direct arylation of oxazole. 117 
Several years after this communication, Miura et al. provided an arylation of 
benzoxazole with aryl iodides and bromides.108 Useful bases for this transformation 
were reported to be K2CO3  as well as Cs2CO3. The coupling was achieved in DMF as 
a solvent and Pd(OAc)2 (5 %) with PPh3 as catalyst and ligand, respectively. Yields 
for these early transformations were reported to be as high as 95 % when Cul was 
used as a co-catalyst. 108 
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Scheme 38. Miura's report of a direct arylation of benzoxazole.'°8 
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 IN cat. (5 %), ligand 	 29 	 35 
Scheme 39. Early attempts by Miura to achieve regioselectivity gave 
mixtures of three different products.109 
45 
Following these discoveries, the field of direct arylation on oxazoles turned quiet for 
a few years, until Sames' report of an arylation of the parent oxazole heterocycle 
using catalytic amounts of copper. This report was however retracted on June 15th, 
2006. 
Following Miura's 1998 discoveries, only three reports until 2006 were 
communicated in the peer-reviewed literature. In 2003, a report again by Miura on 
the arylation of thiazoles appeared in the literature. This report included, next to 
several thiazole arylations, a palladium catalysed direct arylation on a di-substituted 
oxazole. 110 
Br 	Pd(OAc)2 
Ph..rN 	+ 	 P(biphenyl-2-yI)(t-Bu2)2 	PhN 
O 
Cs2003/o-xy1ene 	
0Ph 4,  
CONHPh 	 reflux, 48 h, 33 % Ph 
128 	 129 	 130 
Scheme 40. Generation of a tri-phenyl oxazole via direct arylation.110 
It is noteworthy that the starting material does not contain two phenyl groups, but 
rather has them introduced in the direct arylation step. It seems that the amide acts as 
a directing group to coordinate palladium and therefore brings the aryl-bromide 
(post-oxidative addition onto the Pd) in proximity of the 4-position, which is known 
to be notoriously unreactive towards any direct arylation conditions. Miura does not 
further comment on the loss of the amide functionality on the 5-position or any 
directing effect of the NH-functionality. 
A year later, Mori and colleagues reported a direct arylation of thiazoles in DMSO, 
and Hoarau and co-workers presented a study on the regioselectivity of direct 
arylations on ethyl-4-oxazolecarboxylate (134) investigating a number of ligands and 
palladium sources. III 
COOEt 
PdC12(dppb) (3 %) 	 / \ 
S 	 + 	 Ag F (2 eq 
DMSO, 60°C 
OMe COOEt 5h,58% 
	
131 	 132 	 MeON 	133 
Scheme 41. Formation of 2,5-diarylated thiazole (133) in DMSO using silver 
salts for the first time.' 
Table 2. Conditions provided by Hoarau and co-workers."2 
DO 	Phi (1 eq.) 	DO [Pd] (5 %) EtO0 EtO- 
iigand(10%) 
N 	
I 
N Ph J 
IO 	 N 2 Cs2CO3 (2 eq.) 	O 	 Ph 	o Ph 
solvent, 110°C Ph 
134 
A 	 B 	 C 
135 	136 	 137 
Entry [Pd] Ligand Solvent A (%) B (%) C (%) 
i) Pd(OA02 PPh3  Dioxane 30 12 17 
ii) Pd(OA02 PPh3  DMF 40 0 0 
iii) Pd(OA02 Dioxane 46 0 0 
iv) Pd2(dba)3  NMP 41 0 0 
V) pdjC NMP 0 0 0 
vi) Pd(PPh3)4 Toluene 20 2 6 
We are aware that there is no example of an oxazole arylation in Mon's 2004 
publication, but chose to include this report in the introduction of this thesis due to 
the importance of Mon's example to the research of this thesis. 
In Hoarau's report we also find the first discussion on the mechanistic nature of this 
oxazole arylation. This topic shall be further discussed later in this chapter. 
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EtO 	
Phi (1 eq.) 
EtO Pd(OAc)2 (5 %) 
P(o-Toi)3(10%) 	
PhJ 
I 	N 	 I 	N 0' Cs2CO3 (2 eq.) 	o 
toluene, 110°C, 18 h 
	
Ph 	 Ph 
135 	 137 
Scheme 42. Hoarau's optimised conditions (96 % yield) for the arylation of 
oxazole on the 5- position.' 12 
The only other publication of oxazole arylation methodology prior to the submission 
of our results was a landmark paper by Daugulis and co-workers. 113  In this report, 
Daugulis et al. reported the catalytic use of Cul in DMF at 140 °C using a lithium 
base such as LitOBu  to arylate benzoxazole (58) on the 2-position in less than 30 
minutes. Many examples (Ar-I and Ar-Br) are presented and the commercial 
availability of the starting materials and reagents make this a very useful method. 
Not only oxazoles have been shown to be arylated with these conditions, thiazoles, 
triazoles, purines as well as N-oxide-pyridines also work in good to excellent yields. 
Drawbacks of this method are the high reaction temperatures as well as the use of 
DMF as the solvent. 
Cul (10 % 
DMF, LitOBu 
I:0 
> + Ph! 	 . 	0:0 —Ph 
140°C, 10 mm.  
58 	 106 	 82 
Scheme 43. Daugulis' copper catalysed direct arylations on oxazoles."3 
The following examples of oxazole direct arylations have appeared in the literature 
after our first manuscript was accepted and published. To complete and obtain a full 
review of oxazole arylations to the date of submission of this thesis, the following 
articles must nevertheless be discussed in detail. 
A microwave-assisted method for the arylation of oxazoles has been reported in 2008 
and uses a Pd / Cu co-catalyst system. Reactions are performed at high temperatures 
in a sealed tube. The authors reported the use of 5-phenyl-oxazole (29) with a variety 
of aryl-bromides. Optimised conditions include the use of Cs2CO3, Pd(OAc)2, CuT (1 
eq.) in DMF. Several small 2,5-diarylated natural products have been synthesised 
using this method and are reported with moderate yields. H4 
Pd(OAc)2 (5 %) 
o- 
N + PhBr 	
Cul (1 eq.) 	Ph 
, 
Ph 	 Cs2CO3, DMF 	° 
L  
Ph 
29 	129 	MW, 1500C, 30 min. 	180a 
Scheme 44. Microwave assisted synthesis of 2,5-diarylated oxazotes. 4 
Another 2008 report on the direct arylation of benzoxazole (regioselectivity 
obviously not an issue when using benzoxazole) has been disclosed by Derridj et al.. 
The authors generated symmetrical molecules using their own catalyst, benzoxazole 
(58) and 2,5-dibromothiazole (138) at high temperatures. In addition the authors 
show that their developed methodology works for the arylation of benzoxazole with 
several electron poor and electron rich aryl-bromides. 115 
+ i —Br 
NII .11 
58 	 138 
	
Br S 	
CPPh2 
PPh 
DMF, Cs2CO3, 100-150°C 
20 h, 51% 
N T~ K00 
C ;I 
139 
Scheme 45. Derridj et al. Pd-catalysed direct arylation of benzoxazole with 
di-bromo-thiophene. 5 
Wt 
Following the discovery of the reactivity of the 2-position of oxazole towards direct 
arylation under the 'on water' conditions described in this thesis, Ferrer-Flegeau et 
al. explored the scope of this methodology first described in this thesis, in detail. The 
initial results of the 'on water' 2-arylation of oxazole are reported in this document 
and all the work that followed this discovery is discussed further in the following 
chapters. 116 
Lastly and most recently, Hoarau and colleagues have reported an interesting method 
to generate 2,5 -diaryl-oxazoles."7 Starting from ethyl-4-oxazolecarboxylate (134), 
the authors selectively arylate the 2-position followed by the 5-position with different 
conditions. Most interestingly is the use of aryl-chlorides as coupling partners, aryl-
chlorides have so far not been used in a general way for the direct arylation of 
oxazoles. The authors of this communication provide high yields for aryl-iodides, 
aryl-bromides as well as aryl-chlorides. It seems that the ligands JohnPhos or IMes 
are the crucial components in these cross coupling reactions as yields drop to zero 
should any other ligands be used in these couplings. Further, the authors use a 
saponification / decarboxylation sequence to generate the vacant 4-position on the 
oxazole. Final compounds generated by this methodology are similar to the ones 
reported in this thesis. 117 
Et00C N 
Ar2X EtOOC N 
)1N\>—Ar 2
:0 
Ar5X 	
Ar5 
134 	 140 
Pd(OAc)2 (5%), Cs2CO3, 110°C,18 h 
P(o-tol)3, toluene orJohnPhos (10%), dioxane 
LiOH N 1i ")—Ar 
Ar5 0 
I 80a 
Ar2, Ar5 = each phenyl 
Scheme 46. Synthesis of 2,5-diarylated oxazoles via step-wise arylation of 4-
substituted oxazole."7 
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1.3 Aims of Project 
Following recent advances in the Greaney group in the functionalisation of the 4-
position of oxazoles via C-C bond formation using the broadly applicable Suzuki 
coupling and the general availability of arylation methods on the 2-position (see 
introduction), we set out to develop a methodology to regioselectively substitute the 
5-position using a direct arylation approach and therefore provide easy access to 
useful compounds that have been modified at a late stage of the synthesis.'' 
,—OTf 	°—OTf 
Ph N 
Pd°, ArB(O 141 	
143 
MW  
Pd°, MW 
N 
F_ 
F—C N) 
0 Ph 
142 	 144 
total of 	 total of 
12 examples 4 examples 
75-94 % yield 	 39-69 % yield 
Scheme 47. Ferrer-Flegeau and Greaney's oxazole Suzuki cross-coupling 
reaction using trjflates.7' 
To develop and prove a methodology we needed an oxazole system where the 2-
position is blocked, as it is the most acidic site and certainly reactive towards direct 
arylation conditions. We also wished that the 4- and 5-positions were still vacant. 
Target compounds to show potentially successful conditions were researched in the 
literature and gave several hits. Three of the targets proved very interesting, as they 
show either unusual physical properties or activities in biological assays (Figure 10). 
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MeO OMe 
145 	 180a 	 36 
Balsoxin 2,5-Diphenyl-oxazole 	Texaline 
Figure 10. Structures of balsoxin, 2,5-diphenyl-oxazole and texaline.' 18-120 
Two antimycobacterial natural products, balsoxin and texaline, next to several 
industrially useful scintillators such as 2,5-diphenyl-oxazole were identified. 
1.4 Previous Syntheses 
Before synthesising the above mentioned compounds, previous syntheses of texaline 
and balsoxin were researched and carefully evaluated.' 8"20 It turns out that both 
natural products had been synthesised only once before, both in five steps. Texaline 
via a lengthy and low yielding synthesis (overall yield 3.6 %) using a bromination, a 
reduction and a peptide coupling followed by an intramolecular condensation 
reaction to yield the product. 120 
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0 p-ISA, NBS 
0 	MeCN, reflux 
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BTtII 1  o> 
NaN3, DMSO,RT 
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Scheme 48. The only previously described synthesis of texaline.'2°  
Balsoxin, in comparison, had been synthesised via C-C bond formations in fairly 
high yields. Two Suzuki-reactions, a bromination as well as a decarboxylation are 
presented and the natural product is synthesised in an respectable overall yield of 48 
%118 
CI 
Suzuki 
Ph 
NBS Suzuki 
Ph 
0\\ 	___ 
I 	N 
87% 
0 	___ 
[N 	
86% Br )___\ 	
91 % 
COOEt COOEt COOEt 
151 135 152 
PhN 	
COOEt NaOH/EtOH Ph  
0 	
95% 
OMe 	DMF/H20 
-OMe 	1500C, 60 153 	 74% 
Me 
145 
Balsoxin 
Scheme 49. Previous total-synthesis of balsoxin using a double-Suzuki 
approach.118 
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1.5 Results and Discussion 
1.5.1 Preparation of Starting Materials 
Given the already performed 4-arylation of oxazoles in the Greaney group, with the 
2-position blocked, we set out to attempt to modify the 5-position selectively over 
the 4-position. If the mechanism of this particular reaction involves an electrophilic 
aromatic substitution, we should expect the 5-position of the oxazoles to be most 
reactive as it is the most electron rich site available. To be able to arylate the 5-
position we first needed to synthesise several 2-substituted oxazoles. The selection of 
2-substituted oxazoles as starting materials was based on the electronic effects the 
substituents would have on the oxazole. It was decided that an activated example (p-
methoxy), a slightly less activated (p-methyl), a neutral (phenyl) and the inactivated 
example (3-iodo-pyridine) were to be used to show the broad applicability of this 
chemistry. Two general pathways to generate the 2-aryl-oxazoles have been 
attempted and were successfully used, each for its own reasons. 
First of all the Negishi reaction between oxazole and several aryliodides was 
investigated and successfully used, generating the desired 2-arylated oxazole-
products in excellent yields with a small amount of work-up. However, this reaction 
is costly as the parent oxazole core is expensive (34k / g) when used in multi-gram 
quantities to generate large amounts of starting material for the direct arylation 
screening reactions. 12 1  Nevertheless three starting materials were synthesised in good 
yields using this method and have been fully characterised and matched the literature 
spectroscopic values. It is noteworthy that the addition of solid zinc chloride over the 
commercially available 1.6 M solution in THF is a better way to prepare these 
compounds as described by Reeder et al. The solid ZnC12 was added at once, under 
positive nitrogen pressure avoiding any moisture and air to enter the flask, via the 
addition at low temperatures. 121 
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n-BuLl 
o-_ 	 Pd(PPh3)4 L3 
+ aryihalides 
N 	 ZnCl2 
I 
/ N 
0 
R1  
R1 =CH3 (75%) 154 
= OCH3 (86 %) 155 
=H(78%) 	35 
Scheme 50. Negishi reactions to generate 2-substituted oxazoles via C-C 
bond formation. 121 
The second approach and synthesis of 2-substituted oxazoles is the modified 
Robinson-Gabriel synthesis of oxazole using benzamides (Scheme 51). This reaction 
is best described as messy and sluggish as after a few hours of heating, not all the 
starting materials are consumed at this point, large amounts of polymer-type material 
are formed, which makes the work up of this reaction very unattractive. Dark, tar-
like semi-solid products are formed and yields for these particular starting materials 
never exceed the 50 % barrier for any substituted or unsubstituted benzamide. Yet, it 
represents a fast and inexpensive way to generate multi-gram quantities of the 
starting materials needed for the direct arylation screening reactions. The work-up is 
a drawback as the crude products have to be columned and then distilled under high 
vacuum (< 1 mbar) at temperatures higher than 100°C. For our purposes this method 
was used to generate large amounts of the starting materials 35, 154 and 155.29 
/—\ 
0NH2 0 
	 0 ,-N 
a + 	Ac20 heat 
33 	34 	 35 
Scheme 51. 2-Phenyl-oxazole synthesis using chioroacetaldehyde and 
benzamide.33 
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1.5.2. Initial Screening and Optimisation 
Having four starting materials in hand we set out to test the possibility of a 
regioselective 5-substitution. Using our most activated substrate (mechanism vide 
infra), initial attempts were commenced and results are shown in table 3. 
Table 3. First direct arylation screening of organic solvents and other 
variables. 
base, temp., solvent 0 
+ 	
Pd-source, ligands 
We 
MeO 
155 	 106 	 180c 
Entry Cat.% Base Solvent Pd-source OCProduct 
 5 A92CO3  CH3CN Pd2(dba)3  85 20% cony. 
 5 Cs2CO3 DMF Pd(dppf)C12 85 SM only 
 20 A92CO3  Toluene Pd(dppf)C12 85 29% iso!. 
 20 A92CO3  THF Pd(dppf)C12 85 Traces 
V) 5 AgF CH3CN Pd(dppl)Cl, 85 65% iso!. 
 5 AgF CH3CN Pd(OA02 I PPh3  85 1 	63% isol. 
 5 AgF CH3CN PEPPSI 85 SM only 
 5 AgF THF Pd(dppf)C12 85 Traces 
 5 AgF THF Pd(OAc)2 /PPh3  85 Traces 
As in any methodology project, a screening of several organic solvents, 
temperatures, bases as well as ligands and Pd-sources was initiated. Early results 
showed that the most promising conditions were silver sources such as AgF or 
A92CO3 as Mori had already reported.111 Cs2CO3 for example did not show any 
conversion of the starting materials at all. Acetonitrile, just like DMSO, being a polar 
solvent, produced the most successful results for these trial reactions. Unlike Mon's 
WO 
communication in which he does not comment on the use of alternative palladium 
species, this transformation was able to be catalysed by several different palladium-
sources such as Pd(dppf)C12-DCM (catalyst loading 5 mol %), Pd(dppe)C12, 
Pd(dppb)C12 or Pd(OAc)2 which was used together with additional PPh3 (10 mol %). 
Screening reactions were run at lower temperatures than the general direct arylation 
temperatures, which are generally well above 100 °C. It was the goal to find 
conditions far superior to previously reported conditions. Ambient temperature, if 
possible, would be the ultimate goal, but for screening purposes, slightly elevated 
temperatures were evaluated. Additionally, catalyst loadings were generally higher 
than desired. It was the aim to begin to screen for optimum conditions using 10 mol 
% of catalyst - but if possible - to decrease this amount to the smallest possible value, 
while still getting maximum turn-over numbers (TON's). 
Initial screening experiments did not show any effect of N-heterocyclic carbenes, 
such as PEPPSI (156), to promote the conversion of the starting materials. No 
products were observed in any of the reactions when PEPPSI was used. 
N?N r, __A 
CI. rci 
PEPPSI-SiPr 
156 
Figure 11. Structure of NHC-based catalyst PEPPSI-SIPr. 
As seen in table 3, early conditions reported 85 C in acetonitrile with a couple of 
useful palladium-sources, such as Pd(dppf)C12. Reaction times for these reactions 
were found to be three days (72 hrs). Interestingly, none of the reactions shown so far 
went to completion during this 72 hrs time span. At this point of the project, not a 
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single HPLC and TLC had shown full conversion. Addition of fresh catalyst, as well 
as ligands after 24 hrs did not improve the conversions and higher temperatures also 
failed to improve yields. Noteworthy is the fact, that increased temperatures actually 
decreased the isolated yields of these 2,5-disubstituted compounds due to the 
excessive formation of homo-coupled side products. 
Several disubstituted compounds were generated using these conditions with yields 
ranging from 16 - 63 %. 
OMe 	Me 	CI 
	
OMe 	Br 
OMe 
	
N N O 	N11 	NO 	N 
	
N N O 	N N O 
OMe 	OMe 	OMe 	OMe 
	
OMe 
180c 185c 184c 186c 145 	187c 
63% 	31% 	37% 	19% 
	
36% 16% 
Figure 12. Isolated products and yields of early non-"on water" screening. 
Microwave accelerated conditions did not show any appreciable increase in yields 
and were dismissed after several attempts using the most activated starting material, 
2-(4-methoxy-phenyl)-oxazole (155) with iodobenzene. 
1.5.3. On Water Direct Arylation Discovery 
Following a rather unexpected result by a fellow student (G. Turner) working on 
direct arylation methodology in the Greaney group, in which thiazoles were 
successfully and almost quantitatively arylated with water as medium, we set out to 
test these conditions on oxazoles.122 Similar conditions to the thiazole arylation were 
applied to the above mentioned oxazole test-reaction and showed very promising 
conversions on TLC and HPLC. Up to this point starting material had always be 
observed on TLC at Rf = 0.2 in 100 % DCM, but using water as "solvent" no left- 
over starting materials were observed. After 24 hrs, TLC and HPLC showed full 
conversion of the oxazole starting material. 
o 	 A92CO3, PPh3 
S/Me 	
I Pd(dppf)C12-DCM 
N 	 HO, 60°C, 24h 	 N 	Me 
157 	 106 	 70% 	 158 
Scheme 52. Initial discovery of thiazole arylation "on water". 122 
Reactions performed "in water" have a longstanding tradition and many high-profile 
research groups have contributed extensively to the area of organic transformation in 
the aqueous medium. A few selected examples are highlighted below, the works of 
Grieco, Breslow and Kobayashi are probably the most notable contributions to this 
field of research. 121-121  Several detailed reviews have highlighted the importance and 
need for transformations in water. 126,127 
Cu(03SC11  H23)2 
R 	 or 	 OH 
MeHN 	Sc(03SC11H23)3 	R 
R 	+ 	
(10%) 	
RXNMe 
(S,S)-1 (12%) 
159a-d 	 160 	H2O, r.t., 22h 
162a-d 
Entry R Cu Sc 
yield% ee% yield% ee% 
1 Ph 88 91 96 -97 
2 2-Naphthyl 81 90 76 -96 
3 4-MeC6H4 78 90 85 -96 
4 4-BrC6H4 72 91 88 -97 
PN 
OH 	HO 
(S,S)-1 (12 mol%) 
161 
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R 
R 	 H 
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R OH 
R 
I 64a-d 
Kobayashi's en antioselective meso-epoxide ring-opening reactions in water. 
_L 
CH2C6H5  
N-methylmaleimide 
H20, 2 his, 500C 
/ 	0 
N—Me 
0 
+ C6H5CH2NH2 
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167 
Grieco's retro aza-Diels-Alder reaction in water. 
Scheme 53. Kobayashi and Grieco's work in the aqueous medium. 
The term "on water"-chemistry however can only been found in the literature since 
2005, when Sharpless first used it to described several organic transformations 
discovered in his research group, which did not dissolve in water. 121  In his 
communication he reported multiple organic transformations, such as the Ene-
reaction, epoxide opening reactions, Claisen rearrangements (table 5), cycloadditions 
(table 4), as well as the Diels-Alder reaction. The reactions proceed fast, sometimes 
in only a few minutes, and products are obtained in excellent yields. In more detail - 
Sharpless reported a substantial rate acceleration when insoluble reagents are stirred 
in aqueous suspension, denoted in his paper as "on water" conditions. Ease of 
product isolation, water's unique redox stability as well as safety due to water's high 
heat capacity are just a few advantages over organic solvents. 129 
Me 
Table 4. Quadricyclane and d imethylazod icarboxylate-cycloaddtion solvent 
screening. 
MeOOC N  
+ 	 II 
	
_ 	 N COOMe 
168 	 169 
N 	,COOMe 
N 
/ 	N 
COOMe 
170 
Solvent Time to completion 
Toluene >120 hrs 
EtOAc >120 hrs 
CH3CN 84 hrs 
DCM 72 hrs 
DMSO 36 hrs 
MeOH 18 hrs 
Neat 48 hrs 
On D20 45 mins 
On C6F14 36 hrs 
On H2O 10 mins 
MeOH:H20 (3:1) homogeneous 4 hrs 
MeOH:H20 (1:1) heterogeneous 10 mins 
MeOH:H20 (1:3) heterogeneous 10 mins 
Interestingly Sharpless reported that: "...under homogenous conditions, polar protic 
solvents accelerate the reaction, with observed reaction rates in the following order: 
MeOH:H20 (3:1) > MeOH > DMSO > CH3CN z CH2Cl2 > EtOAc z toluene. 130  This 
trend suggests that hydrogen bonding, charge stabilisation and dipolar effects may be 
important for rate acceleration. 131  While water contributes to such properties in 
homogeneous mixtures, heterogenicity was crucial for observing large rate 
accelerations. Thus, the presence or absence of methanol in a heterogeneous mixture 
made little difference, but the rate slowed considerably when enough methanol was 
used to make the reaction homogeneous. However, heterogenicity in itself is not 
responsible for the rate acceleration as the reaction "on" perfluorohexane was only 
slightly faster than the neat reaction." 
oil 
Further studies by Sharpless also provided insight into the aromatic Claisen 
rearrangement. 
Table 5. "On water" Claisen rearrangement as described by Sharpless.'28 
O 	 OH 
r.t., 120hrs 
	
1IuI1II 	"on water" 
Cl 	100% 	 CI 
171 	 172 
Solvent Yield 
Toluene 16% 
DMF 21% 
CH3CN 27% 
MeOH 56% 
neat 73 % 
on H20  100% 
Other, more recent examples of "on water" chemistry have been published. 
Compounds such as 2-alkyl and 2-aryl-benzofurans can be generated via an 
intramolecular O-arylation using a Cu I TMEDA complex. 
132 
62 
Cul (8.5%), TMEDA (3.5 eq.), 	Cl 
24 hrs, water, 1200C 
91% yield 	 < ~O  
174 UI 
173 
Scheme 54 Synthesis of benzofurane analogues using on water 
techniques. 132 
In addition, Guizzetti et al. have shown that "on water" conditions are useful in the 
preparation of chiral ,13-hydroxy ketones via an enantioselective direct Aldol-reaction 
using 1,1' -binaphthyl-2,2 '-diamine-based (S)-prolinamides.133 
0 	 0 
Je O2N 
175 	 176 
0 OH  
12hrs, water, 
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Scheme 55. Enantioselective direct Aldol-reaction on water. 133 
The role of water in different reaction systems is best described as diverse. Some 
authors highlight the hydrophobic interactions of water and organic molecules. The 
interactions which come from the immiscibility of organic compounds in water can 
bring the molecules closer together, however, this alone can not be responsible for 
the rate acceleration as shown in Sharpless' experiments. Possible hydrogen-type 
bonds have been suggested and a theoretical computational study by Jung and 
Marcus support the hypothesis. 131,111 The authors suggest that the immense "on 
water" acceleration is possibly due to the ease of free OH-groups of interfacial water 
molecules to form H-bonds with the H-bond accepting groups in the transition state 
compared with that of the reactants. This lowers the activation barrier (in this case 
Sharpless' examples were used for the computational study) and therefore the rate of 
the transformation is increased. 
Our early attempts to arylate oxazoles using water gave products in yields ranging 
from 50 - 76 %. We did not see the need of adding extra PPh3 to the reaction mixture 
as the palladium source already had ligands in place and Pd° must be the active 
catalyst for this transformation. It seemed unnecessary to add additional phosphine at 
the time, but practical experiments showed, that with the addition of 10 % of PPh3, 
the reactions go to completion. Without PPh3, yields dropped by as much as 40 %. 
It is worth pointing out that it is rather unusual to see transition metals such as 
palladium catalyse sp2-sp2 carbon-carbon bond formations on water. Most cross 
coupling reactions do indeed work in very polar solvents such as DMF, but water as 
a medium has never been shown to promote any direct arylation reaction until the 
discovery in the Greaney group. 
Given these exciting results, a further screening of palladium sources and ligands 
was initiated and aimed to investigate the general applicability of using palladium 
catalysts in an aqueous environment. Results of this screening reflected the earlier 
screening in organic solvents in which several palladium sources such as 
Pd(dppb)C12 or Pd(dppe)C12 were shown to promote the formation of 2,5-diarylated 
oxazoles. 
The starting oxazole used for the screening was 2-phenyl-oxazole (35) as we decided 
to screen our ligands and palladium sources against an inactivated oxazole. The 
reaction of 2-phenyl-oxazole with 3,4-dimethoxyiodobenzene would then yield the 
natural product balsoxin (145), a target compound envisioned by us previously. 
The optimised conditions turned out to be as follows: 
Aryloxazole (1 eq.), aryliodide (1.2 eq.), base (A92CO3 or AgF, 2.0 eq.), 10 mol 
% of PPh3, 5 mol % of Pd(dppf)C12-DCM, 60°C - 16 hrs, water. 
MOA 
N' 	I  
+ 	EIII1 	
conditions 
OMe 
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35 	 179 
Scheme 56. Generalised reaction scheme for the 5-arylation to generated 
batsoxin. 
The direct arylation reactions described in this thesis using water as a medium are 
not concentration dependent (in a solution sense) as all components are immiscible in 
water. Several control experiments were performed to ensure all the components for 
the direct arylation reaction are crucial and are used in correct amounts. First of all a 
water-soluble base was used to see if an increase or decrease in yield would occur. 
K2CO3 and Cs2CO3 as base were used (even though it is known from the previous 
screening that a silver-source seems essential) and provided yields not exceeding the 
20 % barrier. These results were somewhat expected as it seems that starting 
materials as well as products have to be insoluble for this reaction to occur. These 
"on water" reactions are highly concentrated and this concentration effect certainly 
plays a major role. Sharpless originally termed heterogeneous reactions using water 
as "on water" in his landmark paper in 2005 as described earlier in this document. 128 
In our "on water" direct arylations, a silver mirror can be observed after a few hours 
of heating at slightly elevated temperatures indicating the formation of AgI which 
itself is also insoluble in water possibly driving the reaction towards the side of the 
products. 
Several reactions were also carried out without triphenyphosphine as an extra ligand. 
Triphenyiphosphine turns out to be one of the key factors for this kind of chemistry 
to occur and when omitted, reactions rarely produce yields higher than 50 - 60 
compared to sometimes near quantitative yields when triphenylphosphine is used. 
During the course of this project the mol % of palladium catalyst was also modified. 
As none of the reactions gave> 99 % isolated yields we already suspected a decrease 
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in palladium catalyst to significantly drop the yields. Nevertheless we decreased the 
catalyst loading from 5 mol % to 1 mol % and observed a steep decrease in yields, as 
expected. As a last modification we decided to decrease the equivalents of base from 
two equivalents (actually four equivalents) to 0.5 equivalents (actually one 
equivalent) and also observed a severe decrease in isolated yields for these reactions. 
A wide range of 2,5-diarylated oxazoles was generated using the above described 
optimised conditions and are presented in Table 6. The choice of aryliodides should 
be discussed at this point. Emphasis was put on a highly diverse library of 
compounds, ranging from electron donating to electron withdrawing, sterically 
demanding and even substrates with a potential additional functional handle for 
further modification of the products. 
Table 6 shows a range of products. Iodobenzene for example, could be coupled in 
high yields; electron-donating groups such as p-methoxy-iodobenzene and the 
weaker electron donating p-methyl-iodobenzene could also be attached in good 
yields. In addition the sterically hindered o-methyl-iodobenzene and 1-
naphthyliodobenzene were highly successful and show the strength of this 
methodology. Compounds such as p-bromo and p-chloro-iodobenzene are shown to 
react in good yields as well, giving the compounds a remaining reactivity towards 
further modifications such as Suzuki reactions or iron-catalysed alkylations.'36"37  
The acetophenone moiety of 188 could also act as an electrophilic site that could be 
further modified. Examples of electron-withdrawing groups such as p-
trifluoromethy-iodobenzene and m-nitro-iodobenzene have been explored. The nitro 
species does not work as clean as expected, very likely due to side reactions that 
occur, which make the purification significantly more difficult than any of the other 
examples. 
M. 
Table 6. Overview of 36 membered library of palladium-catalysed direct 
arylations to generate 2,5-disubstituted oxazoles. 
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'= oxazole homocoupling observed, probably due to slow oxidative addition of aryliodide 
Lastly one should mention the heteroaromatic substrates used in this report. It turned 
out to be rather difficult to isolate the thiophene (191) and pyridine (190) examples. 
The 3-iodothiophene was simply too reactive and gave TLC plates that showed up to 
9(!) new spots, most of them highly fluorescent under long and short wavelength 
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UV-light. Purification of the thiophene substrates was simply not possible as no 
major spot was observed, the TLC was uninterpretable (several different mobile 
phases) and any attempts of actually purifying the mixture gave no spot that had any 
isolated mass (weight). 
The pyridine substrates are a different story, it was possible to isolate the products in 
very moderate yields but to our surprise we also isolated homo-coupling products. 
Surprising is the fact that we did not isolate homo-coupling products of the 
aryliodides as it is normally the case but homo-coupling of the oxazole species. 
1 
MeO 	
Tk) 	on water conditions e 0 
 MeO 	 192 	
OMe 
155  
symmetrical homo-coupled 
bis-oxazole 
Scheme 57. Homo-coupling of the oxazole starting materials. 
This is rather unusual and highly interesting as the mechanism for this transformation 
is not trivial and will have to be further investigated in our laboratory. We have not 
investigated this phenomenon in great detail but early results show that only the most 
activated oxazole species (such as the very electron-rich 2-(4-methoxy-phenyl)-
oxazole (155) are able to homo-couple under these conditions. Interestingly, even 
without palladium catalyst, we see a small amount of this product formed. No 
reaction does however occur if both, silvercarbonate and the palladium catalyst are 
left out, suggesting a role of the silver salt. 
To strengthen the utility of this direct arylation approach using water we decided to 
prove the concept on two small natural products, texaline and balsoxin. 
Balsoxin (145) and texaline (36) were both successfully synthesised in 84 % and 74 
%, respectively. In addition, an industrially useful scintillator (2,5-diphenyl-oxazole, 
180a) was also synthesised in 92 % yield, showing the effectiveness and versatility 
of this methodology. 
MeO OMe 
	
64- 	6 
145 	 180a 	 36 
Balsoxin 2,5-Diphenyl-oxazole 	Texaline 
Scheme 58. Balsoxin, 2,5-diphenyl oxazole (scintillator) and texaline. 
Work-up of the above-described reactions is a simple filtration through celite or a 
filter fitted with a fit, followed by several washings with DCM. The resulting bi-
phasic mixture can then simply be extracted after addition of some extra water to 
make the phase separation visible and then the organic phase is dried with MgSO4, 
filtered and solvent evaporated under reduced pressure. These optimised reactions 
can almost be looked at as 'neat' as the high reactivity of the starting materials bases 
itself on the close, almost molten, proximity of all starting materials in the reaction 
vessel. Water in this case acts as a medium absorbing the heat that is put into the 
system. If the reaction is done without water, the yields only drop a few percent, 
proving that there is no real solvent-effect promoting these reactions using water. 
In addition to the direct arylations described above initial attempts to generate bis-
oxazoles have been tried but did not succeed at this point (scheme 59). The product 
of this particular reaction would be a very interesting bis-oxazole (194) with a rare 
oxazole substitution pattern, which has not been shown to this day. Unfortunately 
this reaction does not work, small amounts of what could be product (due to the very 
distinct UV-activity) are seen on TLC but are not able to be isolated via column 
chromatography. Mostly starting material is re-isolated in this case. The steric-effect 
of the phenyl group right next to the iodine might be a reason why this reaction does 
not proceed in good yields, as well as the heteroaromatic nature of the oxazole. One 
me 
could also expect to maybe see some coupling between the iodine and the vacant 2-
position of the oxazole but this has to be investigated in the future and so far has not 
been observed. 
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Scheme 59. Initial attempts to generate bis-oxazoles and 2-arylated indoles 
using our methodology failed. 
1.5.4 Mechanism 
The mechanism involved in the arylation of azoles and heterocycles in general has 
raised some interest over the last few years. Mechanistically, the direct arylation 
reaction of heterocycles is thought to occur primarily via three possible routes: (1) an 
electrophilic aromatic substitution, (2) a carbanion cross-coupling mechanism or (3) 
a palladium-pivalic acid co-catalysed mechanism as proposed by Fagnou and 
coworkers. 131-140  The arylation on the 5-position of oxazole is believed to be of an 
electrophilic substitution nature rather than a cross coupling. Different proposals 
have been put forward for the arylation of the 2-position of oxazole. The main 
mechanisms are discussed in detail below. 
70 
cross-
coupling 
EtOOC N N 
134 
electrophilic 
substitution 
EtOOC", 
C, 
N 
0 
198 
EtOOCN-.NPdAr 
H 
199 
EtOOC Nph  
1351200 
Scheme 60. Possible mechanistic pathways for the direct arylation of 
heterocycles.' 38-140 
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Scheme 61. Mechanism for the arylation of aromatic or heteroaromatic 
compounds as suggested by Fagnou et al.'4°  
Early work by Miura in 1998 suggests that the arylation reactions of 1,3-azoles are of 
an electrophilic character. Miura's report is the first in which the mechanism of the 
arylation of azoles is discussed in detail. 138  Miura comments on the use of palladium 
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and copper, the ladder promoting the arylation on the acidic 2-position of oxazoles 
and thiazoles. When palladium is used by itself, or as a co-metal together with Cu' 
sources, the 5-position is preferentially arylated in good yields. Further, the authors 
rank the C-H bonds on azoles in order of highest electron density, showing that the 
most electron rich atom is CS, followed by C4 and then C2.141 Most interesting are 
the experimental results performed by Miura et al., the authors attempt the same 
direct arylation reaction but using differently substituted azoles, showing that 
electron donating effects of substituents have a direct effect on the obtained yields of 
the reactions. 138  As expected, the most electron-rich examples give the highest yields 
and deactivated azoles tend to react slower. These results further support the 
proposed mechanism. It should further be noted that Miura suggests that the 
electrophilic mechanism is very feasible for the 5-position of thiazoles and 
imidazoles as these positions are most electron-rich. It can only be speculated that 
the electron-poor 2-position reacts via a similar mechanism. 
06 
+ Ar-I 
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Pd°  
II 	 Ar-Pd-I 
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AgI C1/Ar 
Pd0 R 	 35 
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202b 
Scheme 62. Mechanism put forward by Miura and co-workers. 
As a first step, the palladium inserts itself into aryihalide bond via an oxidative 
addition known from other palladium catalyzed reactions such as the Stille or Suzuki 
for example. Then the lone pair from the oxygen of the oxazole can be viewed as the 
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Phi, Pd(OAc)2 / PPh3 
Cs2CO3, DMF, 1000C 
204a-e 
initiator of a flow of electrons around the ring of oxazole to then generate a carbon-
palladium bond and a Wieland intermediate. The base then abstracts a proton a- to 
the cationic oxygen of this Pd" species to regenerate its aromaticity. Reductive 
elimination as the last step of this transformation generates the product in a 2,5-
disubstituted fashion and allows the palladium catalyst to continue its cycle as Pd°. 
Some additional work involving CuT as a co-catalyst has been disclosed by Hoarau 
and co-workers promoting the initially proposed mechanism by Mjura.142"43  
Interestingly, several years later, Zhuravlev and Sanchez communicated a very 
detailed study on the mechanism of the C2 arylation of benzoxazole. '44 The authors 
provide strong evidence for a ring-opening pathway in the palladium-catalysed direct 
arylation of benzoxazoles. A set of kinetic experiments on a series of benzoxazoles 
was performed using Hammett studies, which offer the opportunity to probe the 
electronic demand of Pd-catalysed arylation by having different substituents at the C-
5 position of benzoxazole ring. Using several electronically different benzoxazoles, a 
linear effect was shown, with 5-methoxy on the slow end of the rate of reaction, and 
5-nitrobenzoxazole on the fast side. 5-Nitrobenzoxazole arylated at room 
temperature showing the increase in rate of arylation using this electron-withdrawing 
group. 144 
X5LCN"> 2. 
203a-e 
X = H (a), Me (b), OMe (c), CI (d), NO2 (e) 
Scheme 63. Effect of substituents on the rate of 2-arylation of 
benzoxazole. 144 
Key experiment in this communication is the use of 2-trimethylsiloxyphenyl 
isocyanide as a precursor to the active phenolate, which will be produced in situ via 
addition of CsF to deprotect the hydroxy group. The arylation reaction then occurs in 
less than one hour at 120 °C, giving rise to the ring-closed 2-arylated benzoxazole 
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(204). The reaction also takes place at room-temperature, but at a slower rate (24 hrs, 
10% yield). 
OTMS 	Phi, Pd(OAc)2 / PPh3 0 
base, DMF 	
/Ph O:N 
205 	 82  
base: Cs2CO3, 1200C, lh, 96 % 
base: Cs2CO3 or CsF, 250C, 24h, 10 °" 
Scheme 64. Transformation of ring-opened OTMS-analogue 205 to 2-
phenylbenzoxazole 82.144 
Zhuravlev argues that based on these above results, the direct arylation on the 2-
position of benzoxazoles is inconsistent with the electrophilic mechanism proposed 
by earlier studies. The generation of an isocyanophenolate is reported as a key step 
and the control of the C-H acidity on the 2-position is anticipated to be a very 
important element in developing a possible mild arylation method. 
Detailed computational data calculating the activation barriers for each of the steps in 
the catalytic cycle is provided and supports the anionic mechanism in which a Pd-
isocyanide complex is formed first, followed by an intramolecular cyclisation of the 
phenolate oxygen to generate the Pd-benzoxazole system. This cyclisation step has 
an activation barrier of around 3 kcal / mol, which in comparison, is much less than 
the strength of a hydrogen-bond, which lies at about 5-10 kcal / mol. 
Lastly, a thorough study on the mechanism of indolizines should be mentioned in 
brief as the authors followed a similar thought process in their work. In short, several 
different mechanistic paths such as a Heck reaction, a C-H activation, a cross-
coupling as well as an electrophilic substitution were considered to be possible for 
the 3-arylation of indolizines. This research is of interest to the mechanistic 
discussion of oxazole 5-arylation because final arguments in this paper once again 
evolve around the effect that substituents have on the isolated yields. 145  It seems that 
the direct comparison between electronic effects and yields is once again a viable 
argument. A very interesting experiment by Gevorgyan is shown in scheme 64 where 
a reaction having the possibility to react via a Heck-type mechanism or via an 
electrophilic mechanism is set up. Results show a clean reaction generating only one 
single regioisomer, on C3, not on C5 where a Heck-type product would be expected. 
Ar-I, Pd 
EtOOC 	 - 	EtOOC base 
206 	 Ar 
207 
EtOOC -I::qN/  
208 Ar 
60% 
Scheme 64. Attempts to perform Heck reaction on indolizine 206.145 
The authors then take a further step to understand and support the mechanism by 
providing a screening table of electron neutral and electron withdrawing substituents 
on the position adjacent of where the arylation occurred. Relative rates are clearly 
influenced by the substituents and show a decrease in reactivity when the electron 
withdrawing power of the substituent is superior. This finding supports the existence 
of an 'electrophilic substitution' mechanism further. 
We would like to further note that the direct arylation on 2-aryl-substituted oxazoles 
could technically yield two products, a 2,4-diarylated as well as a 2,5-diarylated 
oxazole. Spectroscopically these two regioisomers are very similar and can only be 
distinguished from each other when compared to literature values - should these 
exist. Molecular weight differences as well as combustion analyses also do not 
provide the means to decide which isomer is formed. Theoretically, based on the 
mechanism postulated above, one should expect to obtain the 2,5-diarylated oxazole. 
This is indeed true as we were lucky enough to grow crystals of one of the 
synthesised compounds. Figure 13 provides a top / bottom view of one of the 
pyridine analogues synthesised. The compound shown is 2-(4-methyl-phenyl)-5-(3-
pyridyl)-oxazole (190b). Having obtained a crystal structure in addition to matching 
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texaline and balsoxin to literature NMR data provides us with strong proof that 
indeed the 2,5-diarylated compounds have been synthesised. 
Figure 13. X-ray top I bottom view of a selected 2,5-diarylated oxazole 
(1 90b). 
1.6. Summary 
In conclusion, a robust method to generate 2,5-disubstituted oxazoles has been 
developed and it has been shown that a large range of substrates can be generated 
from electron rich to electron poor, sterically hindered and even some 
heteroaromatic. The methodology has been taken a step further and two natural 
products showing antimycobacterial activity have been synthesised in good to 
excellent yields. No competing substitution reaction at the 4-position has been 
observed and the amount of aryliodide homo-coupling is kept at an absolute 
minimum compared to reactions done in organic solvents where homo-coupling has 
been observed. 
It seems that the water represents a viable platform (as all components are insoluble 
in water) to allow a highly concentrated reaction to occur in a shorter period of time 
as the formed iodide is also insoluble in water. The use of water can also be 
described as somewhat "green chemistry" even though one should remember that the 
work-up still involves several washings with DCM. Modern methods to generated 
such compounds via direct arylation are among the 'Wanted List' of many 
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pharmaceutical companies. 146  Given the lack of solubility of reactants, reagents and 
products in water, the system is an example of what Sharpless has termed an "on 
water" reaction, whereby the organic components react in a heterogeneous aqueous 
environment. The developed reactions are safer than normal organic reactions due to 
the use of water, which has a high heat capacity. Increased rate and therefore 
increased efficiency are the result of a high effective-concentration which essentially 
acts as the driving force for these "on water" reactions. 
Furthermore, a few selected compounds have been sent away for biological testing 
(1050 tests) on pyruvate kinase which catalyses the final step of glycolisis, the 
conversion of PEP to pyruvate with the production of one molecule of ATP. 
(OH 
HO, 	
+ 2[NADl + 2[ADP] + 2[P] 	 + [AH] + 2 H +2[ATP] + 
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Scheme 65. Transformation of D-glucose to pyruvate (Glycolisis). 
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Scheme 66. Final step of glycolisis shown in detail. 
Our synthesised compounds show very similar structural features as a library of di-
substituted oxadiazole compounds that have been identified via a qHTS.'47 This 
target is interesting as these compounds are potential new therapeutic agents for the 
treatment of trypaonasomiasis and leishmaniasis, tropical diseases caused by 
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parasites. This project is done in collaboration with the global consortium targeting 
the glycolytic pathway of these parasites. 148,149 
These compounds were however insoluble in the conditions required for the 
bioassay. No activities can be reported. 
1.7 Experimental 
General 
NMR spectra were obtained from a Brliker AC250 (250MHz) instrument and 
calibrated to residual solvent peaks: 'H - CDC13, 7.26 ppm and 13C - CDC13, 77.0 
ppm. The 'H-NMR data is presented as follows: chemical shift (in ppm on the 
scale), integration, multiplicity (s= singlet, d= doublet, t= triplet, q= quartet, m= 
multiplet), coupling constant (J in Hz) and structural assignment. The 13C-NMR data 
is reported as ppm on the 6 scale, followed by the structural assignment. High 
resolution mass spectrometry was performed by the EPSRC National Mass 
Spectrometry Service Centre, Swansea, using Finnigan MAT 95XP and Finnigan 
MAT 900XLT instruments ES analysis. The data is presented as the ionisation 
method, followed by the calculated and measured masses. TLC was preformed on 
Merck 60 F254 silica plates and visualised by UV light. Compound purification was 
carried out by wet flash column chromatography using Merck Kieselgel 60 (particle 
size 35-70). Eluent constitution is quoted as ratios or percentages. All solvents were 
dried before use unless otherwise stated. Anhydrous solvents were obtained from a 
solvent purification system supplied by www.glasscontoursolventsystems.com or a 
PureSolv solvent purification system supplied by Innovative Technologies Inc. All 
other chemicals were purchased from a chemical supplier and used as received. 
General procedure for Negishi reactions: 2-p-Tolyl-oxazole (154) 
IRV 
+ O'N 
\—I 
Me j:::r  
Oxazole (0.30 g, 4.41 mmol, 1.4 equiv.) was dissolved in THF (20 mL) under N2 
atmosphere at -78 °C, treated with n-BuLi (1.6 M in hexane, 3.35 ml, 5.35 mmol, 1.2 
equiv. based on oxazole) maintaining an internal temperature below -60 °C. After 
stirring for 10 mm, solid ZnC12 (1.20 g, 9.45mmol, 3.0 equiv.) is added portion wise 
to avoid clumping, the cooling bath is removed, contents warmed to room 
temperature. Once at ambient temperature, the catalyst Pd(PPh3)4 (0.079g, 0.22 
mmol, 5 mol%) and the p-methyl iodobenzene (0.686 g, 3.15 mmol, 1.0 equiv) were 
added and the contents heated to 60 °C and stirred for four hours. The solvent was 
removed under reduced pressure and the contents were partitioned between aq. 
NH4C1 and EtOAc. Extraction and washing with NH4CI, followed by MgSO4 drying 
and filtration of MgSO4, as well as column chromatography in 100 % DCM afforded 
product 154 as a colourless oil (0.376 g, 75 % yield). 'H NMR (250 MHz, CDC13) ö 
7.82-7.78 (2H, d, J= 6.5 Hz), 7.53 (1H, s), 7.12-7.06 (3H, m) 2.24 (3H, 5); '3C NMR 
(63 MHz, CDCI3) 6  162.1 (quat), 140.5 (quat), 138.2 (CH), 129.4 (CH), 128.2 (CH), 
126.2 (CH), 124.8 (quat), 21.4 (CH3); HRMS (El) m/z calcd for C10H9N0 159.0679, 
found 159.0676. 
2-Phenyl-oxazole (35) 
Prepared according to the general procedure. Purification by flash 
chromatography (silica, DCM 100 %) gave the coupled product 35 as a 
colourless oil (0.458 g, 83 % yield), with identical spectral data to that previously 
reported. 150 
2-(4-Methoxy-pheny)-oxazole (155) 
N3 Prepared according to the general procedure. Purification by 
MeO 	
- 	0 flash chromatography (silica, DCM 100 %) gave 155 as a 
colourless oil (0.474 g, 86 % yield) with identical spectral data to that previously 
reported. 121 
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3-Oxazol-2-yl-pyridine (211) 
\11 	/~ 3 
chromatography (silica, DCM 100 %) gave the coupled product as a 
KI 
colourless oil (0.359g, 78 % yield), 'H NMR (250 MHz, CDC13) 6 9.40 
(1H, d, J= 1.5 Hz), 8.83 (1H, dd, J= 4.9 Hz, 1.6 Hz), 8.46 (1H, dt, J= 10.1 Hz, 2.0 
Hz), 7.94 (1H, d, J= 0.8 Hz), 7.50 (1H, m), 7.41 (1H, d, J= 0.8 Hz); '3C NMR (63 
MHz, CDC13) 6 159.4 (quat), 150.9 (CH), 147.5 (CH), 139.3 (CH), 133.8 (CH), 
128.7 (CH), 123.8 (quat), 123.7 (CH); HRMS (El) m/z calcd for C8H6N20 146.0475, 
found 146.0472. 
Direct Arylations. Compounds 180a, b and c, 185a, b and c, 186a, b and c, 187a 
and c, 189a have previously been reported in the literature. 15,151 
Representative procedure: 2-(4-Methoxy-phenyl)-5-phenyl-oxazole (180c) 
M 	
LJ 	 MeO ° 
eO- c(Lo+iY 
A92CO3 (317 mg, 1.15 mmol, 2 equiv.), PPh3 (15.2 mg, 0.058 mmol, 10 mol %), 
Pd(dppf)C12 DCM (24 mg, 5 % mol) were put into a carousel tube and mixed well. 
The aryl iodide (0.078 ml, 0.692 mmol, 1.2 equiv.), followed byp-methoxyphenyl-2-
oxazole (0.101 g, 0.577 mmol, 1 equiv.) were added via pipette. Lastly 4-7 ml of 
distilled water was added via wash bottle and the tube was heated to 60 °C and 
stirred 24 hrs. The dark mixture / melt was filtered through celite using DCM and 
acetone to wash several times. TLC analysis showed a bright blue spot (UV 254 nm) 
with R1= 0.20 (DCM, 100 %). Purification by chromatography (Si02, CH202 100 %) 
gave the pure product (120 mg, 83 %) with identical spectral data to that previously 
reported. 
Prepared according to the general procedure. Purification by flash 
2-Phenyl-5-p-tolyl-oxazole (181a) 
N-- 
Me 	Prepared according to the general procedure. Purification by 
O~Ib flash chromatography (silica, DCM 100 %) gave the 
coupled product 181a as a white solid (113 mg, 83 % yield, 
Mp. 62-63 °C ); 'H NMR (250 MHz, CDC13) 6 8.04-8.00 (2H, m), 7.54-7.51 (2H, 
m), 7.40-7.37 (3H, m), 7.31 (1H, s), 7.18-7.15 (2H, m), 2.30 (3H, s); '3C NMR (63 
MHz, CDC13) 6 160.7 (quat), 150.7 (quat), 134.8 (quat), 131.2 (CH), 130.3 (CH), 
128.8 (CH), 127.4 (quat), 127.2 (quat), 126.7 (CH), 126.2 (CH), 21.9 (CH3); HRMS 
(El) m/z calcd for C16H13N0 235.0992, found 235.0993. 
2-(4-Methoxy-phenyl)-5-o-tolyl-oxazole (181c) 
N 	Me 	Prepared according to the general procedure. 
MeO ° 	
Purification by flash chromatography (silica, DCM
-Cr 
/ 
acetone 99:1) gave the coupled product 181c as a 
white solid (150 mg, 98 % yield, Mp. 71-73 °C ); 'H NMR (250 MHz, CDC13) 6 
8.22-8.18 (2H, m), 7.92 (1H, m), 7.45 (1H, s), 7.46-7.41 (3H, m), 7.17-7.13 (2H, m), 
4.02 (3H, s), 2.68 (3H, s); '3C NMR (63 MHz, CDC13) 6 161.2 (quat), 160.7 (quat), 
150.0 (quat), 134.5 (quat), 131.0 (CH), 128.0 (CH), 127.8 (CH), 127.3 (quat), 126.4 
(CH), 126.0 (CH), 125.9 (CH), 120.1 (quat), 114.1 (CH), 55.2 (CH3), 21.8 (CH3); 
HR1\'IS (El) m/z calcd for C17H15NO2 265.1097, found 265.1094. 
5-o-Tolyl-2-p-tolyl-oxazole (181b) 
N Me Prepared according to the general procedure. 
Me 0 	
Purification by flash chromatography (silica, DCM 100 
%) gave the coupled product 181b as a white solid (129 
mg, 90 % yield, mp. 87-89 °C); 'H NMR (250 MHz, CDC13) 6 8.24-8.21 (2H, m), 
7.99 (1H, ni), 7.54-7.48 (6H, m); 2.74 (3H, s), 2.62 (3H, s); '3C NMR (63 MHz, 
CDC13) 6 161.0 (quat), 150.3 (quat), 140.5 (quat), 134.7 (quat), 131.1 (CH), 129.4 
(CH), 128.2 (CH), 127.3 (quat), 126.7 (CH), 126.2 (CH), 126.1 (CH), 126.0 (CH), 
124.7 (quat), 21.8 (CH3), 21.4 (CH3); HRMS (El) m/z calcd for C17H15N0 249.1148, 
found 249.1146. 
2-Phenyl-5-(4-trifluoromethyl-phenyl)-oxazole (182a) 
N 
Prepared according to the general procedure. 
0 	
\ / CF3  Purification by flash chromatography (silica, DCM 100 
%) gave the coupled product 182a as a white solid (134 mg, 80 % yield, Mp. 97-99 
°C). 'H NMR (250 MHz, CDC13) 6 8.13-8.09 (2H, m), 7.79 (2H, d, J= 8.2 Hz), 7.67 
(2H, d, J= 8.2 Hz), 7.52-7.47 (4H, m); '3C NMR (63 MHz, CDC13) 6 161.9 (quat), 
149.7 (quat), 131.2 (quat), 130.7 (quat), 128.8 (CH), 127.0 (quat), 126.4 (CH), 125.2 
(CH), 124.1 (CH)-(not all peaks assigned); HRMS (El) m/z calcd for C16H10F3N0 
289.0709, found 289.0708. 
2-(4-Methoxy-phenyl)-5-(4-trifluoromethyl-phenyl)-oxazole (182c) 
N 
MeOII 1' 	
Prepared according to the general procedure. 
-CF3  Purification by flash chromatography (silica, 
DCM 100 %) gave the coupled product 182c as a white solid (178 mg, 97 % yield, 
Mp. 132-133 °C); H NMR (250 MHz, CDC13) 8  8.07-8.03 (2H, m), 7.79 (2H, d, J= 
8.2 Hz), 7.68 (2H, d, .1= 8.7 Hz), 7.50 (1H, s), 7.02-6.98 (2H, m), 3.88 (3H, s); 13C 
NMR (63 MHz, CDC13) 6  162.1 (quat), 161.7 (quat), 149.3 (quat), 131.4 (quat), 
128.2 (CH), 125.1 (CH), 124.0 (CH), 119.8 (quat), 114.3 (CH), 55.4 (CH3)-(not all 
peaks assigned); HRMS (El) m/z calcd for C17H12F3NO2 319.0815, found 319.0812. 
2-p-ToIyl-5-(4-trifluoromethyl-phenyl)-oxazole (182b) 
\ 	 Prepared according to the general procedure. 
Me 	
.- 	0 ' / CF3 Purification by flash chromatography (silica, 
DCM 100 %) gave the coupled product 182b as a white solid (144 mg, 82 % yield, 
Mp. 98-100 °C); 'H NMR (250 MHz, CDC13)  6 8.02-7.99 (2H, m), 7.80 (2H, d, J 
7.5 Hz), 7.67 (2H, d, J= 7.5 Hz), 7.53 (1H, s), 7.32-7.28 (2H, m), 2.35 (3H, s); 13C 
MN 
NMR (63 MHz, CDC13) 6  162.2 (quat), 149.5 (quat), 141.1 (quat), 131.3 (quat), 
129.6 (CH), 126.4 (CH), 125.1 (CH), 124.3 (quat), 124.1 (CH), 21.6 (CH3)-(not all 
peaks assigned); HRMS (El) m/z calcd for C17H12F3N0 303.0866, found 303.0867. 
5-(3-Nitro-phenyl)-2-phenyl-oxazole (183a) 
N NO 2  Prepared according to the general procedure. 
o 	
/ Purification by flash chromatography (silica, DCM 100 %) 
gave 183a as a pale yellow solid (129 mg, 84 % yield, Mp. 145-147 °C). 1H NMR 
(250 MHz, CDC13) 6 8.53 (1H, t, J= 1.9Hz), 8.19-8.10 (3H, m), 8.00 (1H, m), 7.63 
(1H, m), 7.59 (IH, s), 7.52-7.49 (3H, m); '3C NMR (63 MHz, CDC13) 6 162.1 (quat), 
148.9 (quat), 148.8 (quat), 130.9 (CH), 130.0 (CH), 129.6 (quat), 129.5 (CH), 128.9 
(CH), 126.8 (quat), 126.5 (CH), 125.5 (CH), 122.7 (CH), 118.8 (CH); HRMS (El) 
m/z calcd for C15H10N203 266.0686, found 266.0687. 
2-(4-Methoxy-phenyl)-5-(3-nitro-phenyl)-oxazole (183c) 
NO2  Prepared according to the general procedure. 
MeO 0 	 Purification by flash chromatography (silica, 
DCM 100 %) gave the coupled product 183c as a yellow solid (145 mg, 85 % yield, 
Mp. 196-198 °C); 1H NMR (250 MHz, CDC13) 6  8.53 (1H, t, J= 1.8 Hz), 8.17 (1H, 
m), 8.09-8.06 (2H, m), 8.00 (1H, m), 7.62 (1H, t, 1= 7.5 Hz), 7.56 (1H, s), 7.04-7.00 
(2H, m), 3.89 (3H, s); 13  NMR (63 MHz, CDC13) 6  161.8 (quat), 148.8 (quat), 
148.4 (quat), 130.0 (CH), 129.8 (quat), 129.4 (CH), 128.3 (CH), 128.2 (quat), 125.3 
(CH), 122.5 (CH), 119.6 (quat), 118.7 (CH), 114.4 (CH), 55.5 (CH3); HRMS (El) 
m/z calcd for C16H12N204 296.0792, found 296.0790. 
5-(3-Nitro-phenyl)-2-p-tolyl-oxazole (183b) 
N-3 
	NO2  Prepared according to the general procedure. 
Me 	
_- 	0 	\ / 	Purification by flash chromatography (silica, DCM 
100 %) gave the coupled product 183b as a pale yellow solid (129 mg, 80 % yield, 
Mp. 157-159 °C); 1H NMR (250 MHz, CDC13) 6 8.55 (1H, t, J= 2.0 Hz), 8.15 (1H, 
m), 8.02-7.97 (3H, m), 7.61 (1H, t, J= 8.3 Hz), 7.56 (1H, s), 7.32-7.26 (2H, m), 2.43 
(3H, s); 13C NMR (63 MHz, CDC13) 6 162.4 (quat), 148.7 (quat), 148.5 (quat), 141.3 
(quat), 130.0 (CH), 129.7 (quat), 129.6 (CH), 129.4 (CH), 126.5 (CH), 125.4 (CH), 
124.1 (quat), 122.6 (CH), 118.7 (CH), 21.5 (CH3); HRMS (El) m/z calcd for 
C16H12N203 280.0842, found 280.0843. 
2-Phenyl-5-p-toiyl-oxazole (184a) 
	
N- 	 Prepared according to the general procedure. cr--, 0 	Me Purification by flash chromatography (silica, DCM 100 
%) gave the coupled product 184a as a white solid (102 
mg, 75 % yield, Mp. 74-75 °C); 1H NMR (250 MHz, CDC13)  6 8.04-8.00 (2H, m), 
7.55-7.51 (2H, m), 7.40-7.37 (3H, m), 7.31 (1H, s), 7.18-7.15 (2H, m), 2.30 (3H, s); 
'3C NMR (63 MHz, CDC13) 6 161.8 (quat), 151.5 (quat), 138.5 (quat), 130.2 (CH), 
129.6 (CH), 128.8 (CH), 127.5 (quat), 126.2 (CH), 125.3 (quat), 124.1 (CH), 122.8 
(CH), 21.3 (CH3); HRMS (El) m/z calcd for C16H13N0 235.0992, found 235.0994. 
2-(4-Methoxy-phenyl)-5-p-tolyl-oxazole (184c) 
N 
/ \ 	
/\ 	 Prepared according to the general procedure. 
0 
\ / Me Purification by flash chromatography (silica, 
DCM 100 %) gave the coupled product 184c as a white solid (149 mg, 97 % yield, 
Mp. 102-104 °C); 1 H NMR (250 MHz, CDC13) 6 7.98-7.94 (2H, m,), 7.53-7.50 (2H, 
in, 7.27 (1H, s), 7.18-7.14 (2H, m), 6.93-6.89 (2H, m), 3.79 (3H, s), 2.31 (3H, s); 13C 
NMR (63 MHz, CDC13)  6 161.3 (quat), 160.9 (quat), 150.9 (quat), 138.2 (quat), 
129.5 (CH), 127.9 (CH), 125.4 (quat), 124.0 (CH), 122.5 (CH), 120.3 (quat), 114.2 
(CH), 55.4 (CH3), 21.3 (CH3); HRMS (El) m/z calcd for C17H15NO2 265.1097, found 
265.1096. 
2.5-Di-p-tolyl-oxazole (184b) 
O
-Me 
Prepared according to the general procedure. 
/ \ 	
Purification by flash chromatography (silica, DCM 
/ Me 100 %) gave the coupled product 184b as a white 
solid (140 mg, 97 % yield, Mp. 106-107 °C ); 'H NMR (250 MHz, CDC13) 8 8.19 
(2H, d, .1= 8.3Hz), 7.80 (2H, d, J= 7.8Hz), 7.57 (1H, s), 7.45-7.41 (4H, m), 2.60 (3H, 
s), 2.58 (3H, s); '3C NMR (63 MHz, CDC13) 6  161.0 (quat), 151.1 (quat), 140.4 
(quat), 138.3 (quat), 129.5 (CH), 129.4 (CH), 126.1 (CH), 125.3 (quat), 124.8 (quat), 
124.0 (CH), 122.6 (CH), 21.4 (CH3), 21.3 (CH3); HRMS (El) m/z calcd for 
C17H15N0 249.1148, found 249.1147. 
5-(4-Bromo-phenyl)-2-(4-methoxy-phenyl)-oxazole (187c) 
Prepared according to the general procedure. 
0 	
Purification by flash chromatography (silica, 
MeO 
/ Br DCM 100 %) gave the coupled product 187c as a 
white solid (158 mg, 83 % yield, Mp. 137-139 °C); 'H NMR (250 MHz, CDC13)  ö 
8.03-7.99 (2H, m), 7.53 (4H, s), 7.38 (1H, s), 6.99-6.96 (2H, m), 3.85 (3H, s); '3C 
NMR (63 MHz, CDC13) 6 161.4 (quat), 149.6 (quat), 132.0 (CH), 127.9 (CH), 127.0 
(quat), 125.4 (CH), 123.7 (CH and quat), 121.9 (quat), 119.9 (quat), 114.2 (CH); 
HRMS (El) m/z calcd for C,6H,2BrNO2 (Br 79)329.0046, found 329.0060, calcd for 
C16H12BrNO2 (Br") 331.0026, found 331.0009. 
1- 14-(2-Phenyl-oxazol-5-5-yI)-phenyll -ethanone (188a) 
N- 
Prepared according to the general procedure. 
0 	M Pufication by flash chromatography (silica, DCM 
100 %) gave the coupled product 188a as a white 
solid (131 mg, 86 % yield, Mp. 105-106 °C); 'H NMR (250 MHz, CDC13) 6  8.11-
8.07 (2H, m), 8.01-7.98 (2H, m), 7.77-7.73 (2H, m), 7.53 (1H, s), 7.48-7.45 (3H, m), 
2.59 (3H, s); '3C NMIR (63 MHz, CDC13) 5  196.9 (quat), 161.9 (quat), 150.1 (quat), 
136.3 (quat), 131.9 (quat), 130.62 (CH), 129.0 (CH), 128.8 (CH), 127.0 (quat), 126.4 
(CH), 125.5 (CH), 123.9 (CH), 26.5 (CH3); HRMS (El) m/z calcd for C17H13NO2 
263.0941, found 263.0950. 
1-{4-[2-(4-Methoxy-phenyl)oxazol-5-yI]-phenyl}-ethanone (188c) 
Prepared according to the general procedure. 
MeO-a--I O Me Purification by flash chromatography (silica, 
0 	DCM 100 %) gave the coupled product 188c as 
a off-white solid (151 mg, 89 % yield, Mp. 148-150 CC); 1H NMR (250 MHz, 
CDC13) 6 8.04-7.80 (4H, m), 7.76-7.72 (2H, m), 7.51 (1H, s), 6.99-6.96 (2H, m), 3.86 
(3H, s), 2.60 (3H, s); '3C NMR (63 MHz, CDC13) 6 197.1 (quat), 162.1 (quat), 161.6 
(quat), 149.6 (quat), 136.2 (quat), 132.1 (quat), 129.0 (CH), 128.1 (CH), 125.4 (CH), 
123.7 (CH), 119.8 (quat), 114.3 (CH), 55.4 (CH3), 26.5 (CH3); HRMS (El) m/z calcd 
for C18H15NO3 293.1046, found 293.1044. 
1- 14-(2-p-Tolyl-oxazol-5-y1)-phenylI -etha none (188b) 
N 	 Prepared according to the general procedure. 
l\ J1 
MeT 'O \ / 	
Me Purification by flash chromatography (silica, 
0 	DCM 100 %) gave the coupled product 188b as 
a white solid (149 mg, 93 % yield, Mp. 132-134 °C); 1H NMR (250 MHz, CDC13) 6 
7.87-7.82 (4H, m), 7.62-7.59 (2H, d, J= 8.5 Hz), 7.38 (1H, s), 7.13 (2H, d, J= 8.0 
Hz), 2.45 (3H, s), 2.26 (3H, s); '3C NMR (63 MHz, CDC13) 6 197.0 (quat), 162.2 
(quat), 149.8 (quat), 141.1 (quat), 136.2 (quat), 132.1 (quat), 129.5 (CH), 129.0 
(CH), 126.4 (CH), 125.5 (CH), 124.3 (quat), 123.8 (CH), 26.5 (CH3), 21.5 (CH3); 
HRMS (El) rn/z calcd for C18H15NO2 277.1097, found 277.1095. 
2-(4-Methoxy-phenyl)-5-naphthalen-1-yl-oxazole (189c) 
Prepared according to the general procedure. 
Purification by flash chromatography (silica, DCM 
Me0 	 100 %) gave the coupled product 189c as a white 
solid (132 mg, 76 % yield, Mp. 72-74 °C); 'H NMR (250 MHz, CDC13) 6 8.37 (1H, 
m), 8.12-8.08 (2H, m), 7.92-7.81 (3H, m), 7.59-7.51 (4H, m), 7.04-7.00 (2H, m), 
3.89 (3H, s); '3C NMR (63 MHz, CDC13) 6  161.6 (quat), 161.4 (quat), 149.9 (quat), 
133.9 (quat), 130.1 (quat), 129.3 (CH), 128.7 (CH), 128.0 (CH), 127.0 (CH), 126.5 
(CH), 126.2 (2x CH), 125.5 (quat), 125.3 (CH), 124.9 (CH), 120.2 (quat), 114.3 
(CH), 55.3 (CH3); HRMS (El) m/z calcd for C20H15NO2 301.1097, found 301.1092. 
5-Naphthalen-1-yl-2-p-tolyl-oxazole (189b) 
Prepared according to the general procedure. 
Purification by flash chromatography (silica, DCM 
MeJ 
	 100 %) gave the coupled product 189b as a white 
solid (133 mg, 81 % yield, Mp. 114-116 °C). 'H 
NMR (250 MHz, CDC13) 6 8.38 (1H, m), 8.09-8.05 (2H, m), 7.94-7.82 (3H, m), 
7.63-7.52 (4H, m), 7.34-7.30 (2H, m); '3C NMR (63 MHz, CDC13) 6 161.7 (quat), 
150.1 (quat), 140.6 (quat), 133.9 (quat), 130.1 (quat), 129.5 (CH), 129.4 (CH), 128.7 
(CH), 127.0 (CH), 126.7 (CH), 126.3 (CH), 126.2 (CH), 125.4 (quat), 125.3 (CH), 
124.9 (CH), 124.8 (quat), 21.5 (CH3); HRMS (El) m/z calcd for C20H15N0 
285.1148, found 285.1144. 
Balsoxin (145) 
OMe 	Prepared according to the general procedure. 
)-I/ We 	Purification by flash chromatography (silica, DCM 
100 %) gave the coupled product 145 as a white solid (136 mg, 84 % yield) with 
identical spectral data to that previously reported: 111  NMR (250 MHz, CHCI3) 
8.11-8.07 (2H, m), 7.50-7.44 (3H, m), 7.33 (1H, s), 7.30 (1H, dd, J= 2.00Hz, 8.4Hz), 
7.19 (1H, d, J= 2.0Hz), 6.93 (1H, d, J= 8.4Hz), 3.90 (3H, CH3), 3.85 (3H, CH3); 13C 
NMR (63 MHz, CDC13) 6 160.5 (quat), 151.2 (quat), 149.4 (quat), 149.3 (quat), 
130.1 (CH), 128.7 (CH), 127.5 (quat), 126.1 (CH), 122.2 (CH), 121.0 (quat), 117.2 
(CH), 111.4 (CH), 107.4 (CH), 56.0 (CH3), 55.9 (CH3); Mp. 149-150°C; HRMS 
(El) m/z calcd for C17H15NO3 281.1046, found 281.1046. 
Texaline (36) 
N-- 
Prepared according to the general procedure. 
Purification by flash chromatography (silica, DCM 100 
%) gave the coupled product 36 as a white solid (114 
mg, 74 % yield) with identical spectral data and melting point to that previously 
reported. 'H NMR (250 MHz, CDC13)  6 9.29 (1H, d, J= 1.5Hz), 8.66 (1H, dd, J= 
1.7Hz, 4.9Hz), 8.30 (lH, m), 7.38 (1H, dd, J= 4.9Hz, 8.0Hz), 7.31 (1H, s), 7.21 (1H, 
dd, J= 1.8Hz, 8.0Hz), 7.14 (1H, d, J= 1.7Hz), 6.90 (1H, d, J= 8.3Hz), 6.00 (2H, s); 
'3C NMR (63 MHz, CDC13) 6 158.12 (quat), 151.83 (quat), 150.75, 148.23 (quat), 
148.14 (quat), 147.40 (CH), 133.12 (CH), 123.63 (quat), 123.49 (CH), 122.47 (CH), 
121.68 (quat), 118.53 (CH), 108.85 (CH), 104.82 (CH), 101.42 (CH2); HRMS (El) 
m/z calcd for C15H,0N203 266.0685, found 266.0684. Mp. 166-168°C. 
3-(2-Phenyl-oxazol-5-yI)-pyridine (190a) 
N 	Prepared according to the general procedure. Purification by 
/ 
I 	 0 	\ / flash chromatography (silica, EtOAc 100 %) gave the 
coupled product 190a as a white solid (42 mg, 36 % yield); 
'H NMR (250 MHz, CDC13) 6 8.99 (1H, dd, J= 0.77Hz, 2.3 Hz), 8.57 (1H, dd, J= 
1.6Hz, 4.8 Hz), 8.12-8.08 (2H, m), 7.98 (1H, ddd, J= 1.7Hz, 2.2Hz, 8.0 Hz), 7.52-
7.47 (4H, m), 7.35 (1H, ddd, J=  0.8Hz, 4.9Hz, 8.0 Hz); '3C NMR (63 MHz, CDC13) 
6 161.9 (quat), 149.3 (CH), 148.4 (quat), 145.6 (CH), 131.1 (CH), 130.6 (CH), 128.8 
(CH), 127.0 (quat), 126.4 (CH), 124.7 (CH), 124.3 (quat), 123.6 (CH); Mp. 153-
156°C; HRrvIS (El) m/z calcd for C14H10N20 222.0793, found 222.0791. 
3- 12-(4-Methoxy-phenyl)-oxazol-5-yll -pyridine (190c) 
N-)N 
Prepared according to the general procedure. 
MeO 	0 
	CON 
/ Purification by flash chromatography (silica, 1:1 
hexane / ethyl acetate) gave the coupled product 190c 
as a white solid (44 mg, 30 % yield); 'H NMR (250 MHz, CDC13) 6 8.98 (1H, s), 
8.57-8.55 (2H, m), 8.08-8.03 (2H, m), 7.96 (1H, m), 7.49 (1H, s) 7.39-7.34 (1H, m), 
88 
7.02-6.98 (2H, m), 3.88 (3H, s); 13C NMR (63 MHz, CDC13)  6 162.1 (quat), 161.6 
(CH), 149.0 (quat), 147.8 (quat), 145.4 (CH), 131.0 (CH), 128.1 (CH), 124.6 (CH), 
123.6 (quat), 119.8 (quat), 114.3 (CH), 55.4 (CH3); MP.  160-161°C; HRMS (El) m/z 
calcd for C15H12N202 252.0895, found 252.0895. 
3-(2-p-ToIyl-oxazol-5-yI)-pyridine (190b) 
N 
IIItiII 
Prepared according to the general procedure. 
Me  Purification by flash chromatography (silica, 1:1 
hexane / ethyl acetate) gave the coupled product 190b as a white solid (45 mg, 33 % 
yield); 111  NMR (250 MHz, CDC13)  6 8.98 (1H, s), 8.57 (1H, s), 8.01-7.95 (3H, m), 
7.51 (1H, s), 7.37-7.26 (2H, m), 2.42 (3H, s); '3C NMR (63 MHz, CDC13) 6 162.2 
(quat), 149.1 (CH), 148.1 (quat), 145.5 (CH), 141.1 (quat), 131.1 (CH), 129.6 (CH), 
126.4 (CH), 124.6 (CH), 124.4 (quat), 123.6 (quat), 21.5 (CH3); MP-  144-148 °C; 
HR1VIS (El) rn/z calcd for C15H12N20 236.0950, found 236.0950. 
2-(4-Chloro-phenyl)-5-phenyloxazole (212) 
N 	 Prepared according to the general procedure for the 
direct arylation on the 5-position. Purification by flash 
chromatography (silica, DCM 100 %) gave the coupled 
product 212 as an off-white solid (105 mg, 71 % yield) with identical spectral data to 
that previously reported. 152 1H NMR (250 MHz, CDC13)  8.04-8.01 (2H, m), 7.72-
7.69 (2H, m), 7.48-7.41 (6H, m); '3C NMIR (63 MHz, CDC13)  6 160.1 (quat), 151.5 
(quat), 136.3 (quat), 129.1 (CH), 129.0 (CH), 128.6 (CH), 127.8 (quat), 127.5 (CH), 
125.9 (quat), 124.2 (CH), 123.5 (CH). 
2-(4-Methoxyphenyl)-5-(2-(4-methoxyphenyl)oxazole-5-yI)oxazole (192) 
MeOth 
o 
OMe 
Prepared according to the genearal 
procedure for the direct arylation on the 
5-position. Purification by flash 
chromatography (silica, DCM 100%) 
gave the homocoupled product in 28% yield. 'H NMR (250 MHz, CDC13) 6 7.95 
21 
(4H, d, J= 8.6Hz), 7.12 (2H, s), 6.94 (4H, d, 1= 8.6Hz), 3.86 (6H, s). '3C NMR (63 
MHz, CDCI3) 6  162.1 (quat), 161.3 (quat), 138.0 (quat), 128.2 (quat), 128.0 (CH), 
120.4 (CH), 114.2 (CH), 55.4 (CH3). Mp. Not available. HRMS: Not available. 
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2.1. Introduction 
2.1.1 Pyrazole and Indazole Numbering and Tautomerism 
Pyrazole is an aromatic 5-membered heterocyclic ring with two nitrogens directly 
next to each other. Following IUPAC rules for heterocyclic structures such as this 
1 ,2-diazole, the first nitrogen is given the number one position, the second nitrogen 
adjacent to the first one is given the number two and the following carbons are then 
numbered in an increasing order from three to five. Tautomerism plays an important 
role in the unsubstituted pyrazole core structure. The nitrogen which is bearing the 
hydrogen is always referred to as the first nitrogen. 111,114  This is of particular interest 
when considering the reactivity of the carbon atoms around the ring and will be 
discussed in detail later in this thesis. 
5[ ,N2. NH 
213 
Figure 14. Numbering and tautomerism of the pyrazole parent heterocycle. 
Indazole, much like pyrazole exists in different tautomeric forms as shown below. 
The indazole building block is aromatic in its nature and contains a 5-membered 
pyrazole fragment which is substituted on two of the three carbons. Indazoles can 
exist as 1H-indazoles or 2H-indazoles. The more stable tautomer, when nitrogen is 
unsubstituted, is the 1H-indazole. The numbering of indazoles, much different than 
the numbering of pyrazoles, does not change depending on the tautomer. 
Commencing with the heteroatom closest to the benzene moiety (Ni) the ring is then 
numbered following IUPAC rules with nitrogen two being (N2) and the sole 
unsubstituted carbon atom of the 5-membered ring becoming (0). Spectroscopically 
all the carbons and hydrogens (NH is rapidly exchanged) of these two structures lie 
within the aromatic regions of the 'H and '3C NMR spectra, further underlining the 
aromatic nature of these compounds. 153,154 
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4. 	
3. 
2 	 NH 
6. 	N 
	
1H-Indazole 	2H-Indazole 
214a 	 214b 
Figure 15. Numbering and tautomerism of indazole. 
Pyrazole and indazole are planar compounds with a conjugated it-electron sextet in 
the cyclic system. The two electrons on the tertiary nitrogen are available for 
donation and give rise to the Lewis basicity while the lone pair of the NH nitrogen is 
involved in the it-electron system. 153,154 
2.1.2 Synthesis of Pyrazoles and Indazoles 
Both the synthesis of pyrazoles and indazoles are generally performed via a classical 
condensation reaction. Pyrazoles are widely generated via a condensation of a 1,3-
dicarbonyl compound with a hydrazine derivative while indazoles are preferably 
synthesised via a condensation of aniline or aniline-analogues with the corresponding 
2-nitro-benzaldehyde. Following the Schifthase formation the imine is then reacted 
with triethyiphosphite to give the 2H-substituted indazole.' 54 
0 0 	 heat 	
R2 
R1 R2 + R
3-NHNH2 	
R3 
215 	 216 	 217 
Scheme 67. Synthesis of substituted pyrazoles using I ,3-dicarbonyl 
compounds. 151 
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H 
NH2 
+ 	
1. 100°C 
I 	 0:_~N_O NO2 	 2. P(OE03 
218 	 219 	150°C 	220 
Scheme 68. Two-step synthesis of 2-phenyl-2H-indazole.154 
The most popular synthetic approach to 1H-substituted indazoles is the condensation 
of 2-hydroxy-benzaldehydes with phenyl hydrazines under refluxing conditions in 
EtOH. 
H 	 NHNH2 
'6 OH 
221 	 216 
EtOH 
1iYN 
reflux 
2-3h 
90% 222 
Scheme 69. Synthesis of 1-Ph-1H-indazole via a condensation reaction. 
This method is highly effective for the generation of 1-phenyl-1H-indazole and its 
analogues. Reaction times are as short as two hours. '54"55 Another synthesis of the 
pyrazole heterocycle is described below (Scheme 70). Using a positive pressure of 
ethyne and diazomethane, this 1,3-dipolar cycloaddition yields the parent pyrazole 
heterocycle without any substituents in excellent yields. 154 
C + 	HC 	
Et20, r.t. 	hi'N 
H2CN 
12-15atm H 
223 	224 	
95% 	213 
Scheme 70. 1,3-dipolar cycloaddition using ethyne to generate unsubstituted 
pyrazole. 154 
2.1.3 Pyrazoles and Indazoles in Natural Products 
Pyrazoles and indazoles, very much like oxazoles belong to the family of 7t-excessive 
heterocycles. Both heterocycles are rather uncommon in nature. To date, only one 
family of natural products containing a pyrazole and only three natural products 
containing an indazole core are known.'56'157 The alkaloid family of withasomnines 
has been reported. 156  Withasomnine (Figure 16, 225) has been isolated from the 
roots of Withania somnfer (Solanaceae), Newbouldia laevis, the shrub Elytraria 
acaulis, and most recently from the stem bark of Discopodium penninervium.' 58 ' 6° 
Withasomnine displays both CNS and circulatory system depressant properties as 
well as being a mild analgesic. 
Ph 
CPN 
225 
Figure 16. Withasomine, a rare pyrazole based natural product. 156 
Nigellidine and nigellicine, both indazole based natural products have been isolated 
from Nigella sativa seeds, which are used for their carminative, stimulatory as well 
as diaphoretic properties. 161 
Me G  SJ Me 
0 	OH 
HO 
226 
	 227 
NigeUidine 
	 Nigellicine 
Figure 17. Two indazole-containing natural products. 
2.1.4 Pyrazoles and Indazoles in Medicinal Chemistry 
Both indazoles and pyrazoles have found broad application in the pharmaceutical 
industry. Pyrazoles in particular have been very successful candidates in the drug 
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development process. Vioxx as well as Celebrex, both COX-11 inhibitors have been 
hailed as potential new blockbuster drugs.' 62,163 
CF 
H 
FN 	I H 
SO2CH3  
228 
Celebrex 
(anti-inflammatory) 
 
229 
RBA 
(anti-cancer) 
 
Figure 18. The pyrazole building-block in medicinal compounds. 
However, both Celebrex and Vioxx have been withdrawn from the market on a 
temporary basis due to side-effects (cardiac arrest). Both of these drugs in addition to 
several others such as pyrazole mevalonolactone (Figure 19, 230) and the anti-cancer 
drug RBA (Figure 18, 229) have the pyrazole fragment as a common feature. It 
should be noted that most pyrazole based pharmaceuticals present with a phenyl 
group (substituted or unsubstituted) on the nitrogen atom. 162,163 
230 
Pyrazole mevalonolactone 
(cholesterol lowering) 
Figure 19. Structure of pyrazole mevalonolactone. 
Indazoles, also known as benzopyrazoles have so far not been marketed as drugs, 
they appear however in the patent literature quite commonly and are associated with 
biological activities towards many drug targets, particularly towards cardiovascular 
diseases.' 64 
2.2 Pyrazole I Indazole Arylations to Date 
2.2.1 N-Arylations 
The N-arylation of pyrazole is a well documented transformation in the literature. 
Generally this type of reaction is catalysed by metals such as copper or cobalt 
(Scheme 71). In 2009, You and co-workers reported the ligand-free Cu-catalysed N-
arylation of pyrazoles. It is noteworthy that these conditions are highly functional 
group tolerant, given that the reactions work well at temperatures as low as 40 °C.165 
	
+ 	
9N Cu I (20%) 	
XIIJ 
NC  
K3PO4 	
MeO MeO 	 H DMF 
231 	213 
400C,40h 	 232 71% 
Scheme 71. Cu-catalysed N-arylation of pyrazole using aryliodides under 
Jeffrey conditions. 165 
Other strategies to generate N-arylated pyrazoles include the iron / copper co-
catalysed reaction of arylbromides or aryliodides with pyrazole. 166 
CuO (10%) 
N 	+ 	I 	
Fe(acac)3 (30/o) 
H 	 CsCO3 (2 eq.) 
DMF, 90°C, 30 hrs 
213 	 106 	 233 
91% 
Scheme 72. Efficient iron / copper co-catalysed arylation of pyrazole. 166 
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Further, Teo and Chua developed an interesting N-arylation in which the components 
are reacted in water. The combination of CoC12 xH20 and the effective ligand N,N-
dimethylethylenediamine allowed the authors to generate a small library of phenyl-
substituted pyrazoles. 167 
I/Br 
213 
CoCl2x6H20 (10%) 	rq7/> 
N  
ligand (20%) 	
R_ 
K3PO4 
H20, 1200C, 36hrs 11 examples 
16-85% 
Scheme 73. Co-catalysed N-arylation of pyrazote using aryihalides. (ligand: 
d med a)167 
An additional example, this time showing the strength of microwave technology, was 
described by Chow et al. in 2009. The authors developed an arylation method using 
amino-acids in addition to the typical copper catalyst needed for such 
transformations. Highlights of this preparation are the lack of solvent as well as the 
introduction of microwave heating to the arylation of pyrazoles. 168 
Br 	
Cut, K3PO4 	 rqo/, 
- 	 N 	L-lysine 	R-J> R H solvent-free 
	
213 	1300C, MW 	6 examples 
27-83% 
Scheme 74. MW-assisted Cu-catalysed N-arylation of pyrazoles using 
arylbromides.'68 
2.2.2 C-Arylations 
Arylation of pyrazoles and indazoles are well known in the literature. 169-171  Pyrazoles 
for example have been arylated using many traditional cross coupling methods such 
as the Stille, Negishi or Suzuki reaction. A Scifinder search for the words 'direct 
arylation' as well as 'indazole' only identified four publications. One of the 
XMI 
publications is a patent regarding the biological activity of indazoles for the 
treatment of diseases associated with protein kinases, showing the medical 
importance of these compounds. The only other relevant article from this query is a 
publication from Laleu and Lautens.'72 The paper describes the one-pot palladium 
catalysed alkylation / direct arylation of 2H-indazoles and triazoles (1,2,3- as well as 
1,2,4-triazoles). Scheme 75 highlights the reaction conditions for this reported 
transformation. It should be noted that the authors added the indazole / triazole 
starting materials via a syringe pump over 20 hrs to avoid catalyst poisoning by the 
nitrogen atoms of the heterocycle. This important problem will be discussed in detail 
in the later stages of this thesis. 
cIIIc:;:; 	
,r—Br 
+ H)J  
234 	 106  
Pd(OAc)2 
ligand, Cs2CO3 
norbornene 	 I Ni 
CH3CN, 900C —N 
53-98% 	 235 
Scheme 75. One-pot alkylation I direct arylation of 2-alkyl-indazoles.172 
Two further examples of direct arylations on similar heterocyclic systems should be 
highlighted in this section. Gevorgyan's palladium catalysed arylation of indolizines 
as described in chapter 1 and Li's palladium catalysed regio-selective arylation of 
imidazo[1,2-a]pyrimidine (236) are clearly closely related and of interest (Scheme 
76). 
Pd(OAc)2 I PPh 
	
Br Cs2CO3 
-~- ~ D—	
L 	7> N.  
N / 0 
+	
1000C, 1 8h 
236 	 129 	
dioxane 	 237 
96% 
Scheme 76. Li and co-workers' Pd-catalysed direct arylation of imidazo[1 ,2-
a]pyrimidine.173 
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As proposed in Gevorgyan's work, Li and colleagues support a mechanism based on 
the electrophilic substitution for these type of molecules. The authors argue that the 
substitution occurs on the imidazole-type part of the compound as it is it-excessive 
with the Western part of the molecule being it-deficient and more likely to be 
attacked by a nucleophile in the positions directly adjacent to the nitrogens, but not 
reactive towards electrophilic substitution.' 73 
The direct arylation of pyrazoles is as uncommon in the literature as the direct 
arylation of indazoles. Firstly, one has to clearly distinguish between the TM-
catalysed direct arylation of pyrazole itself, or the TM-catalysed direct arylation of a 
substituent (such as a phenyl group), which is coupled to one of the nitrogens of the 
pyrazole (also referred to as 'ortho' arylation or 'ortho' direct arylation). The latter is 
a direct arylation of pyrazole based on the directing effects of the nitrogen and is 
generally catalysed by ruthenium as highlighted by much of Ackermann's work. 174 
The concept of using a directing group to control regio selectivity of the subsequent 
transition-metal insertion into a C-H bond was initially reported by Dubeck and 
Kleinman over four decades ago. 175 
9 _ 9 
NN + Cp2Ni 	 CpNi' 
6 
239 
238 	 240 
Scheme 77. First regioselective directing group controlled metallation. 
100 
I NJ 9/, \ 
6 
+ 0 
233 	 129 
RuCI3xH20 (5%) 
K2CO3, 22h 
NMP, 120°C 
64% 
Nfl 
241 
Scheme 78. Ackermann's Ru-catalysed di-ortho arylation of phenyl 
pyrazole.'74 
The only palladium catalysed mono-ortho arylation examples to date were published 
in 2005 by Daugulis and co-workers. 176  The authors described a rather harsh method 
to arylate phenyl-pyrazole using 3 - 5 eq. of aryliodides, 1 - 3 eq. of a silver base as 
well as 5 % catalyst. Reaction times ranged from 42 - 165 hrs (!) and temperatures 
were in the range of 110- 130 °C. 
N') Me Pd(OAc)2 1) Me 
N 	 AgOAc 	N - 
+ 	
110-1300C 
42-l65hrs 
233 	 242 	AcOH 	 243 61% 
Scheme 79. Mono-ortho arylation of phenyl-pyrazole using Pd-catalyst. 176 
Ortho arylation / directing group arylation of heterocycles and its substituents is a 
highly interesting and much researched field (see thesis of Dr. Turner, Greaney 
group, 2008), however we will not discuss this area in detail in this document. 
Recent examples of directing group arylations of heterocycles such as pyridine, 
oxazoline, imidazole etc. exist in the literature. 177-179 
An excellent example showing the power of direct arylation methodology work was 
recently described by Sames et al. This article was published while research on this 
topic was ongoing in our laboratories. Sames described the 5-arylation of SEM-
protected pyrazoles using arylbromides for this sp2-coupling.180  
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Ar 	 Ar 	 SEM-Switch 
Ar-Br  
	
Pd cat. Ar 	SEM-CI (10%) 
SEM 	 SEM CH3CN, reflux 
244 	 245 
Ar 
Ar 	
Ar)~N—SEM 
Ar-Br
N SEM  
Ar N 	Pd cat. 	Ar N 
246 	 247 
Scheme 80. Multiple direct arylations on SEM-protected pyrazole.180 
The above described 5-arylation of pyrazoles represents the first direct arylation of 
any pyrazole in the literature. A highly exciting SEM-switch was used to transform 
the unreactive 3-position into a 5-position. This switch allows for a second direct 
arylation. It is known from empirical data (reported in the above paper) that the 5-
position of N-substituted pyrazole is most acidic, the 4-position is most nucleophilic 
and the 3-position is mostly unreactive as it is neither electron rich nor as acidic as 
the 5-position.' 80 
unreactive 	nucleophilic 
position 
CH position 
- roost acidic 
\ 	5 	C-H bond 2 N-N1 
R 
Figure 20. Reactivity of N-substituted pyrazole. 180 
The SEM-switch allows the previously unreactive 3-position to become a 5-position 
and therefore react in the same way as the initial step of the above sequence. It 
should be noted that the authors of the publication above have not commented or 
investigated any N-phenyl substituted pyrazoles. 
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The only further example of a pyrazole direct arylation was also published by Sames 
and coworkers.18 ' This report in 2003 described the reaction of the parent pyrazole 
heterocycle with iodobenzene under Grignard conditions in which the 3-position of 
pyrazole could be arylated using palladium catalysis. This report however was again 
retracted by Sames on June 21st  2006. 
2.3 Aims of Project 
The importance of pyrazoles and related structures in medicinal chemistry and drug 
discovery is undisputed. 162-16'  The goal of this project was to identify mild and clean 
reaction conditions for the direct transformation of the parent heterocycles into late-
stage-diversified analogues. Traditionally, many of the pyrazole and indazole 
structures have to be diversified at an early stage, sometimes prior to a low-yielding 
condensation reaction. Recent developments of TM-catalysed cross couplings have 
allowed a late stage diversification. However, both the parent heterocycle as well as 
the arylhalide or pseudohalide have to be functionalised prior to the coupling 
reaction as described in the first chapter of this thesis. We seek to develop a method 
to utilise our previously successful on water chemistry to directly arylate pyrazoles 
and indazoles in a mild, selective and efficient fashion. 
2.4 Results and Discussion 
2.4.1 Preparation of Starting Materials 
Starting materials for the screening of the on water conditions were synthesised using 
the previously described (vide supra) methods for the generation of N-aryl-pyrazoles. 
Best yields were obtained when utilising the copper I iron co-catalysed conditions 
described in scheme 72.166 
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2.4.2 Initial Screening and Optimisation 
Initial trial reactions on the on water direct arylation of pyrazoles were performed by 
Clemmentine Stubbs, supervised by Stephan Ohnmacht during a five-month B.Sc. 
thesis at the University of Edinburgh. Initial screening of the previously published on 
water conditions as described by Turner et al. (2007) and Ohnmacht et. al. (2008) 
yielded several arylated pyrazoles in yields of up to 30 %, isolated. '22'182 Following 
the departure of C.Stubbs, I was asked to investigate these reactions further. 
MeO> 
232 
MeO +  
231 
Pd(dppf)C12 (5%) 
PPh3 (10%) 
A92003 (2 eq.) 
water, 16 hrs, 600C 
MeO 
In 
MeOZJ 248 
Scheme 81. Discovery of reactivity of pyrazole towards on water direct 
arylation. 
10 
7 
Figure 21. X-ray crystal structure of 5-arylated pyrazole 248. 
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Having supervised the on water attempts to arylate pyrazole with no organic 
solvents, while also growing crystals to obtain a crystal structure to determine the 
regioselectivity of these reactions, it was decided to investigate the use of organic 
solvents for such a transformation. Table 7 shows a general solvent screen. 
Table 7. Screening of organic solvents. 
/\ + CN 
Meoxi 	
//N) 
231 	233 
conditions 
l6hrs 	
/ 
249 
MeD 
Temp. ('C)  Base(2eq.) Solvent Pd-source(5%) Ligand Product 
1  120 A92CO3 NMP Pd(dppf)C12 PPh3 Formeda) 
120 Ag2003 Dioxane Pd(dppf)C12 PPh3 Formeda) 
120 A92003 THF Pd(dppf)C12 PPh3 Noconv. 
h' 120 A92003 Benzene Pd(dppf)C12 PPh3 Formeda) 
V.  120 A92003 DMF Pd(dppf)C12 PPh3 Formeda) 
14. 120 A92003 o-Xylene Pd(dppf)C12 PPh3 Formeda) 
120 A92003 MeCN Pd(dppf)C12 PPh3 Noconv. 
 120 A92003 DMSO Pd(dppf)012 PPh3 Formeda) 
 60 A92003 Neat Pd(dppf)C12 PPh3 Formeda) 
X. 120 A92003 
Ethyldiglycol  Pd(dppf)C12 PPh3 Noconv. 
' 	Product is formed but conversion is lower than with the 'on water' reaction. 
Entry 1. to x. (Table 7) provide an overview over the success of organic solvents for 
the 5-arylation of phenyl-pyrazole (233). It can be seen that none of the solvents of 
choice have performed better than the on water conditions previously examined. 
Increased temperatures and complete solubility of the starting materials (not the 
silver source) drastically increased the occurrence of side-reactions such as homo-
coupling of the halide. None of the above reactions occurred in a clean fashion and 
therefore showed no advantage over the already existent on water reactions. No 
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further investigations into the use of organic solvents were initiated. Focus was 
directed towards the optimisation of our own on water methodology. 
Table 8. Buchwald ligand screen using Pd(OAc)2 catalyst. 
MeOxc~' + 
231 	233 
conditions 
16 hrs 
MeO 
Car. % Base Soli'. Pd-source Ligand Product 
5 A92003 H20 Pd(OAc)2 1 No cony. 
ii. 5 A92003 H20 Pd(OAc)2 2 No cony. 
5 A92003 H20 Pd(OAc)2 3 No cony. 
iv. 5 A92003 H20 Pd(OAc)2 4 No cony. 
V. 5 A92003 H20 Pd(OAc)2 5 No cony. 
Ali. 5 A92003 H20 Pd(OAc)2 6 No cony. 
vii. 5 A92CO3 H20 Pd(OAc)2 7 No cony. 
5 A92003 H20 Pd(OAc)2 8 No cony. 
Early attempts to optimise our conditions focused on a ligand screen. Novartis UK 
(Dr. A.J. Cuishaw) kindly provided our laboratories with a Buchwald ligand screen 
kit as sold by Aldrich UK. Eight sterically demanding and electronically diverse 
Buchwald ligands (Table 8 and Figure 22) were screened using phenyl-pyrazole 
(233) and the previously moderately successful 4-iodo-anisole (231). 
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Figure 22. Selection of screened Buchwald ligands. 
Pd(OAc)2 was the catalyst of choice as most of the Buchwald ligand literature uses 
either PdC12 or Pd(OAc)2, as the Pd" source. 183 Unfortunately none of the ligands, 
including a test-reaction with PPh3 as the ligand, promoted the formation of an 
arylated pyrazole product. 
Before focusing our research efforts entirely into the strictly Pd-catalysed direct 
arylation, we decided to investigate other potential active transition metals such as 
Rh, Re, Ru and Ce. Table 9 shows the outcome of a detailed screening of available 
metal sources in the Greaney group. It is noteworthy that TM-sources B-E gave 
traces of the desired product on the LCMS. This has to be interpreted with caution as 
the same reaction, without any TM, also provides traces of product. A92CO3 is 
believed to be the reason for this small turnover. If the reaction is run without any 
silver source or with a substitute base such as K2CO3, it does not promote any 
product formation at all. 
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Table 9. TM-screening using 'on water' conditions. 
/\ 	
/N 
MeO 	
+ 
231 	233 
conditions 
çO 16 hrs 
249 
MeO 
Temp. (°C) Base(2eq.) So/v. TM-sowrce(5%) Ligand Product 
1. 60 A92003 H20 A PPh3 No cony. 
u. 60 A92003 H20 B PPh3 Traces 
60 A92003 H20 C PPh3 Traces 
h' 60 A92003 H20 0 PPh3 Traces 
1. 60 A92003 H20 E PPh3 Traces 
vi. 60 A92003 H20 F PPh3 No cony. 
vii. 60 A92CO3 H20 G (± ligand 1) PPh3 No cony. 
viii. 60 A92CO3 H20 H (+ ligand 2) PPh3 No cony. 
ix. 60 A92003 H20 I PPh3 No cony. 
X. 60 A92CO3 H20 K PPh3 No cony. 
A 60 A92003 H20 L PPh3 No cony. 
A = 251, B = 252, C = 253, D = 254, E = 255, F = 256, G = 257, H = 258, I = 259, K = 260, L = 261. 
>- lrH 
NH 
P—< 
251 
Chlorodihydrido[bis(2-di-i-propylphosphino 
-ethyl)amine]iridium(III) 
o=c 	C° 
--A< 
252 
Pentamethyl cyclopentadienyl 
rhenium tricarbonyl 
CI——Q 
253 
Chloro[(1 ,2,3-n)-3-phenyl-2-propenyl] 
[1 ,3-bis(2,6-di-i-propylphenyl)-4,5-dihydro 
imidazol-2-ylidine]palladium(II) 
Dichloro(di-mu-chloro)bis[1 ,3-bis 
(2,6-di-i-propylphenyl) imidazole-2-ylidine 
dipalladium(II) 
/ 
Fe Pdp 
cI 
255 
Chloro(di-2-norbornylphosphino) 
(2-dimethylaminomethyl ferrocen-1 -yl 
palladium(II) 
Tris-(norbornadiene)-acetylacetonato) 
iridium(ill) 
109 
Palladium acetate 
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Pd(OAc)2 
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Figure 23. Structures of screened transition metals. 
Following the unsuccessful screening of ligands (Table 8) and TM-catalysts (Table 
9) the decision was made to thoroughly examine the use of other N-substituted 
pyrazoles while varying the aryihalide at the same time. Table 10 shows preliminary 
data using the standard conditions developed in the first chapter of this thesis with 
slight changes to the reaction temperature. 
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Table 10. Screening of a variety of N-substituted pyrazoles with differing 
halides. 
+ 	
conditions 
N 	 16hrs 	 N-N 
R 	 R1 
Pira:ole Base Halide Pd-source(5%) Temp. ('C Product 
i N-OH3 A92003 p-Br Pd(dppf)012 80 Traces 
ii.  N-OH3 A92003 p -OMe Pd(dppf)C12 80 Traces 
N-(2-pyridyl) A92003 p -OMe Pd(dppf)012 60 Traces 
fl' N-(2-pyridyl) A92003 p-Br Pd(dppf)C12 60 35% 
'• N-(2-pyridyl) A92003 p -0O2Et Pd(dppf)012 80 No cony. 
'• N-(2-pyridyl) A92003 p-CF'4 Pd(dppf)012 80 Traces 
N-(2-pyridyl) A92003 p-OMe Pd(dppf)012 60 Traces 
N-Boc A92003 p-OMe Pd(dppf)C12 60 No cony. 
Lt. N-phenyl3 A92003 p-Br Pd(dppf)C12 60 No cony. 
X. Nphenyla A92003 p-OMe Pd(dppf)C12 60 No cony. 
X. N-SEM A92003 p-OMe Pd(dppf)012 60 Traces 
N-SEM AgF p -0O2Et Pd(dppf)012 60 Traces 
a) 	Aryihalide was added in excess (3 eq.). 
Unsatisfactory results were obtained from this screen. None of the selected N-
substituted pyrazoles were by any means better than the previously explored starting 
materials. None of the N-alkyl reactions worked to give an isolable yield. The only 
example showing promising conversions was the N-(2-pyridyl)-pyrazole when 
coupled with p-bromo-iodobenzene (Entry iv.). Still however, yields did not exceed 
the 30 - 35 % barrier. It should also be noted that if multiple equivalents of halide are 
used, the yields drastically drop. The reason for that is that the effective 
concentration and surface area of each of the reagents is decreased due to the 
existence of a larger amount of a single reactant (Entry x., Table 10). This 
phenomenon has been observed for many of the on water reactions discussed in this 
thesis. 
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A further, more detailed halide screening was initiated and provided an even more in 
depth view into the reactivity of these pyrazoles. 
Table 11. Screening of eight diverse aryihalides. 
+ 
	
conditions 	R\ç 
C _~~ 	 N-N 
R1 	R2 R1 
Pvra:ole 	Base 	Halide 	Pd-source56) Temp. ( 	Product 
N-Ph 	A92003 	m -CF3 	Pd(dppf)C12 60 	Traces 
	
N-Ph Ag2003 p -CN Pd(dppf)C12 60 Traces 
N-Ph 	Ag2003 	p -Me 	Pd(dppf)C12 60 	Traces 
iv. 	N-Ph A92CO3 p -COEt Pd(dppf)C12 60 Traces 
N-Ph 	Ag2003 	o -Me 	Pd(dppf)C 2 60 	Traces 
N-Ph A92CO3 P -CI Pd(dppf)C12 60 Traces 
N-Ph 	A92003 	m -NO2 	Pd(dppf)C12 60 	Traces 
viii. 	N-Ph Ag2CO3 o -lodo- Pd(dppf)C12 60 No cony. 
pyri dyl 
Again, none of the reactions showed a good turnover using our catalytic system 
based on the Pd(dppf)Cl2xDCM and PPh3 combination. At this point poisoning of the 
catalyst by the pyrazole moiety was strongly considered and evidence supporting this 
issue was found in the literature.184"85 It is commonly known that pyrazole have a 
high affinity for transition metals such as copper and palladium. In Lautens' review it 
states: 87 "While yields were lower than those of the analogous pyrrole systems, 
pyrazoles represent a challenging class of heterocycle, since the pyrazole nitrogen 
functionality may tightly bind to the catalyst, thereby acting as a catalyst poison." 
Several papers highlight and even describe specific syntheses of pyrazoles which act 
as strong ligands for these metals. The possibility of adding extra catalyst to our 
system was (e.g. after 6 h or 16 h) made more difficult by having water as our 
'solvent'. Practical issues prevented any real further investigations as all of the 
starting materials were at the bottom of the vial, molten and not dispersed in the 
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water at all. Adding extra catalyst or ligands proved unhelpful as they did not 
submerge or mix with the already molten starting materials. Removal of the water, 
followed by addition of the solids and re-introduction of the removed water also did 
not improve the isolated yields of these transformations. Additionally, slow addition 
of the pyrazole building block was investigated but turned out to be of no use. 
A final ligand screen, based on the limited success of the dppf (diphenylphosphino 
ferrocene) ligand was commenced. Ligands such as dppp (entry i.), dpph (entry ii.), 
2,2-dipyridyl (entry iii.), dppe (entry iv.), dppb (entry v.) as well as dppm (entry vi.) 
all did not show any improvement over the original dppf-type conditions and were 
therefore not isolated. (Table 12). Interestingly, when dppf was added together with 
separate PdCl2, (instead of the commercially available Pd(dppf)C12) no measurable 
conversion occurred. Mixing and controlling the surface area of this heterogeneous 
mixture seem to be of paramount importance. 
Table 12. Ligand screening using on water conditions. 
/N 
/ 	
I 	 conditions 
+ CN 
MeO 	
l6hrs 
231 	233 	 / 	249 
MeD 
	
Cat. % Base (2Eq.) So/v. Pd-source 	Ligand 	Product 
i. 	5 Ag2CO3 H20 PdCl2 dppp Formeda) 
5 Ag2CO3 H20 PdCl2 dpph Formeda) 
5 A92CO3 H20 PdCl2 2,2-bipy No cony. 
iv. 	5 A92CO3 H20 PdCl2 dppe Formeda) 
V. 5 A92CO3 H20 PdCl2 dppb Formeda) 
Vi. 	5 Ag2CO3 H20 PdCl2 dppm Formeda) 
a) 	conversion less than original on water conditions (< 10%). 
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At this point of the project it seemed appropriate to explore other heterocyclic 
compounds closely related to pyrazoles. Indazole, as described earlier presented 
itself to be a worthy choice. 
Br 
+ 	I 	 on water 
14- 
Br CfldIS 
222 	 262 	 263 6 
no conversion 
Scheme 82. Attempt to arylate 1 -phenyl-1 H-indazole. 
The arylation of 1-Phenyl-1H-indazole (222) was investigated but quickly turned out 
to be as unsuccessful as the attempts to arylate pyrazole. 1 -Phenyl- 1H-indazole did 
not provide any product following TLC or LCMS analysis. 
A further screening based on the pyrazole heterocycle was envisioned. A range of 
acids and bases were investigated as additives for the transformation below. The idea 
of a further catalytic additive was taken from the successful use of pivalic acid by 
Fagnou and co-workers.100 The authors described the incorporation of catalytic 
pivalic acid as a proton shuttle for the arylation of benzene with bromobenzene. 
Scheme 83 highlights this exciting finding in more detail. 
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Ar 
	
C)  K2CO KHCO 	
PdL(Ar)Br 
OH_ 
PATHWAY  
R3PPd) 
c 
4KSr 
 
o\ 	
PATHWAY B 
RP-P 	 A + 
K2CO 
Scheme 83. Fagnou's pivalic acid proton shuttle mechanism. 100,101 
Given the success of this discovery we investigated the use of pivalic acid and other 
additives in our system. The 5-position of pyrazole is the most acidic position, 
therefore the potential of C-H bond cleaving by the pivalate anion seemed 
reasonable. However, we could not observe any increase in conversion or yields 
using this method. In fact, this additive (Table 13, entry iv.) turned out to be 
performing worse than the reactions without the pivalic acid. Other additives such as 
K2CO3, Cs2CO3 or Na2CO3 performed equally well as the reaction without additive 
(Entries i., iii., v., vi., vii., viii.) showing that an extra carbonate source is not 
detrimental to the system but in some cases increased the isolated yields by a few 
percent. NH4C1, LiC1, NaOH, Na2HPO4 and NaOAc on the other hand did not 
promote any turnovers and allowed for no products to be formed. 
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Table 13. Additive screening on water. 
' - N 
+ N 
	
I	 conditions 
!N 
\0  MeO 	 l6hrs 
231 	233 
MeO 	
249 
Additive(eq.) Base(2eq) Time TM-source(5%) Ligand Product 
i. K2003(2) A92003 16h Pd(dppf)C12 
ii 
 PPh3 38%a) 
K2CO3 (2) - 72h Pd(dppf)C12 PPh3 Noconv. 
K2CO3(2) A92003 72h Pd(dppf)C12 PPh3 
34%a) 
' PivOH (03) A92003 16h Pd(dppf)C12 PPh3 Traces 
V. Cs2003(2) A92003 16h Pd(dppf)C12 PPh3 As 
111b) 
I"i- NaCO3 (2) A92003 16h Pd(dppf)C12 PPh3 As 
1b)  
Vii. K2CO3 (1) A92003 16h Pd(dppf)C12 PPh3 As iii
. b) 
K2CO3 (2) A92003 16h Pd(dppf)C12 (10%) PPh3 As 
iii.  b) 
ix. K2CO3 (2) - 72h Pd(dppf)C12 PPh3 Noconv. 
X. NaOH (1) A92003 16h Pd(dppf)C12 PPh3 Noconv. 
Xi. NaOAc (1) A92003 16h Pd(dppf)C12 PPh3 No cony. 
xü. LiCI (1) A92CO3 16h Pd(dppf)C12 PPh3 No cony. 
Xiii. Na2HPO4(1)A92003 16h Pd(dppf)C12 PPh3 No cony- x "
. NHCI(1) A92003 16h Pd(dppf)C12 PPh3 Noconv. 
a) isolated yield after silica chromatography b)not isolated but same cony. 
A further more detailed screening of conditions and reagents was attempted. 
Attempts to arylated the N-phenyl pyrazole heterocycle using water / organic solvent 
mixtures did not improve yields (Table 14, entry ii. and iv.). Additionally, the direct 
arylation was investigated in neat conditions, omitting the use of water or any other 
solvent. This transformation yielded the product using Pd(dppb)C12, but the isolated 
yield acquired was lower than the previously obtained yields when water was used as 
the medium (Entry i.). Further the intramolecular direct arylation reaction was 
investigated. The starting material was formed using a known procedure in which 
pyrazole was reacted with 2-iodo-benzylbromide to form 264 (Scheme 84).186 
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F-,\\,N 	Pd(dppf)C12 (5%) 
N PPh3  (10%) 
A92CO3 (2eq.) 	Ni>Jf 
72 hrs, 60°C, H20 
1 0  31% 
264 	 265 
Scheme 84. Intramolecular direct arylation of N-benzyl substituted pyrazole. 
The benzyl-substituted pyrazole 264 was reacted with base, catalyst, PPh3 and stirred 
at 60 °C over the weekend (65 hrs). Compound 265 has not been synthesised 
previously. The only literature reference to this molecule is in a communication of 
Mori and his co-workers. 186  They describe the intramolecular reaction of the above 
substrate as an imidazole, not a pyrazole. Temperatures of 140 °C in combination 
with palladium catalysts are used to generate this imidazole analogue but the 
pyrazole intramolecular product was not successfully obtained (reported yield in 
Mon's paper = 0 %)186  Further examples from the screening (Table 14) include the 
use of triphenylphosphine oxide instead of triphenylphosphine (Entry xi.). This 
reaction was performed to determine if triphenylphosphine indeed was necessary or 
if the phosphine during the time of the reaction actually gets oxidised and then 
becomes active towards the direct arylation. As expected, the use of 
triphenylphosphine oxide instead of triphenylphosphine did not yield any product. 
Additionally, attempts were made to add different amounts of catalysts (and indeed 
PPh3 as well) in a continuous manner to avoid poisoning of the catalyst (see Lautens' 
intramolecular arylation of indazole). This proved very difficult and all attempts 'on 
water' failed with isolated yields well below the previous amounts. (Entry xv., xviii., 
xxiii.) Even the use of DMF as a solvent instead of water did not help to generate a 
yield above 30%. (Entry xii.) 
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Several variations of catalyst loadings were also investigated - using 10 % catalyst 
loading (Entry xiv.) as well as attempting this transformation with a completely 
different catalytic system based on the recent success of the Hermann-Beller 
palladacycle (266), which becomes active at temperatures above 80°C while 
requiring toluene as the solvent and Cs2CO3 as the base of choice.(Entry ix.) 
187-190 
r:.._- 	0-toIyI)2 
0 	
/ (o-tolyl)2 
266 	
LLJ 
Figure 24. Structure of Hermann-BeIIer palladacycle.190 
Both reactions did not produce exciting results with the Hermann-Beller system 
providing no products at all and the 10 % catalyst loading reaction (Entry xiv.) giving 
the same yields as the reactions with 5 % catalytic loading. 
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Table 14. Further screening of selected conditions. 
+ 	(7/I 	
conditions 
N 	 time 	 N-N 
R 	 R1 
Pvra:ole Solvent 	Halide(J.5e4a,) Pd-source(5%) Temp.(C) Thne(h) Product 
 N-Ph Neat p-Br Pd(dppb)C12 60 16 25% 
 N-Ph ToI:H20(4:1) p-Br Pd(dppb)C12 60 16 Noconv. 
 N-Ph H20 p-OMe Pd(dppf)C12 60 16 28% 
 N-Ph MeCN:H20(1:1)p-OMe Pd(dppf)C12 60 16 Traces 
 N-R3 H20 intramoL Pd(dppf)C12 60 72 31% 
 N-Ph H20 p-OMe Pd(dppf)C12 100 16 Traces 
 N-Ph H20- No PPh3 p-OMe Pd(dppf)C12 60 16 No cony. 
 N-Ph H20 p-OMe Pd(dppf)C12 40 16 Traces 
 N-Ph Toluene p-OMe HBP/Cs2003 110 16 Noconv. 
X. N-Ph H20 p-0O2Et Pd(dppf)C12 60 16 ±O21 ,, 
 N-Ph H20/OPPh3 p-OMe Pd(dppf)C12 60 24 No cony. 
 N-Ph DMF p-OMe Pd(dppf)C12(x2) 120 16 Traces 
 N-Ph H20 p-OMe Pd(dppf)C12 60 16 Traces 
 N-Ph H20 p-OMe Pd(dppf)C12(10%) 60 16 32% 
 N-Ph H20 p-OMe Pd(dppf)C12(x2) 60 16 <30%b 
xvi, N-Ph H20 p-OMe Pd(dppb)C12 60 16 <30%b 
 N-Ph H20 p-OMe Pd(dppf)C12 60 2.5 Tracesc 
 N-Ph H20 p-OMe Pd(dppf)C12(x4) 60 24 
<30%d 
xLt NPhe H20 p-OMe Pd(dppf)C12 60 24 Traces 
 N-Ph H20 p-OMe Pd(dppf)C12 60 48 28% 
 N-Ph H20 p-OMe Pd(dppf)C12 60 120 
33% 
 NHh H20 p-OMe Pd(dppf)C12 60 16 Noconv. 
 N-Ph H20 p-OMe Pd(dppf)C12 (X2)' 60 2x16h 35% 
a)intramol. b)not isolated c)2. 5hrs d)4x 2.5% catalyst e)3x30mg pyrazolej)48hrs 
g) 120hrs h)free NH i)2x 5% catalyst 
Following the unsuccessful optimisation studies described above, we decided to 
investigate the possibility of a Cu I Pd co-catalysed system as described many times 
before in the literature.191 Equimolar amounts of copper in addition to a catalytic 
amount of palladium could prove useful for this reaction. Several copper-sources 
were used but none showed any improvement over the previously obtained yields of 
30 - 38 % (Table 15). 
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Table 15. Cu I Pd-co-catalysed reaction attempts. 
/\ 	
/N 
MeO 	+ 
231 	233 
/ N 
conditions 
l6hrs 	 \0 
/ 	249 
MeO 
Cu-source(]eq.) Base(2eq) SoIi'. Fd-source(5016) Ligand 	Product 
1 	Cu(OAc)2 	A92003 H20 Pd(dppf)C12 PPh3 	Traces ' CuO 	A92003 H20 Pd(dppf)C12  
" 
	
CUC12 Ag2003 
PPh3 No cony. 
H20 Pd(dppf)C12 PPh3 	No cony. 
It was now postulated that possibly the pH and the quality of the deionised water had 
an influence on the rate of the reaction. Fully aware that the water in our system 
might solely act as a high heat-capacity agent, we designed a few reaction systems 
involving different water sources / pH values. Having taken pH-measurements over a 
3-day period and observing a pH change from 6 to about 8.5, we knew that the pH of 
our system might be critical to the success of this transformation. From a mechanistic 
standpoint the reaction mixture certainly should be basic for the proton abstraction 
and 13-elimination to occur. Given that two equivalents of A92CO3 are generally 
added to the system we expected the pH measurements to be in the basic region. 
Three different buffer systems (Table 16, entry i., ii. and iv.) were investigated using 
a phosphate buffer and carbonate buffer. Entry i. and ii. both produced no detectable 
conversions but the buffer system at pH-13 showed a similar isolated yield as the 
normal 'non-buffer' conditions. 
Additional modifications of our on water conditions included highly oxygenated 
water, deoxygenated water as well as the use of ionic liquids (Entry iii., vii.-xi.). 
Ionic liquids were used with either silver carbonate or triethylamine as the base, or as 
a mixture of both bases (1:1). (Entry ix. and x.) 
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Table 16. Screen of modified on water conditions. 
N 
/\ 	
/ 
WO + 0 
231 	233 
conditions 
16 hrs 
249 
MeO 
Temp. Base Solve,it Pd-source(5%) Ligand Product 
1 60 A92003 Buffer pH 8.3 Pd(dppf)C12 PPh3 traces 
60 A92003 Buffer pH 7.2 Pd(dppf)C12 PPh3 traces 
1l 60 A92003 H20 (02) Pd(dppf)C12 PPh3 29% 
60 A92CO3 Buffer pH 13 Pd(dppf)C12 PPh3 31% 
60 A92CO3 H20(lMI) Pd(dppf)C12 PPh3 28% 
1'! 60 A92003 H20 (5m1) Pd(dppf)C12 PPh3 <10% 
 60 Et3N Ionic Iiq./H20 Pd(OAc)2 PPh3 No cony. 
 60 Et3N Ionic Iiq./H20 Pd(dppf)C12 PPh3 Noconv. 
 60 A92003/Et3N Ionic Iiq./H20 Pd(OAc)2 PPh3 No cony. 
X. 60 A92003/Et3N Ionic Iiq./H20 Pd(dppf)C12 PPh3 No cony. 
Xl. 120 Et3N Ionic Iiq. Pd(dppf)C12 PPh3 Noconv. 
Again, none of the above conditions proved to have an advantage over our original 
conditions. (phosphate buffer used for entry i., ii. and iv.) 
Lastly, the arylation of pyrazole was attempted using our regularly used mild 
benzyne conditions. 192,193 
0
C~TMS 
OTf 
R1 A 
N R2 
+ 
H  
267 	 268  
TBAT (2 eq.) 
Toluene, 50°C 
C; 0 
269 R2 
Scheme 85. Pintori and Greaney reported the insertion of benzene rings into 
the amide bond. 192 
Aware that the conditions of entry ii. (Table 17) generate benzyne from the TMS-
precursor, we set out to attempt the arylation of pyrazole. Multiple attempts were 
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made at ambient and slightly elevated temperatures, none of which gave any 
products on the LCMS or TLC. If 1-fluoro-2-bromo-benzene is used as a benzyne 
precursor with Mg-metal (Grignard type), heating is required to start the Grignard 
reaction. 
270 
Figure 25. Structure of triphenylene. 
This heating is unfortunately enough to trimerise the active benzyne to triphenylene, 
making this approach not useful. 
Table 17. Benzyne-arylation trial reactions. 
+TMSconditions 	'N ,ll 
aoTf 
R 	 N-N 
a(268) 
b= 1-F,2-Br-benzene (271) 
Base Soli'. Pyrazole Temp. Product 
a CsF MeCN N-phenyl RT. Noconv. 
a TBAT Toluene N-phenyl 50C No cony. 
a TBAF MeCN N-phenyl RT. No cony. 
iv. a TBAT Toluene N-H 5000 No cony. 
V. a TBAT Toluene N-C H3 5000 No cony. 
b none THF N-phenyl 
9000 Full cony. 
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2.4.3 Optimised Conditions 
Following the discovery of a second (much rarer) tautomer of indazole in the 
literature, combined with our knowledge that the 5-position of pyrazole is highly 
reactive towards Pd-catalysed cross couplings, while the 3-position is not, we set out 
to synthesise 2-phenyl-2H-indazole.' 64"54 
H 
NH2 
1. 100°C 
0+ I 	
- 
cr~i N-0 NO2 	 2. P(OE03 
	
218 	 219 	150°C 	220 
Scheme 86. Synthesis of 2-phenyl-2H-indazole. 154 
The synthesis of 2-phenyl-2H-indazole (220) proved rather challenging as the 
formed imine is highly light-sensitive and the purification of the final compound 
involved two distillations, a column and a recrystallisation. Pure 2-phenyl-2H-
indazole (220) was nevertheless isolated and trial reactions began using our mild on 
water conditions. 
The first test reaction of 2-phenyl-2H-indazole with 4-methoxy-iodobenzene (231) 
using the on water direct arylation conditions proved successful and the 2,3-
diarylated indazole 2721 could be isolated as the only product in excellent yield. 
MeO 
OMe 	Pd(dppf)C12 (5%) 
N 	+ 	
PPh3 (10%)
JO 
	
/ N 
Ag2CO3 
'O H20,60°C 
I 16hrs 87% 
220 	 231 	 2721 
Scheme 87. Initial direct arylation trial reaction of 2-phenyl-2H-indazole. 
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Following this early success the system was optimised. All components such as the 
catalyst, the base, the ligand as well as the equivalents of the starting materials were 
varied (quantities only) and provided the optimised conditions as described below. 
Optimised conditions: 
1 eq. Indazole, 1.1 eq. of aryihalide (Br Il), 1 eq. of A92CO3, 5 % catalyst, 10 % 
PPh3, 3 ml of H20, 16 hrs at 50°C. 
2.4.4 Results of On Water Methodology 
We began by examining the regioisomeric 1- and 2-phenylindazoles as substrates. 
The C3 position is markedly less reactive towards substitution in the 1H-series, and 
this was manifested in the direct arylation studies, with l-phenyl-1H-indazole 
undergoing no arylation at 60 °C on water under a variety of conditions. 2-Phenyl-
2H-indazole (220), by contrast, proved an excellent substrate, undergoing clean on 
water arylation with a variety of aryl halides at 50 °C on water. (Table 18) 
ccN 
o 
222 
1 -Phenyl-1 H-indazole 
(IH-series) 
- 
N 
N 
220 
2-Phenyl-2H-indazoie 
(2H-series) 
Figure 26. Phenyl-indazole regioisomers. 
Our catalyst system of Pd(dppf)C12 I PPh3  in the presence of an equivalent of 
A92CO3 produced good to excellent yields of 2,3-diarylindazoles on water. The 
reaction was generally effective for both aryl iodides and bromides, an advance over 
our previous on water studies of azole heterocycles which were restricted to aryl 
iodides. Functional group tolerance was good, with halo (272b, e, and g), electron 
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withdrawing (272d, h, k and 1) and donating (272c, f and i) groups being tolerated at 
both para and meta positions. A single ortho-functionalised aryl iodide was 
productive, but in a diminished 49 % yield (272!). Heterocyclic 2-chloro-4-
iodopyridine produced functionalised indazole 272j in 95 % yield, featuring the 
highly versatile 2-chloropyridine functionality for further manipulation. Arylation 
tended to be most efficient for reactions between solids. This appears to be an 
artefact of mixing, in that use of liquid aryl halides can lead to a small amount 
adhering to the walls of the flask and not being effectively incorporated into the 
heterogeneous reaction mixture. 
Table 18. Palladium catalysed direct arylation of 2-phenyl-2H-indazole on 
water. 
H 	 x 	Ag2CO3 R— 
HO, 16 h, 50 °C 
+  
t- ~/R ' Pd(dppf)Cl2xDCM (5 mol%) 	N-0 
PPh3 (10 mol%) 
X= Br/I 220 	 Y= C/N 
272a-I 
Entry 	 Product 	 Yield (%) 	Entry 	 Products 	 Yield (%) 
Cb76 (An) 
7 
10 272a 	
71 (Br) 	
96 (ArBr) 
Br 	 NO2 
2 	 80(AnI) 	8 	
86 (ArBr) 
Me 	 OMe 
ö 
- 	 70 (Br) 	
87 (An) 91 (Ar!) 
9 
N 
C 
cO2Et CI 
U 77 (ArT) 10 	 95 (ArT) 
4N- 
74 (ArBr) 
0 	 CN 
90 
5 	
(From ArT) 
11 
- 	 69 
k 	
85 (An) 
N N 	
(From ArBr) 
e 
Me 
 6	 49 (ArT) 	12 	 ö 81 (An) 
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CI 
Me 
274d 
87% 
Cl 	 CI 
I CI 
N-0 N' 
274e 
	
274f 
48% 79% 
To fully establish the scope of the arylation we prepared a series of N2-substituted 
indazoles (273a-g). The SEM-protecting group proved stable to the arylation 
conditions, with the versatile 2-SEM protected indazole 274a being formed in high 
yield. Alkyl-substituted indazoles were good substrates, as were 2-para and ortho-
tolylindazoles (274c and d). The 2-iodobenzyl indazole (273e) starting material was 
prepared to examine the possibility of intramolecular cyclopentannulation via direct 
arylation. This reaction proved ineffective under the conditions - when 4-
chloroiodobenzene was added in a competition experiment the intermolecular 
arylation product was isolated in moderate yield. 
R3 
R2_JN_R1 
+ 
273a-g 
Pd(dppf)C12 DCM 	 - 
(5 mol%) 
PPh3 (10mol%) 	 - 
R2— 	N—R1 
A92CO3, H20 
16 hrs, 50°C 	 274a-h 
Cl 
2~N ö 
274b 	 274c 
77% 97% 
0 
N— SEM 
' 
274a 
82% 
OMe 
274h 
83% 
Liver X receptor 
agonist 
274g 
82% 
Liver X receptor 
agonist 
Scheme 88. Library of 2N-substituted indazoles. 
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Functional handles could be incorporated into the indazole ring with the 5-chioro and 
7-methoxy indazole compounds being excellent substrates. Indazole 274g and 274h 
have been reported as part of a library of 1H and 2H-indazoles with activities in a 
range of cardiovascular diseases. 164 
2.4.5 Mechanism 
The exact mechanism of this transformation is not known at this point. Early 
evidence shows that electron donating and electron withdrawing groups have a direct 
influence on the yield of this direct arylation reaction. However, the direct 
comparison of substituents is made more difficult by the dependence of this 
methodology on the morphology of the starting materials. It is suggested by us that 
the mechanism, very much like the mechanism of the oxazole arylations described 
earlier in this document, as well as Gevorgyan's and Li's, is of an electrophilic 
substitution nature. 
Pd  
272a 	 106 
PdAr 
Br-Pd-Ar 
276 	
j 
QN—Q 
220 
ArPd H 
275 	
8 Br 
Scheme 89. Likely mechanism for the direct arylation of 2-phenyl-2H-
i ndazo les. 
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Further work on this project could aim to investigate the mechanistic origin of this 
transformation and the obtaining of a Hammett plot seems a logical extension of this 
work. Sp-sp2 couplings were investigated, using 1 -bromo-2-phenyl acetylene but did 
not provide any products when the 'on water' methods were applied. 
2.5 Summary and Conclusions 
Catalytic direct arylation of indazoles has received little attention; a single elegant 
study from Lautens on the synthesis of annulated 2H-indazoles via intramolecular 
direct arylation being the only extant report in the literature. 172  In summary, we have 
reported the first study of an intermolecular direct arylation of indazoles. Using on 
water reaction conditions, a simple and efficient protocol has been developed that 
produces diverse C3-arylated indazoles under notably mild conditions. 194 
Figure 27. X-ray structural analysis showing C3-arylation of 2-phenyl-2H-
indazole to 272b. 
This methodology provides rapid access to this important class of molecules. 
Furthermore, these reactions were investigated on a larger scale and proved to be 
effective for transformation of 0.9 g of indazole starting material 273c to give 2,3-
diaryl-2H-indazole 274c in 78 % yield. Improvements from the earlier published 
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conditions include the use of aryl bromides instead of aryl iodides, the use of only 
one equivalent of silver base as well as the reduced amount of aryl halides used. 182 
Finally, the reaction temperature of 60 °C applied for the oxazole direct arylations 
was lowered to an even milder 50 °C in the case of most indazole arylations. 
2.6 Experimental 
General 
'H-NMR and '3C-NMR spectra were recorded on Bruker dpx360 (360 MHz), Bruker 
dpx250 (250MHz) as well as a Bruker ava800 (800 MHz) instruments. Melting point 
measurements were obtained from a Gallenkamp melting point apparatus and are 
uncorrected. Electrospray high resolution mass spectrometry was performed by the 
EPSRC National Mass Spectrometry Service Centre, Swansea, using a Finnigan 
MAT 900 XLT double focusing mass spectrometer. The data is recorded as the 
ionisation method followed by the calculated and measured masses. TLC was 
performed on Merck 60F254 silica plates and visualized by UV light. The compounds 
were purified by wet flash chromatography using Merck Kieselgel 60 (particle size 
3570) silica under a positive pressure. Distilled water was used in reactions carried 
out in water as the solvent. 
Representative procedure for the direct arylation of 2H-Aryl-indazoles with 
aryl iodides and aryl bromides on water: 
2,3-Diphenyl-2H-indazole (272a) 
A 5 mL microwave vial was charged with 2-Phenyl-2H-
indazole (50 mg, 0.26 mmol, 1 equiv.), phenyliodide ( 57 mg, 
- 	0.28 mmol, 1.1 equiv.), Pd(dppC12 CH202 (11 mg, 
- 	N 	/ 0.013mmol, 5 mol %), A92CO3 
(72 mg, 0.26 mmol, 1 equiv.) 
and PPh3 (7 mg, 0.026 mmol, 10 mol %). A magnetic stirrer bar was added and the 
mixture of solids was gently shaken for a few seconds to ensure all solids were well 
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mixed. Distilled water (3 mL) was added and the vial was covered with a serum cap. 
The vial and its contents were then heated and stirred in a pre-heated oil bath at 50 
°C for 16 h. After this time the reaction mixture was cooled down to rt. CH202 (4 
ml) was added and the contents of the vial were filtered through a short pad of celite. 
The vial was rinsed once with an additional 1 mL of CH2Cl2. The organic layer was 
separated, and the aqueous phase extracted once with CH202. The organic layers 
were combined and concentrated in vacuo. The residue was purified by flash 
chromatography (silica, hexane / CH2Cl2 1:1) and provided the title compound in 76 
% yield as a white solid. Best purification results were obtained when a gradient 
from hexane (100 %) to CH202 (100 %) was applied. Alternatively, other similar 
sized glass vials can be used as a reaction vessel. 'H NMR (360 MHz, CDC13)  8 7.83 
(1H, d, J= 7.2Hz), 7.73 (1H, d, .1= 7.2Hz), 7.47-7.36 (12H, m), 7.17-7.13 (1H, m). 
'3C NMR (90 MHz, CDC13), ö 148.9 (quat), 140.2 (quat), 135.4 (quat), 129.8 (quat), 
129.6 (2xCH), 128.9 (2xCH), 128.7 (2xCH), 128.3 (CH), 128.2 (CH), 127.0 (CH), 
126.0 (2xCH), 122.5 (CH), 121.7 (quat), 120.5 (CH), 117.7 (CH). Mp. 102-103°C. 
HRMS (ESI) calculated for C19H15N2 (MH), 271.1230; found 271.1232. 
Ethyl-4-(2-phenyl-2H-indazol-3-yl)benzoate (272d) 
CO2Et 	Synthesised according to the general procedure. The residue 
/ 	
was purified by flash chromatography (silica, hexane / DCM 
- 1:1) to afford the coupled product 272d as an off-white solid 
	
/\ 	(77 % yield). 'H NMR (360 MHz, CDC13) 6 7.97 (2H, d, J 
N 	/ 
' 	N' 	7.2Hz), 7.73 (1H, d, J= 7.2Hz), 7.61 (1H, d, J= 7.2Hz), 7.34- 
7.28 (8H, m), 7.07 (1H, t, J=r 7.2Hz), 4.30 (2H, q, J= 7.2Hz, J= 14.4Hz), 1.30 (3H, t, 
J= 7.2Hz). '3C NMR (90 MHz, CDC13), ö 165.9 (quat), 148.9 (quat), 139.8 (quat), 
134.1 (quat), 134.0 (quat), 129.9 (quat), 129.8 (2xCH), 129.3 (2xCH), 129.0 (2xCH), 
128.4 (CH), 127.0 (CH), 125.9 (2xCH), 123.0 (CH), 121.8 (quat), 120.0 (CH), 117.8 
(CH), 61.1 (CH2), 14.2 (CH3). MP-  150-153°C. fiRMS (ESI) calculated for 
C22H19N202 (MH), 343.1441; found 343.1449. 
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3-(4-Bromophenyl)-2-phenyl-2H-indazole (272b) 
Br 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 272b as a white solid (80 % 
N—( 	yield). 'H NMR (360 MHz, CDC13) 6 7.81 (1H, d, J= 7.2Hz), 
7.68 (1H, d, J= 7.2Hz), 7.55-7.52 (2H, m), 7.44-7.36 (6H, m), 
7.24-7.15 (3H, m). '3C NMR (90 MHz, CDC13), 6 148.9 (quat), 139.9 (quat), 134.1 
(quat), 132.1 (2xCH), 131.1 (2xCH), 129.2 (2xCH), 128.8 (quat), 128.5 (CH), 127.1 
(CH), 126.0 (2xCH), 122.9 (CH), 122.7 (quat), 121.6 (quat), 120.1 (CH), 117.9 
(CH). Mp. 109-110°C. HRMS (El) calculated for C19H,2N2Br (M-H), 347.0178; 
found 347.0182. 
3-(4-Methoxyphenyl)-2-phenyl-2H-indazole (272i) 
OMe 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 2721 as a light brown oil (87 
- 	 % yield). 'H NMR (360 MHz, CDC13)  6 7.70 (1H, d, J 
7.2Hz), 7.60 (1H, d, J= 7.2Hz), 7.37-7.16 (8H, m), 7.025 (1H, 
t, J= 9Hz), 6.82 (2H, d, J= 7.2Hz), 3.73 (3H, s, CH3). '3C NMR (90 MHz, CDC13),  6 
159.5 (quat), 148.9 (quat), 140.3 (quat), 135.3 (quat), 130.9 (2xCH), 128.9 (2xCH), 
128.1 (CH), 126.9 (CH), 125.9 (2xCH), 122.1 (quat), 122.0 (CH), 121.5 (quat), 120.6 
(CH), 117.6 (CH), 114.2 (2xCH), 55.2 (CH3). HRMS (El) calculated for C20H16N20 
(M), 300.1257; found 300.1255. 
1 -(4-(2-Phenyl-2H-indazol-3y1)phenyl)ethanone (2721) 
Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 2721 as a light yellow solid 
(81 % yield). 'H NMR (360 MHz, CDC13) 6 7.975 (2H, d, J= 
10.8Hz), 7.83 (1H, d, J= 7.2Hz), 7.725 (1H, d, J= 10.8Hz), 
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7.47-7.37 (8H, m), 7.19 (1H, t, J= 7.2Hz), 2.62 (3H, s). '3C NMR (90 MHz, CDCI3), 
197.3 (quat), 149.0 (quat), 139.9 (quat), 136.3 (quat), 134.4 (quat), 134.0 (quat), 
129.6 (2xCH), 129.2 (2xCH), 128.7 (2xCH), 128.6 (CH), 127.2 (CH), 126.0 (2xCH), 
123.2 (CH), 121.9 (quat), 120.0 (CH), 118.0 (CH), 26.6 (CH3). Mp. 136-138°C. 
HRMS (ESI) calculated for C21H17N20 (MH), 313.1335; found 313.1327. 
3-(3-Chlorophenyl)-2-phenyl-2H-indazole (272g) 
ci 	 Synthesised according to the general procedure. The residue 
/ \ 	was purified by flash chromatography (silica, hexanelDCM 
1:1) to afford the coupled product 272g as an off-white solid 
N--O (96 % yield). 'H NMR (360 MHz, CDCI3) 5  7.77 (1H, d, J= 
7.2Hz), 7.65 (1H, d, J= 7.2Hz), 7.39-7.10 (1 IH, m). '3C NMR 
(90 MHz, CDC13), 6  148.9 (quat), 139.8 (quat), 134.6 (quat), 133.7 (quat), 131.6 
(quat), 130.0 (CH), 129.4 (CH), 129.1 (2xCH), 128.5 (CH), 128.4 (CH), 127.8 (CH), 
127.1 (CH), 125.9 (2xCH), 123.0 (CH), 121.7 (quat.), 120.0 (CH), 117.9 (CH). Mp. 
95-96°C. HRMS (El) calculated for C19H12N2C1 (M-H), 303.0684; found 303.0683. 
3-(4-Cyanophenyl)-2-phenyl-2H-indazole (272k) 
CN 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 272k as a white solid (85 % 
yield). 'H NMR (360 MHz, CDCI3) 6 7.74 (1H, d, J= 7.2Hz), 
7.62-7.57 (3H, m), 7.39-7.17 (8H, m), 7.14-7.10 (1H, m). 13C 
NMR (90 MHz, CDCI3), 6 149.0 (quat), 139.6 (quat), 134.4 (quat), 133.0 (quat), 
132.4 (2xCH), 129.9 (2xCH), 129.3 (2xCH), 128.8 (CH), 127.2 (CH), 126.0 (2xCH), 
123.6 (CH), 121.8 (quat), 119.6 (CH), 118.3 (quat), 118.1 (CH), 111.7 (quat). Mp. 
152-153°C. HRMS (ESI) calculated for C20H14N3 (MH), 296.1182; found 
296.1184. 
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2-Phenyl-2H-indazole (220) 
- 	 This is a known compound. 195 NMR data matched the 
N 	/ literature values. This compound was isolated as a light yellow 
oil in 12% lower yield than reported previously. 'H NMR (360 MHz, CDC13) ö 8.33 
(I H, s), 7.83 (2H, d, J= 7.2Hz), 7.72 (1H, d, J= 7.2Hz), 7.63 (1H, d, J= 7.2Hz), 7.45 
(2H, t, 1= 7.2Hz), 7.32 (1H, t, J= 7.2Hz), 7.24 (1H, t, J= 7.2Hz), 7.04 (1H, t, J= 
7.2Hz). '3C NMR (90 MHz, CDC13), 6 149.8 (quat), 140.5 (quat), 129.5 (2xCH), 
127.9 (CH), 126.8 (CH), 122.7 (quat), 122.4 (CH), 121.0 (2xCH), 120.4 (CH), 120.4 
(CH), 117.9 (CH). 
2-Methyl-3-phenyl-2H-indazole (274b) 
?N-Me 
Synthesised according to the general procedure. The residue was 
purified by flash chromatography (silica, hexane / DCM 1:1) to 
afford the coupled product 274b as a light yellow oil (77 % yield). 
zz~
- 	 'H NMR (360 MHz, CDC13) ö 7.74-7.70 (1H, m), 7.61-7.46 (6H, 
m), 7.35-7.12 (1H, m), 7.09-7.06 (1H, m). '3C NMR (90 MHz, CDC13), 8 148.0 
(quat), 136.0 (quat), 129.6 (quat), 129.5 (2xCH), 129.0 (2xCH), 128.7 (CH), 126.2 
(CH), 121.8 (CH), 121.1 (quat), 120.1 (CH), 116.9 (CH), 38.5 (CH3). HRMS (ESI) 
calculated for C14H13N2 (MH), 209.1073; found 209.1076. 
2-o-Tolyl-2H-indazole (273d) 
Me 	This is a known compound. 195 NMR data matched the 
literature values. This compound was isolated as a light yellow 
oil with a yield 21% below the literature value. 'H NMR (360 
MHz, CDC13) 6 8.11 (1H, s), 7.81 (1H, d, J= 7.2Hz), 7.75 (1H, d, J= 7.2Hz), 7.45-
7.33 (5H, m), 7.15 (1H, t, J= 7.2Hz), 2.25 (3H, s). '3C NMR (90 MHz, CDC13), ö 
149.2 (quat), 140.3 (quat), 133.9 (quat), 131.2 (CH), 129.1 (CH), 126.6 (CH), 126.5 
(CH), 126.3 (CH), 124.3 (CH), 122.1 (CH), 121.9 (quat), 120.3 (CH), 117.9 (CH), 
17.8 (CH3). HRMS (ESI) calculated for C14H,3N2 (MH), 209.1073; found 
209.1072. 
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2-Methyl-2H-indazole (273b) 
This is a known compound. 196 NMR data matched the literature 
C:I—~N-Me values. The compound was isolated as a colourless oil. 'H NMR 
(360 MHz, CDC13) 8 7.86 (11-1, s), 7.67-7.61 (2H, m), 7.30-7.23 (11-1, m), 7.10-7.04 
(1H, m). '3C NMR (90 MHz, CDC13), 6 149.0 (quat.), 125.8 (CH), 123.5 (CH), 
122.0 (quat.), 121.6 (CH), 119.9 (CH), 117.1 (CH), 40.3 (CH3). 
2-((2-Trimethylsilyl)ethoxy)methyl)-3-phenyl-2H-indazole (274a) 
Synthesised according to the general procedure. The residue was 
purified by flash chromatography (silica, hexane I DCM 1:1) to 
afford the coupled product 274a as a yellow oil (82 % yield). 'H 
a N-SEM 
NMR (360 MHz, CDC13) 7.78-7.75 (3H, m), 7.69 (1H, d, J= 
7.2Hz), 7.56 (2H, t, J= 7.2Hz), 7.50-7.46 (11-1, m), 7.35 (1H, t, J= 7.21-1z), 7.11 (11-1, 
t, f= 7.2Hz), 5.71 (2H, s), 3.85 (2H, t, J= 7.21-1z), 0.97 (2H, t, J=7.21-1z), 0.00 (91-1, s). 
'3C NMR (90 MHz, CDC13), 8 148.2 (quat), 136.9 (quat), 129.8 (2xCH), 129.5 
(quat), 129.0 (2xCH), 128.8 (CH), 126.8 (CH), 122.3 (CH), 121.2 (CH), 120.8 (CH), 
117.8 (CH), 79.2 (CH2), 67.6 (CH2), 18.0 (CH2), -.1.4 (3xCH3) HRMS (EST) 
calculated for C19H25N2OSi (MH), 325.1731; found 325.1725. 
2-Phenyl-3-o-tolyl-2H-indazole (272!) 
/ \ 	Synthesised according to the general procedure. The residue 
Me 	 - 	 . 
was purified by flash chromatography (silica, hexane / CH2C12 
1 1:1) to afford the coupled product 272f as a light brown solid 
N 	(49 % yield). 'H NMR (800 MHz, CDC13) 6 7.825 (11-1, d, J 
8.011z), 7.445 (1H, d, .1= 8.011z), 7.41 (21-1, d, f= 8.01-1z), 7.38-7.25 (81-1, m), 7.10 
(11-1, t, J= 8.01-1z), 1.95 (31-1, s). '3C NMR (200 MHz, CDC13), 6 148.7 (quat), 140.3 
(quat), 137.8 (quat), 135.4 (quat), 131.1 (CH), 130.6 (CH), 129.5 (quat), 129.3 (CH), 
128.9 (2xCH), 127.9 (CH), 127.1 (CH), 126.0 (CH), 124.8 (2xCH), 122.5 (quat), 
122.1 (CH), 120.7 (CH), 117.6 (CH), 19.9 (CH3). MP. 92-93°C, HRMS (EST) 
calculated for C201-117N2 (MH), 285.1386; found 285.1387. 
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3-(4-Chlorophenyl)-2-phenyl-2H-indazole (272e) 
ci 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane/DCM 
1:1) to afford the coupled product 272e as a white solid (90 % 
- 	 N—(' yield). 'H NMR (360 MHz, CDC13) 6 7.77 (1H, d, .1= 7.2Hz), 
r 
-N 	7.64 (1H, d, J= 7.2Hz), 7.40-7.22 (1 OH, m), 7.15-7.10 (1H, m). 
'3C NMR (90 MHz, CDC13), 6 148.9 (quat), 139.9 (quat), 134.4 (quat), 134.1 (quat), 
130.8 (2xCH), 129.1 (4xCH), 128.5 (CH), 128.3 (quat.), 127.1 (CH), 126.0 (2xCH), 
122.8 (CH), 121.7 (quat), 120.1 (CH), 117.9 (CH). Mp. 134-135°C. HRMS (El) 
calculated for C19H12N2C1 (M-H), 303.0684; found 303.0682. 
1-Phenyl-1H-indazole (222) 
This is a known compound. 197 NMR data matched the literature 
N' 	values. This compound was isolated as a white solid. 'H NMR (360 
MHz, CDC13) 6 7.89 (1H, s), 7.36 (2H, t, J= 7.2Hz), 7.32-7.27 (1H, 
\/ m), 7.21 (1H, d, J= 7.2Hz), 7.05 (3H, t, J= 7.2Hz), 7.00-6.93 (2H, 
M). '3C NMR (90 MHz, CDC13), 6 157.0 (quat), 143.3 (quat), 141.2 (CH), 130.0 
(CH), 129.5 (2xCH), 129.3 (CH), 120.9 (CH), 119.4 (CH), 118.5 (quat), 116.6 (CH), 
112.6 (CH). 
2-((2-(Trimethylsilyl)ethoxy)methyl)-2H-indazole (273a) 
Crr~N—SEM 
This is a known compound.'98 NMR data matched the literature 
values. Compound was isolated as a colourless oil. 1H NMR (360 
MHz, CDC13) 68.11 (1H, s), 7.75-7.67 (2H, m), 7.30 (1H, t, J= 7.2Hz), 7.10 (1H, t, 
J= 7.2Hz), 5.73 (2H, s), 3.63 (2H, t, J= 7.2Hz), 0.94 (2H, t, J= 7.2Hz), -0.03 (9H, s). 
'3c NMR (90 MHz, CDC13), 6 148.8 (quat), 126.4 (CH), 122.6 (CH), 122.2 (quat), 
122.1 (CH), 120.5 (CH), 117.9 (CH), 81.8 (CH2), 67.5 (CH2), 17.9 (CH2), -1.50 
(3xCH3). 
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3-(4-Chlorophenyl)-2-p-tolyl-2H-indazole (274c) 
	
ci 	 Synthesised according to the general procedure. The 
residue was purified by flash chromatography (silica, 
r hexane I DCM 1:1) to afford the coupled product 274c as N-(>-Me a light yellow solid (97 % yield). 'H NMR (360 MHz, 
-N 	 CDC13) 5 7.81 (1H, d, J= 7.2Hz), 7.67 (1H, d, J- 7.2Hz), 
7.39-7.27 (7H, m), 7.21-7.13 (3H, m), 2.40 (3H, s). '3C NMR (90 MHz, CDC13), 
148.8 (quat), 138.5 (quat), 137.4 (quat), 134.3 (quat), 133.9 (quat), 130.8 (2xCH), 
129.7 (2xCH), 129.0 (2xCH), 128.4 (quat), 126.9 (CH), 125.7 (2xCH), 122.7 (CH), 
121.6 (quat), 120.0 (CH), 117.8 (CH), 21.1 (CH3). MP-  124-126°C. HRMS (ESI) 
calculated for C20H16N2C1 (MH), 319.0997; found 319.0998. 
3-(4-Cyanophenyl)-7-methoxy-2-phenyl-2H-indazole (274h) 
CN 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 274h as a white solid (83 % 
N-') yield). 'H NMR (360 MHz, CDC13) ö 7.65 (2H, d, J= 7.2Hz), 
7.44 (2H, d, J= 7.2Hz), 7.41-7.36 (5H, m), 7.24 (1H, d, J= 
OMe 7.2Hz), 7.11 (1H, t, J= 7.2Hz), 6.65 (1H, d, f= 7.2Hz), 4.05 
(3H, s). '3C NMR (90 MHz, CDC13), ö 150.5 (quat), 142.6 (quat), 139.6 (quat), 
134.5 (quat), 133.1 (quat), 132.4 (2xCH), 129.9 (2xCH), 129.1 (2xCH), 128.7 (CH), 
126.2 (2xCH), 124.4 (CH), 123.4 (quat), 118.3 (quat), 111.6 (quat), 111.3 (CH), 
103.5 (CH), 55.5 (CH3). MP-  185-186°C. HRMS (ESI) calculated for C21H16N30 
(M}f'), 326.1288; found 326.1288. 
3-(4-Chlorophenyl)-7-methoxy-2-phenyl-2H-indazole (274g) 
Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 274g as a white solid (82% 
yield). 'H NMR (250 MHz, CDC13) 8 7.65-7.41 (10H, m), 
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7.26 (1H, t, J= 7.5Hz), 6.825 (1H, d, J= 7.5Hz), 4.24 (3H, s). '3C NMR (63 MHz, 
CDCI3), 8  150.4 (quat), 142.5 (quat), 139.9 (quat), 134.3 (quat), 134.2 (quat), 130.8 
(2xCH), 129.0 (2xCH), 128.9 (2xCH), 128.4 (CH), 128.4 (quat), 126.2 (2xCH), 
123.5 (CH), 123.2 (quat), 111.9 (CH), 103.3 (CH), 55.5 (CH3). MP-  129-131°C. 
HR1'IS (ESI) calculated for C20H16C1N20 (MH), 335.0946; found 335.0947. 
7-Methoxy-2-phenyl-2H-indazole (273g) 
- This compound was synthesised according to a known 
\ / procedure. 195  The residue was purified by flash 
OMe 	 chromatography (CH202, 100 %) to afford the coupled 
product 273g as a brown oil (44 % yield). 'H NMR (360 MHz, CDC13) 6 8.42 (1H, 
s), 7.98 (2H, d, .1= 7.2Hz), 7.55 (2H, t, J= 7.2Hz), 7.42 (1H, t, J= 7.2Hz), 7.315 (1H, 
d, J= 7.2Hz), 7.07 (1H, t, J= 7.2Hz), 6.63 (1H, d, J= 7.2Hz), 4.10 (3H, s). '3C NMR 
(90 MHz, CDC13), 8  150.4 (quat), 143.3 (quat), 140.4 (quat), 129.3 (2xCH), 127.8 
(CH), 124.3 (quat), 123.1 (CH), 121.0 (2xCH), 120.5 (CH), 112.3 (CH), 103.1 (CH), 
55.4 (CH3). HR-MS (ESI) calculated for C14H13N20 (MIHT), 225.1022; found 
225.1019. 
3-(4-Chlorophenyl)-2-o-tolyl-2H-indazole (274d) 
ci 	Synthesised according to the general procedure. The residue 
/ 	
was purified by flash chromatography (silica, hexane / DCM 
- 1:1) to afford the coupled product 274d as a light brown oil (87 e -/\  % yield). 'H NMIR (250 MHz, CDC13) 8.00-7.91 (2H, m), N\ I '\ / 7.60-7.33 (10H, m), 2.10 (3H, s). '3C NMR (63 MHz, 
Me 
CDC13), 8 148.8 (quat), 139.1 (quat), 135.3 (quat), 135.0 
(quat), 134.2 (quat), 131.0 (CH), 130.1 (2xCH), 129.5 (CH), 129.0 (2xCH), 128.1 
(quat), 127.9 (CH), 126.8 (CH), 126.6 (CH), 122.7 (CH), 120.5 (quat), 120.1 (CH), 
118.0 (CH), 17.5 (CH3). HRMS (ESI) calculated for C20H16N2C1 (MH), 319.0997; 
found 319.1000. 
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3-(4-Nitrophenyl)-2-phenyl-2H-indazole (272h) 
NO2 	Synthesised according to the general procedure. The residue 
/ \ 	was purified by flash chromatography (silica, hexane 
I DCM 
1:1) to afford the coupled product 272h as a yellow solid (86% 
I
,N—CJ yield). 'H NMR (250 MHz, CDC13) 6 8.225 (2H, d, J 7.5Hz), 
N 	7.845 (1H, d, J= 7.5Hz), 7.725 (1H, d, J= 7.5Hz), 7.525 (2H, 
d, J= 7.5Hz), 7.46-7.39 (6H, m), 7.25-7.21 (1H, m). '3C NMR (63 MHz, CDCI3), 6 
149.1 (quat), 147.1 (quat), 139.6 (quat), 136.3 (quat), 132.7 (quat), 130.1 (2xCH), 
129.4 (2xCH), 128.9 (CH), 127.3 (CH), 126.0 (2xCH), 124.0 (2xCH), 123.9 (CH), 
122.0 (quat), 119.5 (CH), 118.2 (CH). Mp. 160-162°C. HRMS (ESI) calculated for 
C19H14N302 (MH 4T), 316.1081; found 316.1079. 
2-(2-Iodobenzyl)-3-(4-Chlorophenyl)-2H-indazole (274e) 
ci 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 274e as an orange solid 
(48% yield) 'H NMR (800 MHz, CDC13) 6 7.85 (1H dd, J= 
N' 	7.8Hz, 7.8Hz), 7.76-7.78 (1H, m), 7.61-7.60 (1H, m), 7.47- 
7.45 (2H, m), 7.38-7.36 (1H, m), 7.34-7.32 (2H, m), 7.22 (1H, 
dt, J= 7.2Hz), 7.15 (1H, ddd, J= 7.2Hz), 6.99-6.97 (1H, m), 6.55-6.54 (1H, m), 5.61 
(2H, s). '3C NMR (200 MHz, CDC13), 6 148.5 (quat), 139.4 (CH), 139.2 (quat), 
135.7 (quat), 135.2 (quat), 130.5 (2xCH), 129.5 (2xCH), 129.4 (CH), 128.8 (CH), 
127.7 (quat), 127.5 (CH), 126.8 (CH), 122.5 (CH), 121.2 (quat), 120.1 (CH), 117.6 
(CH), 96.3 (quat), 59.4 (CH). MP-  196-198°C. HR1'IS (ESI) calculated for 
444.9963 C20H15C1N21 (MH), found 444.9960. 
5-Chloro-3-(4-Chlorophenyl)-2-phenyl-2H-indazole (274!) 
ci 
Synthesised according to the general procedure. The 
residue was purified by flash chromatography (silica, 
hexane / DCM 1:1) to afford the coupled product 274f as a 
138 
light yellow oil (79 % yield). 'H NMR (360 MHz, CDC13)  6 8.36 (1H, s), 7.88 (2H, 
d, J= 7.2Hz), 7.75-7.69 (2H, m), 7.54 (2H, t, J= 7.2Hz), 7.42 (1H, t, J= 7.2Hz), 7.27-
7.24 (1H, m). '3C NMR (90 MHz, CDC13),  6 147.2 (quat), 139.6 (quat), 134.7 (quat), 
133.8 (quat), 130.7 (2xCH), 129.2 (4xCH, quat), 128.7 (CH), 128.5 (CH), 127.7 
(quat), 125.8 (2xCH), 122.0 (quat), 119.4 (CH), 118.8 (CH). HRMS (ESI) calculated 
for C19H13N2C12 (MH), 339.0450; found 339.0452. 
5-Chloro-2-phenyl-2H-indazole (2731) 
CI 	 - This is a known compound.199 NMR data matched the 
literature values. This compound was isolated as a light 
brown solid. 'H NMR (250 MHz, CDC13)  6 8.42 (1H, s), 7.975 (2H, d, .1= 7.5Hz), 
7.845 (1H, d, f= 7.5Hz), 7.765 (1H, d, J= 2.5Hz), 7.63 (2H, t, f= 7.5Hz), 7.52 (1H, t, 
J= 7.5Hz), 7.39-7.34 (1H, dd, J= 10.0Hz, 2.5Hz). '3C NMR (63 MHz, CDC13), 6 
148.0 (quat), 140.1 (quat), 129.5 (2xCH), 128.1 (2x overlapping CH), 128.0 (quat), 
123.0 (quat) 120.8 (2xCH), 119.9 (CH), 119.4 (CH), 119.0 (CH). Mp. 146-148°C. 
3-(2-Chloropyridin-4-yl)-2-phenyl-2H-indazole (272j) 
Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane / DCM 
1:1) to afford the coupled product 272j as a yellow solid (95% 
yield). 'H NMR (360 MHz, CDC13) 6 8.375 (1H, d, J= 3.6Hz), 
7.86 (1H, d, f= 7.2Hz), 7.755 (1H, d, J= 10.8Hz), 7.50-7.38 
(6H, m), 7.29-7.25 (1H, m), 7.11-7.09 (1H, m). 13C NMR (90 MHz, CDCI3), 6 
152.1 (quat), 149.9 (CH), 149.1 (quat), 140.5 (quat), 139.4 (quat), 130.7 (quat), 129.5 
(2xCH), 129.2 (CH), 127.3 (CH), 126.0 (2xCH), 124.2 (CH), 123.7 (CH), 122.2 
(CH), 122.0 (quat), 119.3 (CH), 118.4 (CH). Mp. 130-132°C, HRMS (ESI) 
calculated for C18H13C1N3 (MH), 306.0793; found 306.0793. 
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2-Phenyl-3-p-tolyl-2H-indazole (272c) 
Me 	Synthesised according to the general procedure. The residue 
was purified by flash chromatography (silica, hexane I DCM 
1:1) to afford the coupled product 272c as an off-white solid 
(91 % yield). 1H NMR (360 MHz, CDC13)  6 7.715 (1H, d, J 
7.2Hz), 7.63 (1H, d, J= 7.2Hz), 7.38-7.18 (6H, m), 7.11-7.03 
(5H, m). 13C NMR (90 MHz, CDC13), 6 148.9 (quat), 140.3 (quat), 138.3 (quat), 
135.5 (quat), 129.5 (4xCH), 128.9 (2xCH), 128.2 (CH), 126.9 (CH), 126.9 (quat), 
122.3 (CH), 121.6 (quat), 120.6 (CH), 117.6 (CH), 21.3 (CH3). MP-  108-110°C 
HRMS (El) calculated for C20H,6N2 (M), 284.1308; found 284.1309. 
1-(2-Iodobenzyl)-1H-pyrazole (264) 
CN 	Synthesised according to a known procedure.186 'H NMR (250 MHz, CDC13) 6 7.86 (1H, d, J= 5 Hz), 7.60 (1H, s), 7.47 (1H, s), 7.28 (1H, t, J= 
5Hz), 7.00 (1H, t, J= 5Hz), 6.67 (IH, d, J= 5Hz), 6.32 (1H, s) 5.38 (2H, s). 
'3C NMR (200 MHz, CDC13) 6 139.9 (CH), 139.5 (CH), 139.3 (quat), 
129.9 (CH), 129.6 (CH), 128.9 (CH), 128.8 (CH), 106.0 (CH), 100.8 (quat), 60.3 
(CH). 
8H-Pyrazolo [5,1-al isoindole (265) 
Synthesised according to the general procedure (reaction temperature 
s" 	60°C instead of 500C). 'H NMR (360 MHz, CDC13) 6 7.65 (1H, s), 
7.60 (1H, d, J= 7.3Hz) ,7.45-7.32 (3H, m), 6.38 (1H, s), 5.11 (2H, s). 
'3C NMR (90 MHz, CDC13) 6 146.3 (quat), 143.6 (CH), 140.5 (quat), 131.0 (quat), 
128.2 (CH), 127.2 (CH), 123.5 (CH), 120.5 (CH), 96.4 (CH), 52.1 (CH2). 
1-(4-Methoxyphenyl)-pyrazole (232) 
C  N
A round bottomed flask (evacuated and back-filled with nitrogen) 
was charged with Fe(acac)3 (212 mg, 0.6 mmol), CuO (16 mg, 0.2 
IC  OMe 
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mmol), pyrazole (205 mg, 3.0 mmol), and Cs2CO3 (1.3 g, 4.0 mmol). 4-
Methoxyiodobenzene (468 mg, 2.0 mmol, 1 equiv.) was added under nitrogen, 
followed by anhydrous DMF (2 mL). The tube was sealed under nitrogen, and the 
mixture was heated to 90 °C and stirred for 24 hrs. After cooling to room 
temperature, the mixture was diluted with DCM and filtered through a celite filter 
funnel. The filtrate was washed twice with water, and the combined aqueous phases 
were extracted twice with DCM (2x 15 ml). The organic layers were combined, dried 
over MgSO4, and concentrated to yield the crude product, which was further purified 
by silica gel chromatography (1:1 hexanes / DCM) to yield 1-(4-methoxyphenyl)-
pyrazole (232) as a yellow oil (486 mg, 90 % yield); 'H NMR (600 MHz; CDCI3) ö 
7.81 (1H, d, J= 2.4 Hz), 7.69 (1H, J= 2.4 Hz), 7.58 (2H, d, J=  12 Hz), 6.96 (2H, d, J 
12 Hz), 6.42 (1H, t, J= 4.2 Hz). Spectral data matched literature values.' 66  (from 
B.Sc. thesis of C.Stubbs) 
1-(4-Methoxyphenyl)-5-(4-methoxyphenyl)-pyrazole (248) 
Prepared according to the general procedure using 2 
equivalents of the aryl iodide. Purification by silica gel 
IN 
- 	/ \ 	
chromatography (DCM, 100 %) gave the pure product 
\ / We248 as a dark yellow solid (33 % yield, Mp. 93-96 °C); 'H 
MeO 	 NMR (250 MHz; CDCI3) 6  7.68 (1H, d, J= 1.5 Hz), 7.25- 
7.14 (4H, m), 6.89-6.82 (4H, m), 6.45 (1H, d, J= 2.5 Hz), 3.82 (3H, s), 3.81 (3H, s). 
'3C NMR (62.5 MHz; CDCI3) 6  159.3 (quat), 158.6 (quat), 142.7 (quat), 139.8 (CH), 
133.4 (quat), 129.9 (2x CH), 126.5 (2x CH), 123.0 (quat), 114.0 (2x CH), 113.8 (2x 
CH), 106.7 (CH), 55.4 (CH3), 55.2 (CH3). HRMS (El) m/z calcd for C17H,602N2 
280.1206, found 280.1205. (from B.Sc. thesis of C.Stubbs) 
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Chapter 3. 
Towards the Total Synthesis of 
Mechercharmycin A 
142 
3.1 Introduction 
3.1.1 Polyoxazole Containing Natural Products 
Naturally occurring oxazoles were uncommon until about 20 years ago when several 
natural products containing the oxazole moiety were isolated from marine 
microorganisms.39 Marine organisms have long been recognised as potent sources for 
potential lead compounds, which could be developed into new pharmaceuticals. 200 
Two interesting structures isolated in the 1980's include hennoxazole A (as described 
in chapter one of this thesis) as well as ulapualide A. (Figure 28, 277) 
Me Me 	Me 	Me 
I 	I I 
H N 
Me ÔAc 0 
277 
ulapualide A 
Figure 28. Structure of ulapualide A. 
The marine macrolide ulapualide A was isolated by Scheuer et al. in 1986 from the 
egg masses of nudibranch Hexabranchus sanguineus and differs only in the 
oxidation patterns and methyl substitutions when compared to mycalolide A (278), 
another tris-oxazole compound isolated in the 1980's.20' 
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Figure 29. Structure of (-)-mycalolide A. 
Both structures share a highly interesting and synthetically challenging tris-oxazole 
fragment. Research in the Greaney group has yielded a successful route to this tris-
oxazole fragment as described later in this chapter. Pattenden and co-workers have 
described a total synthesis of a diastereomer of the tris-oxazole containing natural 
product ulapualide A based on a straightforward condensation approach as discussed 
in chapter one. The oxazoles were formed using linear chain peptide precursors. 39,202 
HO, 
HO 
HO 	11 
bO H 
C13H27  
279 
bengazole A 
Figure 30. Structure of bengazole A. 
Bengazole A (279), a bis-oxazole in which the oxazoles are not directly coupled to 
each other is shown in figure 30. Interestingly the molecule consists of a 5- 
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monosubstituted oxazole, which is an extremely rare feature, in addition to a typical 
2,4-disubstituted oxazole. Bengazole A and its homologues were isolated from 
marine sponges of the genus Jaspis. Bengazole A exhibits strong antifungal activity 
against Candida albicans and fluconazole resistant Candida strains. 211-211  Molinski et 
al. were the first to report a total synthesis, followed by a more recent disclosure 
from the group of Shioiri.206'207 Both of the total syntheses have been reviewed in 
detail.39 
Directly linked 2,4-azole containing molecules such as ulapualide A have been found 
in nature and shown to exhibit interesting and potent biological activities. 211  Most of 
these oxazole containing natural products share a common framework, a bis- or 
trisoxazole. 
Muscoride A (280) has weak antibiotic activities, it was isolated from the freshwater 
cyanobacterium Nostocmuscorum by the group of Sakakibara.209 The total synthesis 
of this oxazole containing natural product has been reported by several groups. 
Firstly by Wipf and co-workers, followed by Pattenden et al. and most recently by 
the group of Ciufolini.210212 
Me 
Me 	Me 
Me 
/ N( 
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I MeMe 
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muscoride A 
Figure 31. Structure of muscoride A. 
Thiazole-thiazole linked natural products have also been isolated to date. Recently a 
few oxazole-thiazole 2,4-di- and polyazole natural products have followed those 
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reports in the literature. Namely telomestatin (thiazoline, not thiazole) - a strong 
telomerase inhibitor (Figure 4, Chapter 1), leucamide A (Figure 32, 281), YM-
216391 (282) - another cyclic peptide, and most recently mechercharmycin A and B. 
213,214 (Figure 34 and 35, 283 and 284) 
Me 
o'1—I'? Me 
H N—' 
Me _r): NH 
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leucamide A 
Figure 32. Leucamide A. 
Leucamide A (281) is one of the more simple cyclic peptides described within this 
thesis as it only contains three heteroaromatic azole functionalities. It shows mild 
cytotoxic activity and was isolated from a marine sponge (Leucetta microraphis).2  1 5 
The group of Nan have published the total synthesis of this natural product based on 
a well-known valine-derived thiazole precursor previously described by Meyers and 
his co-workers. 216,217 
0 0NO 
N 
0 
N-.?
N, 
N 
282 
Figure 33. Structure of penta-azole YM-216391. 
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A further example - YM-216391 (282) - a poly-azole containing cyclic peptide with 
five directly connected 5-membered heterocycles was first discovered and isolated 
from Streptomyces nobilis.218 This compound's structure is highly similar to the one 
of telomestatin, a potent anti-cancer molecule. Pattenden has described the only total 
synthesis of this interesting natural product in 2005 and more biological data is still 
required to determine the putative activities of this compound.219 
Finally, the structure and properties of our target molecule are discussed. 
Mechercharmycin A (283) is a four-oxazole, one-thiazole containing cyclic peptide 
with a molecular weight of 708 da. Mechercharmycin B is the acyclic version of 
mechercharmycin A (284), both were isolated from the marine microorganism strain 
ES7-008.208 Mechercharmycin B does not have any appreciable biological activity, 
mechercharmycin A however has been shown to have very strong cytotoxic activities 
(anti-tumour). 220 
The structure of mechercharmycin A is very distinct; it consists of a tri-peptide part 
which contains a centred L-valine residue with an D-a//o-isoleucine to one side and 
an exo-double bond residue (from the elimination of the serine hydroxyl group) to 
the other. 
H(N(—/ 
0 0 H 
zz 1r' o 
N 	 N i 
-u 
283 
Figure 34. Structure of mechercharmycin A (C35H32N807S)  (IB-0121 1). 
Connected via the nitrogen of the isoleucine is a fully substituted oxazole bearing a 
phenyl group at its 5-position and another oxazole on its two-position. This second 
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oxazole itself has a vacant 5-position and is connected to the only thiazole in the 
molecule. Like the oxazoles it connects to, the thiazole has a free 5-position and 
connects to the fourth, directly linked, azole via its 2-position. This third oxazole 
(fourth azole clockwise) is coupled in the same fashion to the last oxazole. The cyclic 
ring structure is obtained when considering the bond between the 2-position of this 
very last oxazole and the internal carbon of the exo-double bond. 
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Figure 35. Structure of mechercharmycin B (C35H36N8010), the linear 
congener of mechercharmycin A. 
Biologically active natural products as lead compounds for the pharmaceutical 
industry and its drug discovery programs have a longstanding tradition. Many of 
today's drugs and pharmaceuticals have only been discovered or at least been 
optimised because a natural product provided an early insight into potential 
biological activities. The story of taxol (Paclitaxel) being a perfect example; taxol, a 
mitotic inhibitor used in cancer chemotherapy was discovered in 1967 and is still 
used, without any modification to its original structure, in today's anti-cancer 
treatments (e.g. breast cancer).22' 
3.1.2 Previous Total Synthesis of Mechercharmycin A 
The total synthesis of mechercharmycin A has been achieved only once to this date. 
The research group of Alvarez has reported a synthetic route based on known peptide 
chemistry. 52  The key step in their synthesis is a Hantzsch macrocyclisation. As 
pictured in scheme 90, the synthetic sequence is commenced with a series of peptide 
I MM 
couplings. The Boc-protected tri-peptide 285 is cyclised to a bis-oxazoline fragment 
using the commercially available DAST reagent. The bis-oxazoline fragment 286 is 
then oxidized to the bis-oxazole structure 287 utilising a DBU-CC14 in pyridine 
procedure. Further functional group interconversion of the methyl-ester 287 to the 
thio-amide 288 in two steps (73 % over two steps) provided one of the three major 
fragments needed for the convergent synthesis of IB-O 1211. 
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Scheme 90. Synthesis of two key-fragments of mechercharymycin A. 
The second azole containing fragment was synthesised in a similar fashion, starting 
with a peptide coupling to produce compound 289. This di-peptide was then turned 
into highly functionalised oxazole 290 via the previously described sequence of 
DAST cyclisation followed by oxidation using DBU-CCI4. The rert.butyl protected 
primary alcohol as well as the Boc-protected amine were simultaneously deprotected 
using TFA. The produced material was directly coupled via an EDC I HOBt 
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activated peptide coupling with BrCH2C(OMe)2CO2H to give compound 291. 
Finally modification included a previously seen cyclisation via DAST at low 
temperature, followed by oxidation of the oxazoline fragment to bis-oxazole 292. 
Further steps towards the total synthesis are presented in detail below (Scheme 91). 
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Scheme 91. Final steps towards the bio-mimetic synthesis of 
mechercharymycin A. 
Bis-oxazole fragment 292 was coupled with prior synthesised di-peptide 293 (both 
unnatural amino-acids) using a standard peptide coupling procedure (EDC, HOBt, 
DCM, r.t.) to form compound 294 in excellent yield. A further peptide coupling 
between compound 294 and the bis-oxazole structure 288 was successfully employed 
and yielded the highly functionalised tetra-oxazole 295. The penultimate step in this 
total synthesis was the deprotection of the primary alcohol using formic acid at 
reflux. Lastly, as mentioned earlier, the key step - a Hantzsch macrocyclisation - 
was described. An unsatisfactory yield for the last two steps was reported to be 11 %. 
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Given this final result, the total synthesis of mechercharmycin A (283) was 
accomplished in a respectable overall yield of just under 3.4 %52  Features of this 
approach are a repetitive peptide coupling, cyclisation and oxidation sequence as 
well as the Hantzsch macrocyclisation. This report is currently the only publication 
regarding the total synthesis of mechercharmycin A. 
3.2 Aims of Project 
The aim of this project is to establish a strong, high yielding and convergent 
synthetic route for the total synthesis of the biologically active natural product 
mechercharmycin A. If at all possible, our previously developed methodologies 
should be used .71,116  A non-peptidic approach is highly desired as this total synthesis 
should highlight the power of modern carbon-carbon bond forming reactions using 
transition metal catalysis. We envision a previously unseen direct arylation approach 
as the main highlight of this work, including a key direct-arylation macrocyclisation 
step to form the desired natural product. This synthesis should later allow the large 
scale synthesis of this target compound, possibly producing this molecule in 500 mg 
- 1 g. Further biological investigations of this compound are of great interest and 
could further highlight the biological effects of this cyclic peptide. 
3.3 Previous Work in the Greaney Group 
Research into oxazole-containing compounds has been a main topic in the Greaney 
group since its beginning. I am the second Ph.D. student fully dedicated to oxazole 
research. Prior to this work, a Ph.D. student (Dr. B. Ferrer-Flegeau) investigated 
oxazoles and their reactivities in detail. Highlighted below are some of the early 
findings of the Greaney group in the area of transition metal catalysed oxazole sp2- 
sp2 couplings. 
The first report on oxazoles published by the Greaney group was a publication 
highlighting the functionalisation of the oxazole 2- and 4-position using a Suzuki 
coupling reaction. 2-Aryl-4-triflyloxazoles were shown to undergo rapid, MW- 
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assisted couplings with a variety of boronic acids as described in chapter one of this 
thesis. This work formed the basis of oxazole-related research in the Greaney group. 
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Scheme 92. Ferrer-Flegeau and Greaney's work on Suzuki couplings using 
oxazoles. (as Scheme 47) 
Continuous research into oxazole containing structures next revealed the first direct 
arylation of oxazoles on the 5- and 2-position by Ohnmacht et al. using on water 
conditions as described in the first chapter of this thesis. 182 
This work described the synthesis of two small oxazole containing natural products 
in combination with over 30 other directly arylated examples. 
iR1  
N 	Negishi 
0 
I 	 iR2 
Direct Arylation 
as described in 
chapter 1 
Scheme 93. Ohnmacht et al. reported the first 5- and 2-arylations of 
oxazoles on water. 
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Shortly after this report, Ferrer-Flegeau et al. published the work on the 
regioselective Suzuki-Miyaura cross-coupling of 2,4-dihalo oxazoles followed by 
Stille couplings. This work firstly describes the work in the Greaney group towards 
the synthesis of bis- and tris-oxazoles, a fragment seen in many poly-oxazole 
containing natural products such as hennoxazole A or ulapualide A, and of 
importance to the total synthesis of mechercharmycin A.222 
Suzuki-Miyaura 
coupling 
V—Ph  
Stille coupling 
x 
296a (Br) 
296b (I) 
X = Br, I 
Ph 
Ph N N r,j)Ph 
297 
75% yield 
Scheme 94. Ferrer-Flegeau et al. reported the formation of a tris-oxazole 
fragment.222 
The last and most recent publication investigating oxazole reactivities authored by 
Greaney and Ferrer-Flegeau is highlighted below. This interesting publication further 
describes the synthetic efforts towards poly-oxazoles, this time investigating the 
effects and scope of direct arylation methodology. The authors describe the stepwise 
elongation of 4-substituted oxazole 134 to poly-oxazole 299 via a palladium 
catalysed method based on Hermann-Beller's palladacycle. It is this paper and the 
results shown in scheme 95 that formed the basis for the retrosynthetic route for the 
total synthesis of mechercharmycin A described within this chapter. 
2x Direct 
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Scheme 95. Formation of tris-oxazoles via TM-catalysed direct arylation.116 
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The only literature precedent of poly-oxazoles (tris-oxazoles and higher oligo-
oxazoles) coupled via a TM-catalysed methods other than the Greaney group's work 
to this date is the work of Inoue and co-workers. 223  Their 2007 communication 
provides a detailed look into an iterative two-step strategy for C2-C4' linked poly-
oxazoles (300d) using the Suzuki-Miyaura reaction. Drawbacks of this approach are 
the need for excessive functional isati on of the precursors and the extremely linear 
approach. 
TBSN/7CO2R 
300a 
next 
iterative 
operation 
XN/7CO2R 
300d n+2 
step 1 = halogenation 	
X2)-CO2R 
n 
300b 
step 2 = Suzuki-Miyaura 
cross couplings 
TBS\TN'7 Bpin 
300c 2 
Scheme 96. Synthesis of bis-, tris-, tetrakis-, pentakis- and hexakis-
oxazoles 223 
3.4 Results and Discussion 
3.4.1 Retrosynthesis 
Based on the above shown results obtained in the Greaney group over the last several 
years it was decided to disconnect the structure of mechercharmycin A in a highly 
convergent fashion. Retrosynthetic analysis provided four fragments. The analysis 
focused on either breaking a simple peptide bond or disconnecting using a site in the 
molecule where a sp2-sp2 cross coupling could later be utilised. 
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Scheme 97. Retrosynthetic analysis of mechercharmycin A. 
The ability to synthesise 2,4-diiodo-oxazole (309) (scheme 101) has clearly 
influenced our decision to generate fragments A and B.116 Both fragments will be 
generated using similar approaches. Scheme 98 shows in detail the further 
breakdown of fragments A and B into readily available (via synthesis, not 
commercially) molecules. 
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Scheme 98. Detailed retrosynthesis of fragments A and B. 
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Possible key-transformation in this total synthesis would be a direct arylation 
macrocyclisation, catalysed by a transition metal, possibly coordinating up to four of 
mechercharmycin A's nitrogens, which present themselves to the inside of the 
molecule. The authors postulate that this is possible, knowing that tris-oxazoles such 
as kabiramide C and halichondramide have the capacity to sequester and transport 
metal ions in vivo using the curve-linear array of the oxygen and nitrogen bearing 
ligand binding sites in their structures. 224  Further support is given by the existence of 
a coordinated sodium ion in the crystal structure of IB-O 1211. 52 
Figure 36. Top-down X-ray structural analysis of mechercharmycin A (283) 
(NaOMe removed from center). 
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Figure 37. Side-view of mechercharmycin A (283) (NaOMe removed from 
center). 
This is a very ambitious step, however, the authors believe that highly optimised 
conditions, including the correct dilution could make this reaction possible. 
51N 	 Ph 
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	 283 
Scheme 99. TM-catalysed macrocyclisation to form cyclic peptide 283 using 
a direct arylation approach. 
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We decided to chose this novel and highly uncertain approach following close 
inspection of Professor Pattenden's work in this area. Pattenden was first to 
synthesise a tris-oxazole fragment and did so in a respectable 14 steps with an overall 
yield of 6 %225  The Pattenden group have published extensively on macrocyclisation 
reactions of poly-azole containing cyclic peptides. 221,121  Most of their work describes 
macrocyclisations using peptide bond formations in very undesirable yields, 
generally below or around the 40 % yield mark. It needs to be noted at this point that 
the yield quoted in the previous sentence is only obtained when one of the internal 
azoles is not yet cyclised to a five-membered ring. Pattenden and co-workers have 
investigated the macrocyclisation reactions of penta-azoles (all connected to each 
other and therefore completely flat) via peptide bond formation and have provided 
strong experimental evidence that the macrocyclisation of such systems is not 
possible at all .228  Due to the extreme similarity of our target compound to the 
compounds described in Pattenden's work we decided to opt for a different approach 
and accepted, that many years of detailed research in the Pattenden group would very 
likely also prove themselves correct and therefore not of use for our target 
compound. In addition, we were keen to show the strength of direct arylation in a 
macrocyclisation step. To the best of our knowledge this has to date never been 
achieved. 
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Figure 38. Compounds generated via peptide-bond macrocylisation in the 
Pattenden group. 
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3.42 Synthesis and Synthetic Steps 
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Scheme 100. Synthetic route for the generation of fragments A and B. 
Scheme 100 shows the possible synthetic strategy for the synthesis of fragments A 
and B. Both fragments are generated in a similar fashion, using the previously 
published approach discovered by Ferrer-Flegeau and Greaney. Further manipulation 
of the precursor to fragment A with a halo-thiazole could prove effective. 
Synthesis of fragments C and D should be straightforward using known literature 
procedures. 10,129  The di-peptide fragment D is a known compound and has been 
described in the literature by Doi et al. on their way to generate telomestatin.5°  
Fragment C can be synthesised in one step using Elimarm's chiral sulphinamide 
chemistry. 229'23° This procedure should provide easy access to fragment C and any 
analogs possibly required. 
First synthetic efforts were directed to the generation of 2,4-diiodo-oxazole (309). 
Following the procedure of Ferrer-Flegeau et al., compound 309 was formed in a 
reaction that required 14 days to complete. Isolated yields were generally in the 
range of 50 - 70 %. Optimisation of these rather slow reaction conditions was not 
attempted as the reaction proceeded well at the described temperature. 
159 
LHMDS, DMPU -780C 
C
o 	THF, 12, 14 days,r.t. 
N 	 I 'fl- N 
1 309 
Scheme 101. Synthesis of 2-4-diiodo-oxazole. 
Following the synthesis of compound 309, 2-Tips-4-iodo-oxazole 298 was generated, 
once again following the previously developed method from the Greaney group. 
Isolated yields of this transformation ranged widely, from < 10% to around 70%, 
depending on the quality of starting materials and reagents. Absolutely dry solvents 
were necessary for this transformation to occur. 
n-BuLl, THF, -780C 
0 	TIPS-OTf, 0°C-,,t. 	0 
	
/>H I/>—TIPS 
N 	 N 
309 	 298 
Scheme 102. Synthesis of 2-Tips-4-iodo-oxazole. 
Following the successful synthesis of 2-Tips-4-iodo-oxazole (298), its coupling 
partners for the envisioned direct arylation were generated in excellent yields. 
CID], Et3N, THF, 	 0 
0 	 0 	- r.t.,24hrs 
HOH + EtO IIN 	80% 	
O> 
310 	 311 	 OEt 134 
00 DBU, THE 
,11,,,c 	0 	- 	r.t.24hrs 	
Ph 
XON 	0 UEtO 	 0  +  
82% 
312 	 311 	 OEt 200 
Scheme 103. One-step synthesis of oxazole precursors 134 and 200.142 
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With both starting materials in hand, the direct arylation reaction to form bis-
oxazoles 306 and 308 were attempted and shown to be a success. Compound 306 had 
previously been generated in the Greaney group, compound 308 however was a 
novel molecule. Both syntheses generated the target compounds in moderate to good 
yields. Compound 308 was isolated in a much lower yield due to the existence of the 
phenyl substituent on the 5-position of the oxazole, which clearly changes the 
electronic nature of the precursor. This decreased isolated yield proved to be true as 
this reaction was repeated several times, always yielding the final bis-oxazole 308 in 
a lower yield compared to the non-phenyl-substituted oxazole 306. 
In order to further modify this bis-oxazole 308 we needed to remove the Tips-
protecting group. This can be done in two separate ways. Firstly, compounds 306 and 
308 can be isolated and then put into a room temperature solution of TBAF (1 
equiv.) for 30 mins. Washing and extracting of that solution provides the deprotected 
bis-oxazoles in high yield. Secondly, the deprotection of compounds 306 and 308 
can be achieved in situ; after the work-up stage (following the extraction) the organic 
phase containing either compound 306 or 308 is dried with MgSO4 and filtered. The 
filtrate (compound still dissolved in DCM) is then put into a small Erlenmeyer flask 
and TBAF (1 equiv. of 1M solution in THF) is added. Similar to the first procedure 
the solution is stirred for 30 mins and then re-extracted to yield the final product in a 
combined yield (over two steps) of 82 % for 306 and 46 % for compound 308. 
	
0 	 0 
,>—TIPS + ,11 ,>—H 
EtO2C 
298 	 134 
HBP 	\ o 150/ 
2 eq. Cs2CO3 	
<\ 
toluene, 110°C NN1- 
TBAF, 30 mins, r.t. 	
CO2Et 
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1. HBP(5%) 	a 
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N 
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Scheme 104. Final steps of each cross coupling step is the removal of TIPS 
protecting group using TBAF. (as Scheme 100) 
Deprotection of Tips-protected bis-oxazole 353 (see experimental) provided 
fragment B in excellent yields via a sequence of four synthetic steps. This compound 
was stored at room temperature until further modification was necessary. 
Compound 308 needed further modification via another direct arylation step. The 
starting material needed for such a transformation was 2-Tips-4-bromo-thiazole 
(305). This compound has been described in the literature only once before.23' This 
report provides a rather tedious synthesis of the title compound via three strong base 
reactions (2x n-BuLi, lx LDA). We attempted a different approach which proved 
successful; however only low yields of 2-Tips-4-bromo-thiazole (305) were isolated. 
n-BuLi 	 n-BuLi 	 s 	Br  LDA, -78°C 	S S 	TIPS-CI S-.. Br2 __________ 
Br 	 TIPS\ 	 TIPS 	 - TIPS\ 
N 	82% 	 N 83% 	 N 	86% 	 N Br 
313 314 	 315 	 305 
Halogen-dance reaction 
Scheme 105. Sole known synthetic procedure for the formation of 305231 
Ot_s 	POBr3 
N 68% 
316 0 
n-BuLi, THF 
S-78°c, TIPS-OTf 
Br— i 
N Br 41% 
317 
TI PS _<NTiBr 
305 
Scheme 106. New synthetic approach to 2-Tips-4-bromo-oxazole. 
Having both starting materials in hand, a second direct arylation was attempted and 
proved successful in its first try. Bis-oxazole 308 was reacted with 2-Tips-4-bromo-
oxazole 305 under the previously identified conditions using Hermann-Beller's 
palladacycle and Cs2CO3 as the base of choice at elevated temperature. 
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1, 
TI 
HBP(5%) 
Q 	Ph.0 
2 eq. Cs2CO3 
toluene, 11O°C 
H— . 	j1 < 
NO 
2 eq. Cs2CO3 
toluene, 110°C I ,TIPS+ NPh 
Et02C 	N TBAF, 30 mins, r.t. 2-Tips-4-Br-thiazol 
298 	 200 42% (2 steps) 308 	CO
2Et 49% 
303 
Fragment A 
Scheme 107. Formation of protected tris-azole fragment A via direct 
arylation. 
Once again in situ deprotection of the Tips-protecting group was achieved. A small 
optimisation study was launched to see if the yields of the coupling reaction (Table 
19) could be increased using microwave technology. 
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Table 19. MW-accelerated screening of direct arylation conditions. 
Ph 
Ph 	 OCOEt 
_____ 	
- + 	
3Omins MW N 
TIPS' 	
CO2Et 
N 	 N 	 2 eq. Cs2CO3 
	
298 	 200 	 10% HBP cat. 	
TIPS 	
318 
Solvent Temperature (°C) Result 
Toluene 120 30% yield 
Dioxane 120 24% yield 
DMF 135 no product 
THF 70 no product 
NMP 150 no product 
DMA 150 no product 
Water 110 no product 
starting material recovered 
40% starting material recovered 
Multiple temperatures were screened and changes in the amounts of reagents were 
investigated. No conditions to increase yields were identified. 
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Table 20. Follow-up screening based on the success of toluene and dioxane 
as solvents. 
+ 
TIPS 	N 
298 
Ph 	 60mins MW 
12000 
	
N 	 2 eq. Cs2CO3 
200 10% HBP cat. 
Catalyst (10%) Solvent Result 
PEPPSI Dioxane no product 
PEPPSI Toluene no product 
Pd2dba3 Dioxane no product 
Pd2dba3 Toluene no product 
Pd(dppf)C12 Dioxane no product 
Pd(dppf)C12 Toluene no product 
Crystal growth of intermediate 308 was made possible when a solution of 
dichioromethane and diethyl ether was allowed to slowly evaporate over several 
days. X-ray crystal analysis of the generated needle-like crystals allowed the 
visualisation of this highly planar bis-oxazole. 
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Figure 39. X-ray analysis of compound 308 after Tips-deprotection step. 
Having fragment A and B in hand, attention was now turned to the synthesis of 
fragment C. 
As mentioned earlier, Ellmann's sulphinamides should provide quick and easy access 
into a class of reactive imines. The choice of 'Ellmann imines' was not our initial 
choice. We envisioned a simple benzyl protecting group to be of use, which can then 
be removed via a mild hydrogenation reaction. Early work into the synthesis of 
compounds with the substructure 301 (in which the imine is a non-sulphinamide) 
quickly showed that these compounds are highly unstable. Following several weeks 
of dedicated research to find a set of conditions it was decided to abandon the benzyl 
protected imine and investigate more stable schiff bases. (Note: Ellmann's imine 
analogue 301 is stable at room temperature for several weeks under nitrogen) 
Synthesis of compound 301 was straight forward yielding the imine in excellent 
yield. 
0 
II 
H 0 	0 
+ 	
if 	cus04, DCM, r.t. 	 N 
TBDMSO 	
NH2 	
92% 	 H 
319 	320 	 301 OTBDMS 
Scheme 108. Synthetic route to generate fragment C.229 
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3.4.3 Connecting Fragments 
Major problems occurred when trying to connect fragment B to fragment C. It was 
thought that a strong base, such as n-BuLi, could easily deprotonate (see ring 
opening mechanism of oxazoles at the 2-position) the oxazole and then attack the 
electrophilic carbon atom of the imine. 
Table 21. Attempts to couple fragment B to fragment C. 
0 	 EtO2C 
CO2Et 	 N N> 	 CO2Et 
CO2Et 	H 
NO or 	
301 OTBS 	 N 	or 	
H 	Ph 
0 	 HN 
0 
OTBS 
	
306 	 200 	 OTBS 
A B 0 321 	 322 
Starting Material Base (1.1 eq.) Result 
A n-BuLi no addition 
A LHMDS no addition 
A Cs2c03  no addition 
A iPrMgCl no addition 
A iPrMgCl/Licl no addition 
B n-BuLi no addition 
B LHMDS no addition 
B Cs2CO3  no addition 
B iPrMgCl no addition 
B iPrMgCl/Licl no addition 
In fact, deprotonation of the 2-position of oxazole is a trivial reaction and has been 
achieved many times throughout the work of this thesis. However, in this case the 
generated anion did not attack imine 301 in any way. Imine 301 quickly proved to be 
highly stable and unreactive towards the attack by the 2-position of oxazole. 
Switching the base from n-BuLi to LHMDS did not increase the reactivity of the 
imine towards this reaction. Additionally, iPrMgCl was thought to possibly enhance 
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the rate of carbon-carbon bond formation in this transformation. The reason for this 
was a 2001 publication by Ellmann and colleagues in which they described the 
addition of Mg-based organometallics to imines.232 Scheme 109 provides a detailed 
look at the conditions and the use of Grignard-type precursors for addition reactions 
onto imines. 
0 0 
Et20, -780C  
)çSN + JMgCI 	 + 
OTBS 323 	 OTBS 	R OTBS 
301 or 
'anti-Ellmann 	 Ellmann' 
MgCI 	 325a 325b 
324 	 I I R = benzyl = 1:1 (anti Ellmann : Ellmann) 
R= butyl >1O:1 	 I 
Scheme 109. Use of Ellmann's homochiral tert.-butylsulfinamide in addition 
reactions. 
Several different methods were researched and attempted, one of them using LiCI as 
an additive to avoid any dimer formation of the Grignard reagent (Scheme 110).233 
None of the methods described provided any respectable amounts of the desired 
product on the LCMS. The only product visible on a regular basis was the addition 
product of iPrMgCl and the imine (Figure 40, 328). 
Me 	 Me ci Me 
Li Mg-< instead of dimer 	>-M pg—K 
Ci Me 	 Me C Me 
326 	 327 
Scheme 110. LiCI additive to prevent dimer formation of the Grignard 
reagent.233 
0 11 
NH 
Pri 
OTBDMS 
328 
Figure 40. Major product identified by LCMS. 
The reason for choosing Cs2CO3 as a base for the deprotonation of the 2-position of 
the above mentioned oxazole starting materials 306 and 200 was a paper by Sanchez 
and Zhuravlev in 2007. This publication was discussed in detail in the first chapter 
and highlights the ability of this base to generate the ring-opened form of oxazole, 
therefore generating a highly nucleophilic anion, which theoretically should attack 
the imine functionality at once. 144 
Following no real success in the preparation of a coupled molecule from fragment B 
and C, focus was turned away from the direct modification of the 2-position of 
oxazole via treatment with strong bases. This change of direction was supported by a 
brief chat with Prof. Ellmann at the BOSS conference in Belgium. Prof. Ellmann was 
already aware of the difficulties imposed by the ring opening mechanism of oxazoles 
when attempting to couple the 2-position of an oxazole with his suiphinamide 
analogues. A completely new approach was therefore drawn out and preparation of 
the starting materials got on its way (Scheme 111). 
0 	 0 	 NaHCO3 
NH2 + EtO Br 60
°C, THF, 8hrs 
0 
329 	 330 	
65% 	
331 OEt  
Scheme 111. One-step synthesis of ethyl 2-vinyl-oxazole-4-carboxylate.234 
The idea was to epoxidise the vinyl functionality of 331 using oxidising agents such 
as mCPBA or H202. It quickly turned out to be more difficult than expected with all 
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epoxidation attempts failing. Use of prolonged reaction times, excessive amounts of 
mCPBA as well as even small amounts of heating (behind blast shield at all times) at 
40 °C did not provide any epoxidised material. Further reactions were attempted 
using reagents such as hydrogen peroxide or the rarely used peroxy-phthalate. All of 
these attempts did not provide any evidence of an epoxidation of the double bond. 
Table 22. Epoxidation attempts with conditions using 2-vinyl-oxazole-4-
carboxylate (331) - attempts to epoxidise ethyl 2-vinyl-oxazole-4-carboxylate 
331 failed. 
cN 
331 OEt 
bH,r.t. 
p 
mCPBA, DCM, r.t. 
O 
332 OEt 
  
Oxidant / eqiv. Time (h) / temp. Result 
mCPBA /2 72/ r.t. no epoxidation 
mCPBA /1.2 1-24 / r.t. no epoxidation 
mCPBA / 6 3 / 40°C no epoxidation 
mCPBA / 12 24 / r.t. no epoxidation 
H202 / 1.2 24 / r.t. no epoxidation 
H202 / 1.2 48 / r.t. no epoxidation 
peroxy-phtalate 2-48 / r.t to reflux no epoxidation 
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Given these discouraging results, further investigations into the modification of this 
double bond were started. It was found that a Sharpless aminohydroxylation could be 
of 	use. 235  This reaction uses the vinyl-oxazole, K20s02(OH)4 as well as 
(DHQ)2PHAL in combination with a carbamate, an aqueous solution of NaOH and 
MeCN. Hydantoin or hyposulfite can be used as the oxidant. 
K2[0s02(OH)4] (cat.) 
R 	cieNa chiral ligand  
+ 	N I 
R" 	H20, ROH 	HN 	
R" = S02R", COR', CO2R', alkyl, aryl 
R1 	 R" R 
333 	334 	 335 
Scheme 112. General reaction scheme for the syn-selective Sharpless 
aminohydroxylation.236 '237 
OH 	 OH 
H EtO2C-\ 
N  
0 	 NO 	 1N 0 
or 
H2NO 	
conditions 	
0 	 0 IN 
Y 
 EtO2C EtO2C 
335a 
331 	 336 [,JJ 	335a 	LjJ 
leq. 	 3eq. 
Conditions: K20s02(OH)4 (4 mol%), NaOH (3 eq.), IOBuCI (3 eq.), H20, n-PrOH, (DHQ)2PHAL (5 mol %), 1,3-
dichloro-5,5-dimethyl-hydantoin (3 eq.). 
Scheme 113. Attempted oxyamination of 2-vinyl-oxazole-4-carboxylate 331 
using Sharpless' conditions. 
Several attempts to aminohydroxylate ethyl 2-vinyl-oxazole-4-carboxylate (331) 
were made but no isolated products were obtained. The product could be seen on the 
LCMS in 'small amounts' (amounts based only on UV traces), however TLC 
analysis and purification using silica did not produce any respectable amounts of 
product. After only a few attempts the decision was made to abandon this approach 
due to certain lack of selectivity in this transformation. 
171 
Following several weeks of investigations into the modification / connectivity of 
fragments B and C, a complete change of direction was envisioned. This decision 
was made due to the failure of the above described experiments as well as the general 
lack of reproducablity of the synthetic step from 2,4-diiodo-oxazole to 2-Tips-4-
iodo-oxazole (Scheme 102). 
A new approach based on a classical transformation, the Hunsdiecker reaction, was 
designed. This approach would use a pre-formed (via peptide couplings) oxazole 
moiety, which has all the functionalities already installed at the required 2-position 
and would not require the use of any Tips-protecting groups. Scheme 114 shows the 
new approach to generate this highly useful substrate. 
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Scheme 114. Novel approach to the poly-azole moiety of mechercharmycin 
VA! 
Prior to the synthesis of oxazole precursor 337, a trial reaction was run and showed 
highly promising results. 5-Phenyloxazole-4-carboxylic (341) acid was transformed 
into 4-bromo-5-phenyloxazole (343) in two steps in an overall isolated yield of 68 %. 
This is highly exciting as Barton and Zard stated: "The reaction is very sensitive to 
the presence of water and to the purity of the silver carboxylate but otherwise works 
173 
well with saturated aliphatic, and especially primary carboxylic acids."238 No 
Hunsdiecker reaction on a heteroaromatic molecule was mentioned or highlighted in 
this report. The Hunsdiecker literature up to today only provides one example of an 
oxazole —carboxylic acid silver salt. 118 
200 
OD Li 
	
N OH 
KOH OHj _ 
AgNO3 THF:HO 
°b° 
341 
0 / 	
Br2 
75°C 
342 	 343 
68% over 3 steps 
Scheme 115. Hunsdiecker test-reaction using 5-phenyloxazole-4-carboxylic 
acid. 
0 
	
Br2, 	0 	 0 
R 0 
Ag -AgBr RAOr - 	 Br 	
Br 	 R-Br 
342 	 343 
Scheme 116. Mechanism of the Hunsdiecker (Borodin) reaction. 
Given this success, a large scale peptide coupling, following the procedure in scheme 
117, was initiated. Several steps later the highly functionalised oxazole 337a was 
isolated and Hunsdiecker reactions could be commenced on the actual substrate. 
0 	 0 	Peptide 0 0 	LIOH coupling 	 DAST 
N 	 _J_-N 	 _J_N H OEt 	IOH 	I NO 
0 	 o o 344 345 	 346 	OH 
* * * 
MeO 	DBU 
____ 	 o MeO 	LiOH 	
O\= HO 
4 0__~~' Br3C bj70 	 4 Y
0 
347 	 348 	 337a 
Scheme 117. Five-step synthesis of functionalised oxazole 337a. 
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Commercially available 344 was firstly reacted in wet THF with LiOH to afford the 
acid 345. Acid 345 was then further modified using a peptide coupling with L-Ser-
OMe HCl to give structure 346. DAST (Diamino-sulfur-trifluoride) then cyclised the 
di-peptide to the desired oxazoline intermediate 347, which in turn was oxidised 
using the standard procedure of DBU I Br3CCI. The freshly prepared oxazole was 
then once again put into wet THF and LiOH, providing the free acid 337a for further 
modification. This synthetic sequence is known and has been reported in the 
literature. 239 
With the highly modified oxazole-carboxylic acid 337a in hand, first attempts into 
the Hunsdiecker reaction were started. Ideally the acid should be converted into the 
silver salt using silver nitrate and then treatment with a bromine source would furnish 
the desired halogen on the 4-position of the oxazole compound (Scheme 116 - 
mechanism). 
Given that the Hunsdiecker reaction is a classical reaction and has been discovered 
several decades ago, the reaction conditions shown in the literature are highly 
optimised and very specific. 240  For example, the use of iodine instead of bromine, 
known as the Simonini reaction, affords esters instead of the halogenated product. 
0 
2R&8 	
12 	0 
Ag -0O2 ROR 
342 	 349 
Scheme 118. Simonini reaction.241  
Based on a literature screening, two possible methods for the functional group 
transformation of the acid to the halide were identified. Br2 or NBS were the most 
commonly used halide sources and have been shown to promote a vast amount of 
Hunsdiecker reactions in the past. It should be mentioned at this point that almost all 
of the Hunsdiecker and Borodin reaction literature transforms cinnamic acid 
analogues into the corresponding bromo-derivatives. Aware of this fact but given the 
success of our trial reaction using 5-phenyloxazole-4-carboxylic acid (341) it was 
decided to investigate the use of bromine first. 
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Table 23. Reaction conditions for the Hunsdiecker reaction of 350 with Br2 
and NBS. 
0 	 GAg 
JN NO 
350 
* 
conditions 	
0 
 
4  N	N Br 0__~~
Ir 
'O 
337b 
Time / Temp. Solvent Br-source Result 
2 I r.t. Cd 4 Br2 1.0 eq. no cony. 
8 I reflux 0014 Br2 excess decomp. 
2 I reflux 0014 Br2 1.0 eq. decomp. 
10mm 	I reflux CCI4 Br2 1.0 eq. decomp. 
2 I 50°C CCI4 Br2 1.0 eq. decomp. 
1.5 	reflux CCI4 NBS 1.1 eq. decomp. 
1.5 / r.t. Cd 4 NBS 1.0 eq. decomp. 
2 I r.t. Cd 4 NBS recry. decomp. 
2 I reflux CCI4 NBS recry. decomp. 
Transformation of acid 337a into the silver salt 350 was spontaneous and provided 
the product in excellent yields as a light brown solid. Silver-salts of carboxylic acids 
are extremely light-sensitive and should be stored away from light sources at all 
times. It quickly became apparent however that the use of bromine would be a 
disadvantage due to the unreactive nature of our starting material under the selected 
conditions. Conditions were varied in such that the temperatures were increased from 
the standard ambient temperature up to 75 °C or 100 °C, amounts of bromine were 
varied from 1 to 3 equivalents, concentrations were changed as well as reaction times 
were constantly modified. None of the described conditions provided any 
encouraging conversions, new spots discovered on TLC plates were immediately 
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subjected to mass spectrometry analysis, to see if bromine isotopes could be found. 
None of the reactions involving bromine as the halogen source worked and 
investigations were changed to the other bromine-source, NBS. 
Opposite to some of the previously described bromine reactions, most of the 
reactions run with NBS readily decomposed the starting material. Initial reactions 
were performed under refluxing carbon tetrachloride but were quickly changed to 
ambient temperature due to the constant decomposition of the starting material. Even 
at ambient temperature only small amounts of starting material (the acid, not the 
silver salt of course) could be re-isolated, with the remaining mass being 
unidentifiable polar spots. Any new spots apparent upon TLC analysis were once 
again analysed using mass spectrometry techniques to detect possible bromine 
isotopes. No bromine isotopes were discovered at any point in time. 
Given a limited timeframe due to the apparent completion of the 3-year Ph.D. 
research period, a short investigation into the use of a Barton-decarboxylation was 
started. A handful of reactions were attempted but the Barton-ester 351 was not 
isolated in a successful manner, these reactions did not prove successful in my hands. 
HOc 
O 
DCC, DMAP
__1j- 	
s o 
351 
Barton-ester 
0 
CI3CI-I 
352 337a 
Scheme 119. Proposed Barton-decarboxylation sequence. 
3.5 Summary 
The above chapter describes the design and subsequent retrosynthetic analysis of the 
total synthesis of the biologically active natural product mechercharmycin A, also 
found under the name of IB-O 1211. Further, four key fragments have been identified. 
Three of the four key fragments (A, B and C) have been successfully synthesised 
with the fourth fragment (D) being a di-peptide already known in the current 
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literature. Direct arylation methodologies previously discovered in the Greaney 
group were used to generate complex bis- and tris-azole fragments. Further, a novel 
approach for the generation of 2-Tips-4-Br-thiazole is described, which reduces the 
synthetic steps from the current three to a useful two steps. 
All attempts to couple fragment B and fragment C have been shown to be 
unsuccessful, promoting a complete change in the retrosynthetic approach. Finally, 
investigations into the direct transformation of an aromatic carboxylic acid via its 
silver-salt using a classical Hunsdiecker reaction proved only successful with the 
test-substrate. 
36 Conclusions and Future Work 
Prior to the discovery of a decarboxylative coupling of oxazoles (by Dr. Zhang, post-
doe 2010, Greaney group) the conclusion of this chapter would have highlighted the 
need for further investigations into the Barton-decarboxylation reaction using 
Barton's ester. Given our recent discovery of decarboxylative direct arylation, focus 
and future work now changed towards the development of a broadly applicable 
methodology. Several high yielding examples of this extremely interesting coupling 
have been isolated and progress has already been made to use this methodology 
towards the total synthesis of mechercharmycin A. 
3.7 Experimental 
General 
'H-NMR and 13C-NMR spectra were recorded on BrQker dpx360 (360 MHz), BrUker 
dpx250 (250MHz) as well as a Brüker ava800 (800 MHz) instruments. Melting point 
measurements were obtained from a Gallenkamp melting point apparatus and are 
uncorrected. Electrospray high resolution mass spectrometry was performed by the 
EPSRC National Mass Spectrometry Service Centre, Swansea, using a Finnigan 
MAT 900 XLT double focusing mass spectrometer. The data is recorded as the 
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ionisation method followed by the calculated and measured masses. TLC was 
performed on Merck 60F254 silica plates and visualized by UV light. The compounds 
were purified by wet flash chromatography using Merck Kieselgel 60 (particle size 
35-70) silica under a positive pressure. Distilled water was used in reactions carried 
out in water as the solvent. 
Ethyl 2-(oxazol-4-yI)-5-phenyioxazole-4-carboxylate (308) 
Bis-oxazole 318 (0.060 g, 0.136 mmol, 1 equiv.), was 
- 	o 	/ o dissolved in DCM (2 ml) in a round bottom flask. To the 
solution, TBAF 1.6 M (1.02 ml, 0.164 mmol, 1.2 equiv.) was 
OEt 	 added via syringe at ambient temperature. After 25 minutes, 
10 ml of DCM and 20 ml of deionised water were added and the two phases were 
separated via extraction. The aqueous phase was washed with DCM (2x 10 ml) and 
the combined organic layers were dried with MgSO4. Filtration, followed by 
evaporation of the solvent afforded the crude product. Column chromatography in 
hexane : EtOAc (1:1) afforded the product in 82 % yield (32 mg) as an off-white 
solid. 1H NMR (400 MHz, CDC13) 6  8.43 (s, 1H), 8.12-8.10 (m, 2H), 8.02 (s, 1H), 
7.50-7.44 (m, 3H), 4.47-4.41 (q, 2H, J=7.1 Hz), 1.42-1.38 (t, 3H, J= 7.1Hz). 13C 
NMR (100 MHz, CDCI3) 8  161.4 (quat), 154.8 (quat), 152.5 (quat), 151.3 (CH), 
139.1 (CH), 130.0 (CH), 129.2 (quat), 128.2 (2x CH), 127.9 (2x CH), 127.5 (quat), 
126.1 (quat), 115.7 (quat), 61.1 (CH2), 13.8 (CH3). HR1'IS (El) mlz calcd for 
C15H12N204 285.0875; found 285.0878. 
Ethyl 2-(2-(2-(triisopropylsilyl)thiazol-4-yl)oxazol-4-yl)-5-phenyloxazole-4-
carboxylate (303) 
Compound 308 (55 mg, 0.196 mmol, 1.0 equiv.) 
- 	0 	/ 0 	was added to a vial containing Cs2CO3 (128 mg, 
0 	 0.392 mmol, 2 equiv.), Hermann-Beller- 
OEt 	 palladacycle (10 % mol) and 2-Tips-4-bromo- 
TIPS 
thiazole (305) (69 mg, 0.216 mmol, 1.1 equiv.). To 
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the mixture was added dry toluene (3 ml) via syringe. The solution was stirred at 140 
°C for 4 hrs in a Biotage microwave reactor (Initiator). Work up included removal of 
the MW-vial lid, addition of DCM (10 ml) as well as deionised water (10 ml), 
followed by phase separation and washing of the aqueous phase with DCM (2x 5 
ml). The combined organic layers were dried using MgSO4. Evaporation of the 
solvents at reduced pressure provided the crude product, which was purified using 
silica chromatography (hexane : EtOAc 9:1) to then afford the pure product in 46 % 
yield. 'H NMR (400 MHz, CDC13) 6  8.48 (s, 1H), 8.44 (s, 1H), 8.20-8.15 (m, 2H), 
7.55-7.49 (m, 3H), 4.50-4.44 (q, 2H, J= 7.1 Hz), 1.57-1.48 (sept, 3H), 1.46-1.42 (t, 
3H, J=7.1 Hz), 1.21-1.19 (d, 18H, J= 7.5 Hz). '3C NMR (100 MHz, CDC13) 6 172.6 
(quat), 162.0 (quat), 158.8 (quat), 155.4 (quat), 153.4 (quat), 145.9 (quat), 139.3 
(CH), 130.8 (quat), 130.5 (CH), 128.8 (CH), 128.4 (CH), 128.1 (quat), 126.7 (quat), 
124.3 (CH), 61.6 (CH2), 18.5 (CH3), 14.3 (CH3), 11.7 (CH). HRMS (El) mlz calcd 
for C27H33N304SSi 524.2039; found 524.2029. 
4-Bromo-5-phenyl oxazole (343) 
To a solution of 5-phenyl-4-carboxylic acid (250 mg, 1.32 mmol) 
and potassium hydroxide (72 mg, 1.5 mmol) in water (10 ml) was 
I) added a solution of silver nitrate (105 mg, 1.5 mmol) in water (10 
Br 	ml). The reaction mixture was stirred at room temperature for 2 hrs 
and filtered. The salt was washed with water, air dried, and finally dried under 
vacuum at 60 °C overnight. The salt was suspended in carbon tetrachloride (10 ml) 
under a nitrogen atmosphere, and bromine (224 mg, 1.4 mmol) was added drop wise. 
The reaction mixture was heated under 75 °C for 1.5 hrs and then filtered. The 
filtrate was partitioned between 2 M sodium hydroxide (10 ml) and dichioromethane 
(25 ml) and the aqueous layer was further extracted with dichloromethane (2 x 25 
ml). The combined organics were washed with brine (25 ml), dried (MgSO4), and 
evaporated. The residue was purified by flash chromatography (hexane : ether, 9:1) 
and gave compound 343 in an overall yield of 68 %. 'H NMR (250 MHz, CDC13) 
7.95-7.91 (214, m), 7.87 (s, lH), 7.46-7.39 (3H, m). 13C NMR (63 MHz, CDC13) 
HE 
149.6 (CH), 146.6 (quat), 129.4 (CH), 129.0 (2xCH), 126.6 (quat), 125.5 (2xCH), 
110.8 (quat). HRMS (El) mlz calcd for C9H6BrNO 222.9627, found 222.9626. 
Ethyl 5-phenyl-2-(2-thiazol-4-yl)oxazol-4-yl)oxazole-4-carboxylate (304) 
Synthesised according and analogues to the 
- 	O7O 	previously described Tips-deprotection method 
using TBAF. 'H NMR (400 MHz, CDCI3) 8 8.64 (s, 
OEt 	 1H), 8.48 (s, 1H), 8.44 (s, 1H), 8.20-8.15 (m, 2H), 
7.55-7.49 (m, 3H), 4.50-4.44 (q, 2H, J= 7.1 Hz), 1.57-1.48 (sept, 3H), 1.46-1.42 (t, 
3H, J=7.1 Hz), 1.21-1.19 (d, 18H, J= 7.5 Hz). '3C NMR (100 MHz, CDC13) 6 172.6 
(quat), 162.0 (quat), 158.8 (quat), 155.4 (quat), 150.0 (CH), 145.9 (quat), 139.3 
(CH), 130.8 (quat), 130.5 (CH), 128.8 (CH), 128.4 (CH), 128.1 (quat), 126.7 (quat), 
124.3 (CH), 61.6 (CH2), 18.5 (CH3), 14.3 (CH3), 11.7 (CH). HRMS (El) mlz calcd 
for C18H14N304S 368.0705, found 368.0713. 
4-Bromo-2-(triisopropylsilyl)thiazole (305) 
Br---e
:--\sDry THF (25 ml) was added to a flask containing 2,4-dibromo 
thiazole (1.0 g, 4.12 mmol, 1.0 equiv.) at room temperature under 
y 	nitrogen atmosphere. The solution was cooled to -78 °C using a 
/ dry ice / acetone bath and then n-BuLi 1.6 M I hexane (2.77 ml, 
1.1 equiv.) was added drop wise via syringe. The solution was stirred at that 
temperature for another 10 minutes, then allowed to go to 0 °C at which the Tips-
OTf (1.16 ml, 1.05 equiv.) was added quickly but drop wise. The solution was 
allowed to reach room temperature and left stirring for 20 - 40 minutes. Water (50 
ml) was added to quench the reaction as well as diethyl ether (50 ml). The two 
phases were separated and the aqueous phase was washed with ether (25 ml). The 
combined organic phases were dried over MgSO4, filtered and the solvent was 
evaporated under reduced pressure. Silica-gel column chromatography using hexane 
EtOAc ( 9 : 1) afforded the final compound 305 as a colourless oil in 41 % (527 
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mg). 111 NMR (400 MHz, CDC13) 6 7.38 (s, 1H), 1.47 (sept, 3H, J= 7.4 Hz), 1.11 (d, 
18H, J= 7.4 Hz). HRMS (El) mlz calcd for C12H23BrNSSi 320.0498; found 
320.0503. 
2,4-Dibromo-thiazole (317) 
	
Br 	This is a known compound. A mixture of thiazolidine-2,4-dione (3.40 r
zzz~ 
g, 29.0 mmol) and phosphorus oxybromide (25 g, 87.0 mmol, 3.0 
Br equiv.) was heated at 110 °C. After 3 hrs, the reaction mixture was 
cooled to room temperature and cautiously hydrolysed with crushed ice (also put 
flask in ice-bath). The resulting mixture was extracted with ether (2 x 200 ml) and 
the combined organic extracts were dried over MgSO4, filtered and concentrated 
under reduced pressure. The crude material was purified by silica gel 
chromatography (pentane : ether 99 : 1) to afford the final compound in 61 % yield 
(4.3 g). '3C NMR (63 MHz, CDC13) 6 136.2 (quat), 124.1 (quat), 120.8 (CH). 
Ethyl 2-vinyloxazole-4-carboxylate (331) 
- 	o 	This is a known compound. NaHCO3 (11.4 g, 136 mmol) in 
N 	 powder form was added to a dry flask equipped with a stirrer. This 
COOEt was followed by the addition of acryl amide (2.41 g, 33.9 mmol) as 
well as THF (130 ml). The suspension was stirred and a first batch of bromo-
pyruvate (5.2 ml, 37 mmol) was added via syringe. The flask was heated to 60 °C for 
15 hrs and then another batch of bromo-pyruvate (3.0 ml, 21.0 mmol) was added. 
This mixture was stirred at 60 °C for another 8 hrs after which the flask was cooled 
to room temperature and the solid particles filtered. The filtrate was solidified by 
removing solvents under reduced pressure. The obtained solid was redissolved at 0 
°C in THF (15 ml). Further, still at 0 °C, TFAA (15 ml) was added and the mixture 
was then allowed to reach room temperature over night. After 20 hrs, NaHCO3 was 
added to neutralise the pH. (Caution!). Further, EtOAc (300 ml) and water (300 ml) 
were added and the two phases were separated. The organic phase was dried with 
MgSO4 and filtered. The crude product was purified over silica using 3 : 1 (hexane: 
EtOAc) to afford the pure product 331 in 59 % yield. 131 1H NMR (400 MHz, CDC13) 
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8.20 (s, 1H), 6.74-6.67 (dd, 1H, J= 11.3, 17.7 Hz), 6.34-6.30 (d, 1H, J= 17.7 Hz), 
5.79-5.66 (d, 1H, J= 11.3 Hz), 4.47-4.41 (q, 2H, J7.1 Hz), 1.42-1.38 (t, 3H, J 
7.1Hz). '3C NMR (100 MHz, CDC13) 8  161.4 (quat), 161.2 (quat), 143.4 (CH), 134.4 
(quat), 124.0 (CH), 122.7 (CH), 61.3 (CH2), 14.4 (CH3). 
Ethyl 2-(2-(triisopropylsilyl)oxazol-4-yl)-5-phenyloxazole-4-carboxylate (318) 
Ethyl -5 -phenyloxazole-4-carboxyl ate (31 mg, 0.177 
- 	0 	/ 0 	mmol, 1.2 equiv.) was added to a vial containing 4- 
0 	N 	N TIPS Iodo-2-triisopropylsilanyl-oxazole (50 mg, 0.142 
0Et 	 mmol, 1.0 equiv.), Cs2CO3 (93 mg, 0.284 mmol, 2.0 
equiv.) and Herrmann-Beller catalyst (0.007 g, 5 mol %). To this mixture was added 
dry toluene (2 ml) via syringe. The suspension was stirred at 115 °C in the sealed 
tube for 24 hours. DCM (5 ml) and deionised water (10 ml) were added the 
following day and the aqueous phase was washed once with DCM (5 ml). The 
combined organic layers were dried using MgSO4, filtered and the solvent removed 
using reduced pressure. The crude product was purified by silica gel chromatography 
using 9:1 (hexane : EtOAc) to give the bis-oxazole 318 in 56 % yield. Both starting 
materials were isolated during chromatography and combined accounted for the rest 
of the mass. 'H NMR (400 MHz, CDC13) 5 8.53 (s, 1H), 8.12-8.10 (m, 2H), 7.51-
7.44 (m, 3H), 4.49 (q, 2H, J= 7.1 Hz, 14.2 Hz), 1.51-1.39 (m, 6H), 1.16 (d, 18H, J= 
27.4 Hz). '3C NMR (100 MHz, CDC13) 8  170.5 (quat), 162.1 (quat), 155.0 (quat), 
154.1 (quat), 142.0 (CH), 130.3 (CH), 129.7 (quat), 128.7 (2x CH), 128.3 (2x CH), 
128.0 (quat), 126.9 (quat), 61.5 (CH2), 18.2 (6x CH3), 14.3 (3x CH), 10.8 (CH3). 
2,4-Diiodooxazole (309) 
i 	The compound was synthesised according to Vedejs' procedure with 
modifications. 1,3-Oxazole (1.00 ml, 14.900 mmol, 1 equiv.) was 
I 	dissolved into a mixture of anhydrous THF (6.4 ml), anhydrous DMPU 
(5.2 mL), and cooled to -78 °C. LHMDS (32.80 ml, 1M in THF, 2.2 equiv.) was then 
added drop wise and stirred for 1 h. After this time, solid iodine (7.600 g, 29.800 
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mmol, 2 equiv.) was added to the reaction mixture and stirred for an additional 30 
min at -78 °C. The cooling bath was then removed and the reaction mixture was left 
to warm to rt and stirred for 14 days under a low positive pressure of N2. The 
reaction mixture was then poured into a mixture of aqueous Na2S203 (10%, 100 ml) 
and diethyl ether (100 ml). The organic layer was washed with brine (100 ml) and 
dried over MgSO4. After filtration, the solvent was removed in vacuo. The residue 
was purified by flash chromatography (silica, hexanes / EtOAc, 9:1) to give the title 
compound 309 (3.701 g, 77 % yield) as a white solid. Mp 98-100 °C. 1 H-NMR (360 
MHz, CDC13) 8 7.76 (1H, s). 13C-NMR (90 MHz, CDC13) 6 83.12 (quat), 101.56 
(quat), 148.93 (CH). HRMS (ESI) calculated for C3H1N012 320.8142; found 
320.8145. 
4-Iodo-2-triisopropylsilanyl-oxazole (298) 
i 	 2,4-Diiodooxazole (500 mg, 1.558 mmol, 1 equiv.) was dissolved in 
dry THF (15 ml) and cooled to -78 °C. n-BuLi (1.17 ml, 1.870 mmol, 
TIPS 1.2 equiv.) was added drop wise to the cooled solution and the mixture 
was stirred for 20 mm. Triisopropylsilyl trifluoromethanesulfonate (0.44 ml, 1.636 
mmol, 1.05 equiv.) was then added slowly and the reaction mixture was stirred an 
additional 10 mins at -78 °C. At this point the cooling bath was removed and the 
reaction mixture was stirred for an additional 30 min at room temperature. The 
reaction mixture was quenched with water (50 ml) and diluted with diethyl ether (50 
ml), the organic layer was washed with brine (50 ml), dried over MgSO4, filtered and 
concentrated in vacuo. Purification by flash chromatography (hexanes / DCM, 4:1) 
yielded 487 mg (yield 89 %) of the desired product 298 as a light yellow oil. 'H-
NMR (3 60 MHz, CDC13) 5 1.11 (18H, d, J= 7.2 Hz), 1.34-1.46 (3H, m), 7.79 (1H, 
S). 13C-NMR (90 MHz, CDC13) ö 10.90 (CH), 18.28 (CH3), 81.83 (quat), 144.47 
(CH), 171.00 (quat). HIRMS (ESI) calculated for C9H8N204 351.0510; found 
351.0500. (Further purification can be achieved via Kugelrohr distillation 
(recommended for the direct couplings). 
as 
Ethyl 2-(2-(triisopropylsilyl)oxazole-4-yl)oxazole-4-carboxylate (353) 
A 5 mL microwave type vial was charged with 50 mg of 
) -	N TIPs 298 (50 mg, 0.142 mmol, 1 equiv.), 4-Ethyl- 
OEt 	
oxazolecarboxylate 134 (25 mg, 0.177 mmol, 1.2 equiv.), 
Hermann's palladacycle (7 mg, 5 mol %), Cs2CO3 (93 mg, 0.284 mmol, 2 equiv.) 
and anhydrous toluene (1 ml). The vial was equipped with a magnetic stirrer bar, 
sealed and flushed with N2. The vial and its contents were heated and stirred in a 
preheated oil bath at 110 °C for 16 hrs. After this time the vial was cooled to rt and 
the reaction mixture poured into a mixture of water (20 ml) and Et20 (30 ml). The 
organic phase was separated and the aqueous layer was re-extracted twice with Et20. 
The organic layers were combined, dried over magnesium sulphate and after 
filtration the solvent was removed in vacuo. The residue was purified by flash 
column chromatography (silica, hexane I EtOAc, 9:1) to give the coupled product 
353 as a yellow oil (42 mg, 81% yield). 1H-NMR (360 MHz, CDC13) 6 1.18 (18H, d, 
J= 7.50 Hz), 1.38 (3H, t, J= 7.14 Hz), 1.40-1.49 (3H, m), 4.45 (2H, q, J- 7.14 Hz), 
8.27 (1H, s), 8.52 (1H, s). '3C-NMR (90 MHz, CDC13) 6 10.91 (CH), 14.27 (CH3), 
18.28 (CH3), 61.33 (CH2), 129.63 (quat), 134.41 (quat), 141.98 (CH), 143.44 (CH), 
156.42 (quat), 161.08 (quat), 170.52 (quat). HR1VIS (ESI) calculated for 
C18H28N204Si 364.1813; found 364.1809. 
Ethyl 2-(oxazol-4-yl)oxazole-4-carboxylate (306) 
A 10 ml round bottom flask was charged with compound 353 
N 	(97 mg, 0.266 mmol, 1 equiv.), THF (5 ml) and aqueous TBAF 
OEt 	 (1 M, 0.41 ml, 0.410 mmol, 1.5 equiv). The reaction mixture 
was stirred for 25 min at rt, then diluted with water and extracted twice with DCM. 
The organic phase was washed with saturated aqueous NH4C1, brine (2x) and dried 
over magnesium sulphate, which after filtration and concentration in vacuo gave bis-
oxazole 306 as a white solid (88 mg, 83% yield). Mp 117-119 °C. 1 H-NMR (360 
MHz, CDC13) 6  1.34 (3H, t, J= 7.1 Hz), 4.36 (2H, q, J = 7.1 Hz), 7.98 (1H, s), 8.26 
(1H, s), 8.37 (1H, s). 13C-NMR (90 MHz, CDC13) 6  14.17 (CH3), 61.33 (CH2), 
129.48 (quat), 134.48 (quat), 139.65 (CH), 143.62 (CH), 151.78 (CH), 151.78 (CH), 
155.33 (quat), 160.79 (quat). HRMS (ESI) calculated for C9H8N204 208.0479; found 
Alternatively, compound 306 can be prepared by re-diluting the dry crude from the 
previous step with 5 mL of THF, adding TBAF (0.14 ml, 1M in THF, 1.0 equiv) and 
stirring 25 min at rt. The mixture was then diluted with DCM and washed with 
NH4CI and brine (2x), dried over magnesium sulphate and after filtration the solvent 
was removed in vacuo. The residue was purified by flash column chromatography 
(silica, hexane / EtOAc 1:1) to give the coupled product 306 as a white solid (21 mg, 
71% yield, over 2 steps). 
Ethyl 2-((S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl)-oxazole-4-
carboxylate (348) 
1e 	To a solution of N-Boc-Ser-OH (13.0 g, 53.0 mmol) in 
BocN—t-Me 
CH202 (159 ml, 3.0 ml / mmol) was added H-Ser- 
OMe•HCI (9.1 g, 58.3 mmol), HOBt (8.6 g, 63.6 mmol) and 
OMe 	 DIEA (12.0 ml, 68.9 mmol) at room temperature, and the 
mixture was cooled to 0 °C. To the mixture was added EDCIHC1 (11.2 g, 58.3 
mmol) at the same temperature and stirred at room temperature. After being stirred at 
the same temperature for 1 h, the mixture was poured into 1 M HCI at 0 °C. The 
aqueous layer was extracted twice with ethyl acetate. The organic layer was washed 
with 3 M HC1, saturated aqueous NaHCO3 and brine, dried over MgSO4, and filtered. 
The filtrate was concentrated in vacuo. The residue was used for the next reaction 
without further purification. To a solution of dipeptide in CH202 (159 ml, 3.0 ml! 
mmol) was added a solution of DAST (8.4 ml, 63.6 mmol) in CH2C12 at —78 °C 
under argon. After being stirred at the same temperature for 1 h, the mixture was 
poured into saturated aqueous NaHCO3 at 0 °C. The aqueous layer was extracted 
twice with ethyl acetate. The organic layer was washed with saturated aqueous 
NaHCO3 and brine, dried over MgSO4, and filtered. The filtrate was concentrated in 
vacuo. The residue was used for the next reaction without further purification. To a 
solution of oxazoline in CH2Cl2 (159 ml, 3.0 ml! mmol) was added DBU (24 ml, 
159 mmol) at 0 °C under argon. To the mixture was slowly added BrCC13 (15.6 ml, 
159 mmol) at the same temperature. After being stirred at room temperature for 3 
hrs, the mixture was poured into 3 M HCl at 0 °C. The aqueous layer was extracted 
twice with ethyl acetate. The organic layer was washed with 3 M HC1, saturated 
aqueous NaHCO3 and brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo. The residue was purified by column chromatography on flash 
silica gel with 20% ethyl acetate in hexane to afford 348 (11.5 g, 35.5 mmol, 67% 
over 3 steps) as a yellow powder. The obtained NMR spectra matched the literature 
values. 1H NMR (400 MHz, DMSO-d6, 80°C) 6 8.71 (1H, s), 5.08 (1H, dd, J= 2.89 
Hz, 6.76 Hz), 4.27 (1 H, dd, J = 6.76 Hz, 9.42 Hz), 4.02 (1H, dd, J = 2.89 Hz, 9.42 
Hz), 3.81 (3H, s), 1.63 (3H, s), 1.52 (3H, s), 1.31 (9H, bs). 
2-((S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazoline-4-yJ)-oxazole-4-carboxyliC 
acid (337a) 
Me 	To a solution of methyl ester 348 (6.0 g, 18.4 mmol) in 
O BocN±Me MeOH (37 ml, 2.0 ml / mmol), THF (37 ml, 2.0 ml / mmol) 
and H20 (9.2 ml, 0.5 ml / mmol) was added LiOH 'HO 
OH 	
(1.04 g, 25.0 mmol) at 0 °C. After being stirred at the same 
temperature for 3 hrs, the mixture was acidified with 3 M 
HC1 at 0 °C. The aqueous layer was extracted twice with ethyl acetate. The organic 
layer was washed with brine, dried over MgSO4, and filtered. The filtrate was 
concentrated in vacuo. The residue was recrystalised with hexane I CH202 to afford 
337a (5.5 g, 17.5 mmol, 95 %) as a white powder. The obtained NMR spectra 
matched the literature values. 'H NMR (400 MHz, DMSO-d6, 80 °C) ö 8.59 (1H, s), 
5.07 (1H, dd, J= 3.38 Hz, 6.76 Hz), 4.26 (1H, dd, J= 6.76 Hz, 9.18 Hz), 4.01 (1H, 
dd, J= 3.38 Hz, 9.18 Hz), 1.63 (3H, s), 1.52 (3H, s), 1.31 (9H, bs). 
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An efficient two-step palladium catalysed synthesis of 2,5-
disubstitated oxazoles is reported. 
The functionalisation of heteroaromatic compounds by tran-
sition metal (TM) catalysed C-C bond formation comple-
ments classic condensation chemistry as a strategy for poly-
functional heteroaromatic synthesis) Whereas classic hetero-
cyclic synthesis frequently involves the preparation of appro-
priately substituted acyclic precursors which undergo cydo-
condensation as a final step, TM-catalysed cross couplings 
offer the possibility of taking the parent, commercially avail-
able heteroarcues and selectively functionalising the C-H 
bonds around the heteroarene nucleus. The two approaches 
are illustrated in Scheme I for a 2,5-disubstituted azole synth-
esis. Whilst the condensation route is generally reliable and 
built upon many years of literature precedent, the preparation 
of the appropriately substituted precursor I is necessarily 
multi-step and the subsequent condensation is usually carried 
out under forcing conditions. The TM-catalysed approach 
offers significant advantages of speed and synthetic expediency 
in comparison, along with the potential for mild C-C bond 
forniing reaction conditions. 
Importantly, the cross-coupling route enables the introduc-
tion of diversity at a late stage, rather than the early stage 
mandated by the condensation approach, a strategic advan-
tage2 in the type of intensive analog synthesis required by 
contemporary medicinal and agrochemical chemistry. 
The TM-catalysed approach becomes even more attractive 
if direct arylation can be incorporated as a C-Cbondforisiiug 
react5011.3 Here, the stoichiometric metallation required for 
classic cross-couplings such as the Suzuki-Miy aura, Stille and 
Negishi reactions is dispensed with, in favour of direct C-H 
bond functionalitation.4 We now report the preparation of 
assorted 2,5-diaryloxazoles using TM-catalysed chemistry. 
Negishi coupling at the 2-position using a stoicltiometric 
zincate followed by direct arylation at the 5-position under 
mild 'on water' conditions. The oxazolehetcroarene structure 
'University of -Edinburgh, School of Chemistry, Joseph Riads 
Building, icing's j8uildings, West Mains ltd. Edinburgh. tiE EE9 lilT 
Global Discovery Chemistry, Nos'arri.s fiorsham .eneardi Centre, 
Wbnblediir,nt P,sad, Borshom, West Sussex, UK AH12 5AB 
t CCDC 671459. For ciyttalloaphic data in OF or other electronic 
format see DO!: 10.1 039[b719466h 
Electronic supplementary infonnation (ES!) available: Experimental 
procedures and characterization data for all new compounds. See 
DOL 10.1039fb7194661i 
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has widespread application in medicinal, agroclimnical, 
natural products and materials chemistry.5 
Taking commercially available oxazole as our starting 
point, we functionalised the 2-position using a Negishi cross-
coupling protocol developed by Reeder and co-workers.°  
Following lithiation with n-BuLi at —7 C, solid ZnCl2 is 
added to form the zincate, which subsequently undergoes Pd-
catalysed coupling with aryl iodides at 60 C. The procedure 
proved very effective for the preparation of the four 2-arylated 
oxazoles 6a-d, 6b having been exemplified in Reeder's work 
and 6a, c, d being newly prepared using this nrethonl. With 
these substrates in hand, we turned our attention to the direct 
arylation of the oxazole 5-position. We have recently devel-
oped an effective on wate17 method for the direct arylation of 
heteroarenes;5 high yields of arylated products are produced 
under far milder conditions than those typically employed in 
literature heteroarene arylations. 
We were pleased to observe that the on water direct aryla-
tion is effective across a wide range of aryl iodides (Table I), 
with yields being good to excellent for the 2-substituted 
oxazoles 6a-c. The scope of aryl iodide covers electron rich 
(entries 5 and 6), electron poor (entries 3, 4, 7 and 9), sterically 
hindered (entries 2 and 10) as well as aryl iodides which 
contain additional functional handles for further elaboration 
such as aryl halide (entries 7 and 8) and acyl (entry 9). The 
process was poorly effective for pyridyl iodides,9 producing 
very slow reactions with low yields of the oxazoyl pyridines 
(30-36%), with homocoupling of the oxazole being the 
dominant side-reaction)°  
The average yield across the 30 examples in Table 1 was 
15%, illustrating the power of the direct arylation method for 
the rapid assembly of ftinctionaliscd heteroarenes. This is the 
first study of oxazole arylation that examines substrate range; 
Rl, 
1.M,ilIetep 
2 pmporatbn 2 o regioselestive 
ThSsol.C-Cboin 
formation 
1 R 	x N11- 
3. Cornmerma5y 
avaikabie  
21 0, S 
Scheme 1 lteteroaiene synthesis vie condensation and TM-catalysed 
methods. 
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Table 1 	 n-BuLj, ZnCI,, 
.78 C, 11W; then 
A92CO3 	 Pd(PPh(, (10 recl%(. 
/ N 	Pd(dppflCl7 0CM (5 mo!%) 	 .> •- 60 'C 
PPh3 (10 mo!%), H50 	 N 	 I 
R1O"C 
R2 - 	 R X 	 0 N 	P X 
	
R1 	 R2_ 
6a R'=H 	
8-17 	 4aC.RH) 	5 	6(XC,RH) 	83% 6bROMe 4b(XCR0CH5) 6b(XC.A=OCl-l) 86% 
6cR'=CH3 	 4c(XC,RCl-ti) 6c(X=CR=CH) 75% 4d(XNR'H) 	 6d(XNRH) 	78% 
Scheme 2 2-Aryloxa2ole synthesis via Neshi cross-coupling. 
Entry 	Products 	 Yield (%) 
I 	
N—R 	
92 	 conditions 
83 antabtel MeO</ _0 1O  - 	 92 	 - 
8a-c 	 —N 	 MoO 	N 
2 	 N Me 	 83 	
Ba Balsoxin, 18 
R'°'o 	
98 conditions 
- 	 90 -s- astablel  1 	 o 9 O 	N 
80 	 '-N 	 74% 	 LN 
98 6d Texsiline,19 
CF, 	90 
I (ta-c 	 Scheme 3 Synthesis of balsoxin and texaline. 
4 	 N 84 NO 	 85 	texaline are 2,5-diaryloxazoles isolated from Amyris species of 
80 plant in the Caribbean, 12.11  with texaline reported to have 
Its-c 
N 	
. 	 antimycobacterial activity against Mycobacterium tuberculo- 
-O- 
-. 	 84 s67, M. avium and M. kanyasii. 14 
- 	 Me - 	 97 	 The aforementioned Negishi coupling of aryl iodides with 
12a-c 	 oxazole introduced the requisite 2-aryl substituent. A direct 
76 
89 	arylation at the 5-position with the electron rich aryl iodides 
6 	
R'°T Nrl,  OMe 	79 3,4methoxyiodobena and 3,4-methylenedioxyiodoben- 
l3a-c 	 rena afforded balsoxin, 18, and texaline, 19, respectively, in 
90 	good yield (Scheme 3). The power of the direct arylation 
87 approach can be appreciated in comparison to literature 
CI 	 92 
preparations of these two natural products. Hodgetts and 
No 	 68 	Kershaw synthesised balsoxin in 7 steps, 40% overall yield 
83 in a Suzaki-Miyaura approach, starting from ethyl 2-amino 
8 	
P Br 	 70 	oxazole carboxylate,'0 whilst Copp and co-workers synthe- 
sised texaline in 6 steps, 4% overall yield using a condensation 
86 approach. 16 9 	
0 Me 	89 	 In conclusion,we have developed a mild direct arylation 
16a-c 	
0 93 method for the synthesis of 2,5-disubstituted oxazoles and 
10 	 85 
applied it to the two-step assembly of balsoxin and texaline. 
N 	 We thank Novartis, The EU and the University of Min- 
0 
9  81 	burgh for funding. The EPSRC mass spectrometry service at 
17a-e 	 the University of Swansea is acknowledged and Prof. Simon 
Parsons (School of Chemistry, University of Edinburgh) is 
thanked for assistance with X-ray crystallography. 
previous arylations of the oxazole 5-position having been 
confined to individual substrates and uniformly taking place 
at elevated temperatures." Preliminary results suggest that the 
on water arylation will be effective for the acidic a.zole 2-
position; treatment of 5-phenyloxazole with p-chloroiodoben-
rate afforded the 2,5-diaryloxarole product in a good 71% 
yield.' 
Having established the method for the 2-step synthesis of 
2,5-diaryloxazoles, we applied the chemistry to the rapid 
construction of two oxazole natural products. Balsoxin and 
1242 1 Chem. Common., 2008, 1241-1243 
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The efficient palladiurncatalyzed synthesis of e range of substituted 2H-lndazoles via C H arylation is reported. Reactions are perlormed on 
water and provide a direct and mid route toward 2,3-diaryl indacoles of widespread biological significance. 
Direct arylation is a powerful approach to the synthesis of 
functionalized arenes that offers an alternative to conven-
tional cross-coupling mcthods,1'2 The direct manipulation of 
C—H bonds in catalytic C—C or l2—X bond formation avoids 
the preparation and use cf stoichiometric organometallics, 
conferring the strategic benefit cf streamlined, operationally 
simple synthesis with reduced byproduct formation. 
A feature of current direct arylafion methodology, is the 
lu& itnoctiul teilipesatuses required to effect C—C bond 
formation, with relatively few systems being reported to date 
that proceed below 1CO 	The development of new 
systems that function at milder temperatures A,  ill significantly 
enhance the scope and functional group tolerance of direct 
arylation as a general method of sp2 C—C bond formation. 
We are addressing this issue through the development of 
direct arylation chemistry that works on water .4  We have 
found that on water ccnditicns, where substrate and catalyst 
system form a heterogeneous mixture in pure water, can be 
extremely effective for high yielding direct aryl ations under 
mild conditions.t We now wish to report our results on the 
application of on water arylation to the indazole substrate. 
University of Edinburgh. 
'Novartis Horshani Research Centre. 
(1) Renir.t reviews (a) McGlackeri, C. P.; Batenan, '.,.M. Clean. .0cc 
Rev. 2009, 10. 2447-2404 (s) Daugulis. 0.; Do, H-C.; Shahashos. D. 
Ace Cites Re:. 200.42. 104-126. Ic) C'ie.i, K,: Engle. K. H.; Wang, 
D,.H4 Yu. I -Q  ,&sgee. Cites., let. Ed 2909, 42, 5094-51 15. 
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Although rare in nature, the indazolc hctcrocycic has vast 
application in medicinal chemistry, particularly in the field of 
kinase inhibition! Direct arylation at the C3 position would 
significantly simplify synthetic routes to this important class of 
hetercarene. Catalytic direct arylaticrm of iuslazoler has received 
little attention, a single elegant study from Laitens on the 
synthesis of annulated 2H-indazoles via intramolecular direct 
arylation being the only extant report in the literature. 
Ph 
1.phnyIndazoie 1 2-ph ryIed.oI. 2 
(1'4scrc3) (2)45.CrCSl 
FIgure 1. IH and OH indazoles. 
We began by examining the regroisomeric 1- and 2-çkie-
tmvliimdoteolea as subsets ales (Figure 1). 'line C3 pusiliomi is known 
to be markedly k-its rea'tise toward s,*retilntim in the. 1 H-series, 
and (Isis was miiamiifestui us our direel au3laliomm etudie. with 1 
nnrlssrgc.ing no arvltin on water nnde.r the, mild conditions 
we were looking lo develop. 2-Hiezmyliidcreule,5 by caitsatd, 
proved an earcellet substrate., undergoing clean on water 
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arylation with a variety f aryl halides at just 20 'C on water. 
A catalyst syoteni of Pd(df)C12/P1?1 7 oi Pd(dppl')Cl/PPl17 iii 
the presence of an equivalent of Ag2CO-; ircduced good to 
exer.11cnt yields of 2,3-diaiylindazolcs an water. The reaction 
was generally effective for both aryl iodides and bromides, an 
advance over our previa_ir on water sTudies of azole heterocycles 
which were restricted to aryl iodides: iTable 1). 
Functional group tolerance was good, with halo (entries 
2, 5. and 7), electron withdrawing (entries 4, It;, 11, and 121, 
and electron donating (entries 3, 6, and 9) groups being 
tolerated at both para and meta positions. A single ortho-
fllnctionali7ed aryl indide was grududhas, but in a diminithed 
49% yield (entry 6). Heterocyclic 2-cl_iloro-4-icidopyridine 
produced functionalized indazole 4j in 95% yield, featuring 
(2) Selected reant examples: (o) Ackerinarn L.; Vicente. R. Org. Le:t. 
2009. 21. 4922-4925. (9) Rene. 0.; Lapointe. D.; Fagooc, K. Org LeO 
2009. 12. 45604563. (c) Condito. D A.; Lauten&N..4ezgeor Chen IrS. 
Ed 2009. 48. 6713-67:6. (4) Lapointe. C'.: Fagisu. K. Org Lett 2009, 
12, 4160-4163. (e) Stcrr, T. K.; Bouroarn, C 3.; Thatcher, R. 2., Fe 
OrneUac, S.: Whitwood A. C.; Faclomb, 1.!. S.1 Org OSen 2009. 74. 
5010-5321. (f)W Y.. Kan, 2; Wang, N.;Su,W.;Hong,!ot. Org. Le:! 
2009, 11, 5346-3249. (o) Thou. H.; Xc, '8.-H.; Churn, W.-,t.; Lob, T.-?. 
Asgew C3ee, Cot Ed. 2009,4e, 5355-5357. 1T) Kawano. T., Yoshizund, 
T., Hirano, K.; Sa:ob, T.; M:ura, M. O.'g Let! 2009, 22, 3072-3075. (1) 
Prirnao, N.; E:oc;illen, A.; Lancelot, 2.-C.; Rault, S. Tetrothedius 2009, 65, 
6340-6353. (j) Ycoldzum( T.; Sa:oI 7.; Hirano, K.; Maouo, F.; Ctita. 
A.; COcoa, J.;Miura. N. Tero2iedrcn Lett. 2009,50.3273-2276. 1k) Wang, 
2-0,.; MarcO, F:.syrthes02409, 1405-1427. (1) Schippeo, F.!.; E1SaIfi6, 
24.; Whipp, C. 2.. Fngriou, K. Trtrohedrc'r 2409, 65, 4977983. (0) 
Kobay0001, 0.: Uragacei, U.; Oarnatawa, '1. c'rg Lett 2409, 21, 2019-
2683 (r.) Wang, C.; PieL I., C4loiiva, ?.JAat Qoeeo. ,Soc 2009, 251. 4I9-
4192. (o) Liegault, B.; Laponte, F.; Cane. L.; Ylasnova, A.. Fagnou. K. 
I Org. 06cc. 2009, 74, 1826-1834.4): Scthppor, Dl.; Caropeac, L.-C.; 
Fap_ic, K. TetrOMedror. 2009, 65, 3105-5194. (q Roger, 1.; Pozgar. F.; 
Faucet, H. I Org. Chest. 2009. 74, 1179-1136. (o) Roger. 2.; D.:'ucel, H. 
Ado. ':'06 OWeS. 2009. 551, 1977-1993. (0) Rrdo igozcA.; Moi'die WI. 
SysoU.00$ 2009, 630-654. 1) KleuLo, M.. Onto!, 8.., Klspelauva, B.. H(-onb, 
Gig, Bio'eooi. Chem, 2000, 71 806-865 (u) loyoo. L. S., 3ate, K. A. 
Org Lett. 2(09, 21, 2792-2795.',v) Nan_iSo, 04.; Tanca, 50,  Sugie. A.; 
M_in6uohi, D.; Kourn_ija, 36., Nea, K., Moot, A. Cr Lett 2000. 12. 2297-
2200. (w) Crilthrnac, 8..; Ja_iquec, T. U.; Scare, D I Am G7oeso Per. 
2009. 232. 2042_2,0rt. (at) Yotpharc S.; Bergman, R. C.. E'llnoan, J. A. 
Org. Lett. 2009, 22. 1311-1514, ly)  Join E.; Yomomotc, T.; Ironic K. 
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C.: DocooS H.; SontulL, N. Ear 7 0.'g Circe 2000. 4311 1050. (no) 
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2009. 65, 7406-3491. (at) .&ckern_iann, S.; A.tharnmer, A.; Penner, S. 
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Table 1. Palladium-Catalyzed D'uce_it Arylation of 
2-Plieny1'uidai4olo 
H 	 x 	ACO5 
H20 
 Oe Q' M1S%) - 
edo,as% 	'i-ri 
YciN 	 'on.' 
entry 	product ydd 	entry pendant yidd 
C From 
'6(S CI,  
1 Art) 
'r 94 
5_i—.) 
IF,ni  
(ArHr5 
40 AnOn 4g 
Sb 
2 (Art) 	8  1,IJI'n-'',t 
(Arllrt 
I OSte 
St 7 
- 
(,,) 	1 9 _.,[ . Art) 
(ArH,( , 
41 
Cole, 
'67 
Cl 
ian. 
Xdo 
(Art) 10 — 95 Art) 
IAtBr) C:;—C) 
Ci 
90 
(Art) cc 165 
-O c:A-o 
{Art) 
(ABe) 
4P 4k 
6 (Art) .Art( 
41 
X_noy atrirtunc cf product OS  Reart.ono nun at 00 'C ' ('c000dilion.v 
.&4 0CC, (I equivl, P16th, 00 aol %), Pd(dpct)Cl,'CCN (5 aol 
iodide 11.1 equiv). 2.p9.en'!indazcle (lequrd. 'vaao, 50 'C, 16 I_i. Isolated 
yilds after 8i00 vhrorn2to4)aphy. 
the highly versatile 2-chloropyridirie functionality for further 
manipulation (entry 10). 
In practical terms the reactions were very simple to run 
and purify—a feature of on water chemistry. The catalyst 
system and substrates were premised prior to the addition 
of water, with good mixing being crucial for successful 
arylation. While. this was easily achieved for solid reactants 
(entries 2, 3. 4, and 9-10), care needed to be taken for 
reactions involving liquid aryl halide's to prevent the reagent 
from adhering to the walls of the flask and not being 
effectively ineorpnrate.d into the heterogeneous reaction 
titiNute. 
225 
206 
To fully establish the scope of the arylation we prepared 
a series of N2 substituted indazoles and subjected them to 
on water arylation (Table 2). 
Table 2. Direct Arylation of Various 2H-Substituted Indazo1est 
Pd)dppflCl2OCM 	 R3 
(5 mol %) 
PPtr3 )lO Mot %) 	 / \ 
R2_J "NR1 I---R 	 - 
	
- 	A92CO3 
H20- 16 h. 50 °C R2- 	N-R' 
2 
4 
--------------------------------------------------------------------- 
1N-SEM ~a?N-atde CIL, 
4m (82%) 	 4n (77%) 	 40 (97%) 
Cl 
o C 
O 	O 	Cl 
b 	
-C 'i-0 
4p (87%r 
C1 
4q )48%) CN 	4r (79%) 
aN 
 
Q ?O 
We 	 M e 
4s(82%) 	 45(83%) 
Liver X receptor Liver X receptor 
agonist 	 agonist 
Reaction run at 60 °C. Conditions: Ag2COa 0 equiv). PPha (10 mol 
%), Pd(dppflClDCM (5 mol %). Aryl iodide (1.1 equiv), 2.phenylindazole 
(1 equiv), water. 50 °C. 16 h. Isolated yields after SiO2 chromatography. 
The SEM protecting group proved stable to the arylation 
conditions, with the versatile 2-SEM protected indazole 4m 
being formed in high yield. Alkyl-substituted indazoles were 
good substrates, as were 2-p- and o-tolylindazoles 40 and 
4p. The 2-iodobenzylindazole starting material was prepared  
to examine the possibility of intramolecular cyclopentannu-
laticxi via direct arylation. This intramolecular reaction proved 
ineffective under the conditions—when 4-chloroi odobenz.ene 
was added in a competition experiment the intermolecular 
arylation product was isolated in moderate yield. Functional 
handles could be incorporated into the indazole ring with 
the 5-chloro- and 7-methoxyindazole compounds being 
excellent substrates. Indazoles 4s and 4t previously have been 
prepared in 5 steps as inhibitors of liver X receptor-mediated 
cardiovascular disease.9 
The combination of a silver salt and on water conditions 
was essential for successful arylation. Replacing A92CO9 
with common inorganic bases such as alkali metal carbonates 
proved completely ineffective with water as solvent. Cor-
respondingly, using acetonitrile in place of water under our 
reaction conditions gave poor yields of asylated indazoles 
(129lic. yield of 4o, with 80% of starting indazole recovered). 
Sequestration of halide from the palladium catalytic cycle 
by Ag appears pivotal to achieving arylation at 50 <C on 
water. 
In summary, we have reported the first study of intermo-
lecular direct arylation of indazoles. Using on water reaction 
conditions, a simple and efficient protocol has been devel-
oped that produces diverse C3-arylated indazoles under 
notably mild conditions. 
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